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Summary 
Herpes simplex virus type 1 (HSV -1), like other members of the Herpesviridae, 
has the ability replicate in different cell types and cause latent infection. Replication of 
the viral genome requires a multitude of reactions that require protein catalysts. 
Herpesviruses in general encode many of their own replication enzymes in the viral 
genome allowing the efficient production of progeny virus. The reason why 
herpesviruses, and many other viruses, encode enzymes that essentially duplicate the 
function of cellular enzymes is presumably to increase the efficiency of virus 
replication in host tissues. This may be especially important to the herpesviruses 
during latent infection. HSV -1, for example, must replicate in both mucosal and 
neuronal tissues. For productive infection and spread to a new host the virus must 
reactivate from resting neurons where the availability of cellular replication machinery 
is limited. 
To ensure the efficient transfer of genetic information to the next generation the 
fidelity of genome replication must be high. Many enzymes are involved in the 
replication of DNA although the number of these functions that are virally encoded 
varies dramatically between different virus families. DNA polymerase provides the 
main catalytic function for the replication of DNA and, despite its high processivity, 
retains the ability to faithfully replicate the DNA template with considerable fidelity. 
This accuracy is only possible if there is a balanced pool of the four 
deoxyribonucleotides necessary for DNA synthesis: dATP, dCTP, dGTP and dTTP. 
Disruption of the nucleotide pool can lead to increased mutation rates and DNA 
fragmentation. Transfer of intact genetic information is crucial and in order that these 
pools are maintained, many viruses encode their own version of specific nucleotide 
metabolism enzymes. 
This thesis deals with the investigation of one of these enzymes, deoxyuridine 
triphosphatase (dUTPase). This highly specific enzyme converts dUTP to dUMP thus 
reducing the available pool of uracil for DNA misincorporation. Uracil can also occur 
in DNA by the deamination of cytosine which is potentially mutagenic. To counteract 
this, a repair mechanism has evolved mediated by uracil DNA glycosylase. This 
excision repair process involves a local strand break in the DNA backbone. Excessive 
uracil incorporation induces multiple rounds of excision repair and can lead to DNA 
fragmentation. dUTPase also acts to supply dUMP for the synthesis of dTTP. 
dUTPase is ubiquitous in nature and found in both prokaryotic and eukaryotic 
organisms. Many, but not all, viruses encode their own dUTPase. This is also true of 
the herpesviruses where members of the a- and y-subfamilies encode a dUTPase 
whereas members of the r3-subfamily do not. The dUTPase of HSV-l was originally 
found to be non-essential in tissue culture. Only recently has interest in the herpesvirus 
dUTPase increased when experiments using the mouse model demonstrated that HSV-
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1 mutants which lacked dUTPase activity had over a 1000-fold reduction in 
neurovirulence, neuroinvasiveness and reactivation from latency (R. B. Pyles, N. M. 
Sawtell & R. L. Thompson, Journal of Virology 66:6706-6713, 1992). There have 
been several subsequent reports of dUTPase- mutant viruses replicating with wild type 
kinetics in tissue culture but being severely impaired during growth in vivo. These 
include dUTPase- mutants ofFIV, EIA V, CAEV and visna virus. 
Analysis of primary sequence data revealed a subset of open reading frames that 
were predicted to encode dUTPases based on five areas of local primary sequence 
conservation (Motifs 1-5) (D. J. McGeoch, Nucleic Acids Research 18:4105-4110, 
1990). This was subsequently confirmed by the characterisation of several of these 
predicted protein products. The differences in the primary sequence organisation of 
these motif regions allowed the description of two distinct dUTPase classes. The class 
I dUTPases are encoded by a diverse range of organisms and are characterised by a 
trimeric arrangement with subunit protein lengths approximating 150 amino acids. The 
class II dUTPases are specific to the herpesviruses and are characterised by a 
monomeric arrangement with a protein chain length approximately double that of their 
class I counterparts. It has been proposed that the class II dUTPases arose by the 
intragenic duplication of the class I open reading frame. 
The first structure of a dUTPase was published with the crystallisation of the 
E.coli version (E. S. Cedergren-Zeppezauer, G. Larsson, P. O. Nyman, Z. Dauter & K. 
S. Wilson, Nature 355:740-743, 1992). Subsequently structures of FIV, EIA V and the 
human dUTPase have now been published. To date there is no available structure of a 
class II dUTPase. In this thesis the class I structures were used as a basis to investigate 
the HSV -1 class II dUTPase in terms of structural and evolutionary relationships. 
To allow a defined approach to functional analysis of the HSV-l dUTPase a 
tertiary structural model was generated for the class II enzymes. Following intensive 
primary sequence analysis a method was devised from comparing class I and class II 
sequences directly. Secondary structure prediction programs were utilised to judge the 
basic structural similarities between the two classes allowing the proposition of several 
defined hypotheses. The available class I structural information was utilised in order to 
characterise highly conserved structural elements within the class I group. It was then 
possible to relate this data set to class I primary sequences and subsequently to the 
generation of a class II model. Various modelling techniques were used based on the 
constraints on the structural organisation that could achieve a functionally active 
monomer plus the set of hypotheses defined in the earlier work. 
Mutagenic analysis of the HSV -1 dUTPase was then possible using the class II 
model as a reference. Several targets were investigated based on predicted functionally 
important regions. Analysis of these mutant enzymes was performed using purified 
recombinant HSV-l dUTPase expressed from the T7 E.coli expression system. The 
results are discussed with regard to the evolution of structure and function in the class 
II enzymes. 
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Non-Standard Abbreviations 
A 
APS 
ATP 
B.subtilis 
BSA 
bp 
C 
cpm 
dAMP 
dATP 
dCMP 
dCTP 
dGMP 
dGTP 
dTMP 
ddATP 
ddCTP 
ddGTP 
ddTTP 
dTTP 
dUMP 
dUTP 
dUTPase 
DNA 
DNase 
DMSO 
ds 
DTT 
E.coli 
EDTA 
EGTA 
EtBr 
FPLC 
G 
HEPES 
IPTG 
adenine 
ammonium persulphate 
adenosine 5'-triphosphate 
Bacillus subtilis 
bovine serum albumin 
base pair 
cytosine or carboxy terminal end of protein 
counts per minute 
2'-deoxyadenosine 5'-monophosphate 
2'-deoxyadenosine 5'-triphosphate 
2'-deoxycytidine 5'-monophosphate 
2'-deoxycytidine 5'-triphosphate 
2'-deoxyguanosine 5'-monophosphate 
2'-deoxyguanosine 5'-triphosphate 
2'-deoxythymidine 5'-monophosphate 
2',3' -dideoxyadenosine 5'-triphosphate 
2',3'-dideoxycytidine 5'-triphosphate 
2',3'-dideoxyguanosine 5'-triphosphate 
2',3'-dideoxythymidine 5'-triphosphate 
2'-deoxythymidine 5'-triphosphate 
2'-deoxyuridine 5'-monophosphate 
2'-deoxyuridine 5'-triphosphate 
deoxyuridine triphosphatase 
deoxyribonucleic acid 
deoxyribonuclease 
dimethylsulphoxide 
double stranded 
dithiothreitol 
Escherichia coli 
ethylenediamine tetra-acetic acid 
ethylene glycol-bisCj3-aminoethyl ether)N,N,N',N'-tetraacetic acid 
ethidium bromide 
fast protein liquid chromatography 
guanme 
N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid 
isopropyl thiogalactoside 
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Kb 
Kbp 
KDa 
MAb 
MCR 
Mr 
MW 
N 
OD 
ORF 
PBS 
PCR 
PEG 
pfu 
PMSF 
RNase A 
rpm 
RNA 
RT 
S.cerevisiae 
SDS 
ss 
T 
Taq 
TEMED 
TK 
TLC 
Tris 
ts 
/-1 
UV 
wt 
kilobase( s) 
kilobase pair( s) 
kilodalton 
monoclonal antibody 
multiple cloning region 
relative molecular mass 
molecular weight 
unspecified nucleotide; amino terminal end of protein; asparagine 
optical density 
open reading frame 
phosphate butTered saline 
polymerase chain reaction 
polyethylene glycol 
plaque forming units 
phenylmethylsulphonyl fluoride 
ribonuclease A 
revolutions per minute 
ribonucleic acid 
room temperature 
Saccharomyces cerevisiae 
sodium dodecyl sulphate 
single stranded 
thymine 
Thermus aquaticus DNA polymerase 
N,N,N,N tetramethyl ethylenediamine 
thymidine kinase 
thin layer chromatography 
tris(hydroxymethyl )aminomethane 
temperature-sensitive 
mIcro 
ultra-violet radiation 
wild type 
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Table of Amino Acids 
Amino acid Three letter code Single letter code 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine GIn Q 
Glycine Gly G 
Histidine His H 
Isoleucine He I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
Mutation Abbreviations 
Each mutant dUTPase enzyme that was constructed was given a specific code. 
The first number indicates the motif involved (see section 1.4.8). The next 
letter/number/letter combination indicates the amino acid single letter code (above) and 
position of the wt residue followed by the single letter code of the mutant residue. 
For example, mutant enzyme 3Y100A has the tyrosine residue, at position 100 
in the motif 3 region, mutated to an alanine. An 'N' replacing the first number 
indicates a non-motif mutation. For example, NC76A has the cysteine mutated to an 
alanine at a locus outside the motif regions. 
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Virus Abbreviations 
BHV-I 
BHV-2 
BHV-4 
CAEV 
CCV 
EBV 
EHV-I 
EHV-2 
EHV-4 
EIAV 
FIV 
GCMV 
HCMV 
HHV-6 
HHV-7 
HIV 
HSV-I 
HSV-2 
HVS 
lAP-HI 8 
KSHV 
MCMV 
MDV 
MHV-68 
MMTV 
MPMV 
PRY 
SHV-2 
SRV-I 
VZV 
bovine herpesvirus I 
bovine herpesvirus 2 
bovine herpesvirus 4 
caprine arthritis-encephalitis virus 
channel catfish virus 
Epstein-Barr virus 
equine herpesvirus I 
equine herpesvirus 2 
equine herpesvirus 4 
equine infectious anaemia virus 
feline immunodeficiency virus 
guinea pig cytomegalovirus 
human cytomegalovirus 
human herpesvirus 6 
human herpesvirus 7 
human immunodeficiency virus 
herpes simplex virus type 1 
herpes simplex virus type 2 
herpesvirus saimiri 
hamster intracisternal A particle 
Kaposi's sarcoma associated herpesvirus 
(also referred to as human herpesvirus 8) 
murine cytomegalovirus 
Marek's disease virus 
murine herpesvirus 68 
mouse mammary tumour virus 
Mason-Pfizer monkey virus 
pseudorabies virus 
salmonid herpesvirus 2 
simian type D retrovirus 
varicella-zoster virus 
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Chapter 1 - Introduction 
1.1 Overview 
The research presented in this thesis concerns the herpes simplex virus type 1 
(HSV-1) enzyme deoxyuridine triphosphatase (dUTPase). The introduction is designed 
to give an overview of the herpesviruses and summarise the current state of knowledge 
on dUTPases. The first chapters deal with background information on the more 
general aspects of the Herpesviridae including classification, role in human 
pathogenicity and replication. Further chapters are concerned specifically with the 
function of the dUTPase enzyme in a wide variety of organisms and in relation to 
potential antiviral targets and cancer therapy. The Escherichia coli enzyme, which 
forms the basis for the molecular modelling of the HSV-1 dUTPase, is dealt with in a 
separate chapter. The introduction concludes with details of the HSV-1 dUTPase and 
provides the starting point for the work presented in this thesis. 
1.2 The Biology of the herpesviruses 
1.2.1 Characteristics and classification of the Herpesviridae 
The Herpesviridae is a large family with almost 100 members characterised to 
date. Herpesviruses infect a wide range of higher eukaryotic hosts and most animal 
species studied have yielded at least one member. The family is defined by the 
architecture of the virion which is composed of four morphologically distinct 
components termed the core, capsid, tegument and envelope (reviewed by Rixon, 
1993). The virion core contains the virus genome ranging in size from 125 to 230kb 
and present as linear double-stranded DNA (Epstein, 1962). Initial studies based on 
electron microscopy described the DNA arrangement as a toroid structure around a 
central protein (Furlong et al., 1972; Nazarian, 1974). Later studies indicate that the 
viral DNA is in a liquid crystalline form within the capsid (Booy et al., 1991). The 
capsid is icosahedral in shape, approximately 100nm in diameter and consists of 162 
capsomeres (Wildy et al., 1960). The tegument is an amorphous proteinaceous region 
that surrounds the capsid and is in turn surrounded by the envelope (Roizman & 
Furlong, 1974). The envelope consists of a lipid bilayer derived from the host cell 
membranes and exhibits glycoprotein spikes on the surface (Spear & Roizman, 1972). 
Historically the herpesviruses have been classified according to their biological 
properties and divided into three subfamilies, designated the a-herpesvirinae, 13-
herpesvirinae and y-herpesvirinae (Roizman et al., 1992). With few exceptions, this 
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classification corresponds with the genetic relationships determined by comparisons of 
amino acid sequences and gene organisation (McGeoch, 1989). Genomic analysis also 
provides a basis for assigning potential functions to homologous genes in related 
subfamilies (McGeoch & Davison, 1986~ McGeoch et at., 1993). There are now 14 
complete herpesvirus sequences available (Table 1.1) which has allowed the 
determination of evolutionary relationships. 
Virus Size (bps) Reference 
Epstein-Barr virus 172282 (Baer et a/., 1984) 
Varicella-zoster virus 124884 (Davison & Scott, 1986) 
Herpes simplex virus 1 152261 (McGeoch et a/., 1988a) 
Human cytomegalovirus 229354 (Chee et aI., 1990) 
Equine herpesvirus 1 150223 (Telford et aI., 1992) 
Channel catfish virus 134226 (Davison, 1992) 
Herpesvirus saimiri 112921 (Albrecht et aI., 1992) 
Equine herpesvirus 2 184427 (Telford et aI., 1995) 
Human herpesvirus 6 159321 (Gompels et aI., 1995) 
Human herpesvirus 7 144861 (Nicholas, 1996) 
Human herpesvirus 8 140500 (Russo et aI., 1996) 
Murine cytomegalovirus 230278 (Rawlinson et aI., 1996) 
Murine herpesvirus 68 118237 (Virgin et aI., 1997) 
H~!]~~s simplex virus 2 154746 (Dolan et aI., 1998) 
Table 1.1 Fully sequenced genomes of the herpesviruses. 
The above table shows the herpesviruses that have been sequence with the respective genome size and 
author reference. 
These sequenced genomes vary widely in a number of aspects including length 
(Table 1.1), gene content and overall arrangement which are discussed in Section 1.2.4. 
However, there is a subset of approximately 40 genes which are conserved between all 
the a-, ~- and y-herpesviruses implying a common ancestry (Davison & Taylor, 1987~ 
McGeoch, 1989). In general, classification using genome analysis is in agreement with 
previous studies employing biological properties, although there are exceptions. EHV-
2 and EHV -5 were originally classified as ~-herpesviruses (Plummer et ai., 1969), 
however analysis of fragments from their genomes demonstrated their correct 
classification as distinct y-herpesviruses (Telford et ai., 1993). Genomic analysis of 
MDV showed that it was more closely related to the a-herpesviruses rather than the y_ 
herpesviruses with which it was originally classified (Buckmaster et ai., 1988). 
Similarly, HHV-6, originally classified as a y-herpesvirus on the basis of its biological 
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properties, has since been shown to be more related to the (3-herpesviruses, in particular 
to HCMV (Gompels et al., 1995; Lawrence et ai., 1990). 
The sequencing of channel catfish virus (CCV) has yielded information on a 
herpesvirus from a lower vertebrate species. It was initially defined as a herpesvirus 
based on the morphological characteristics of its virion and as a member of the (X-
herpesvirinae based on its biological properties (Roizman, 1982). Analysis has shown 
that it does not possess the subset of genes that is common to the other herpesviruses. 
It has been suggested, based on this lack of similarity, that CCV may have evolved 
independently from the mammalian herpesviruses (Davison, 1992). Sequence data 
from salmon herpesvirus 2 (SaIHV-2) support a relationship with CCV and it is likely 
that both fish viruses may have to be assigned to a separate subfamily (Bernard & 
Mercier,1993). Recent investigation of the genome ofsalmonid herpesvirus 1 (SaIHV-
1) has shown that this virus also shares homology with CCV at the amino acid primary 
sequence level and is again unrelated to the mammalian herpesviruses supporting the 
classification of fish herpesviruses as a distinct subfamily (Davison, 1998). 
The wealth of sequence information from complete and partially sequenced 
members of the Herpesviridae has allowed phylogenetic analysis. It has been found 
that certain genes are highly conserved between evolutionary closely related members 
(McGeoch, 1990a). Gene sets within each subfamily, although closely related to each 
other, are substantially divergent from the other subfamilies. Using various gene sets 
as markers for evolutionary relatedness, it has been possible to construct phylogenetic 
trees and infer evolutionary timescales. This analysis closely groups the herpesviruses 
into the three recognised subfamilies (x, (3, and y. These three subfamilies are clearly 
defined even when using diverse gene sets such as those from the viral DNA 
polymerase, DNA helicase and glycoprotein gB. In actual fact, these studies have 
allowed substantial resolution of evolutionary relatedness beyond the three subfamily 
categories (Figure 1.1). Sub lineages within each subfamily reveal how individual 
members are related to one another with far greater resolution than the biological 
classification system alone. 
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Figure 1.1 Phylogenetic distance trees from various gene sets_ 
Trees were derived from aligned amino acid sequence comparisons using the neighbour-joining distance 
method_ (A) Tree derived from the DNA helicase gene set (UL5). (B) Tree derived from the DNA 
polymerase gene set (UL30). (C) Tree derived from a combined group of 10 members with 8 gene sets. 
The approximate root position is indicated by an arrow (see text below). Adapted from (McGeoch et ai., 
1995). 
Studies on the molecular phylogeny of the a-herpesviruses revealed that the 
branching pattern of their phylogenetic tree could be efficiently transposed onto their 
corresponding host tree (McGeoch & Cook, 1994). This strongly indicates that these 
viruses co-speciated with their host organisms. This finding makes it possible to 
calculate an evolutionary timescale for all the herpesviruses using the palaeontological 
data available from their hosts. The radiation of the three subfamilies has been 
suggested to occur approximately 180-200 million years ago with the major 
sublineages being generated about 60-80 million years ago (McGeoch et aI., 1995). 
These figures are based on the assumption that all members in the group have 
experienced a constant molecular clock and that there are no strong biasing effects 
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from base composition variations. The approximate root position is shown as an arrow 
on Figure 1.1(C). From this root position it can been seen that the initial radiation 
occurred between the a-herpesvirus and the precursor of the J3 and y subfamilies. 
Each of the three defined subfamily groupings exhibits characteristic biological 
properties. The members of the subfamily a-herpesviruses are characterised by 
variable host range, relatively short reproductive cycle (usually less than 24 hours), 
rapid spread and cytolytic infection of cells in culture. Latent infection is frequently 
established in sensory ganglia. Members of this subfamily include herpes simplex 
virus 1 (HSV-I), herpes simplex virus 2 (HSV-2), varicella-zoster virus (VZV), 
pseudorabies virus (PRV) and equine herpesviruses I and 4 (EHV-I and -4). 
In general the J3-herpesviruses have a restricted host range with slow viral 
replication and lytic progression. The infected cells frequently become enlarged. 
Latent infections are usually established in secretory glands, lymphoreticular cells and 
the kidneys. Members of this subfamily include human cytomegalovirus (HCMV), 
murine cytomegalovirus (MCMV), human herpesvirus 6 (HHV-6) and human 
herpesvirus 7 (HHV -7). 
The y-herpesviruses also have a restricted host range and cannot infect 
experimental animals outside the family or order of their natural host. Replication 
occurs typically in T or B lymphocytes and latent infection is frequently established in 
lymphoid tissue. Members of this subfamily include Epstein-Barr virus (EBV), 
herpesvirus saimiri (HVS), equine herpesvirus 2 (EHV-2) and murine herpesvirus 68 
(MHV-68). 
1.2.2 Pathogenicity of the human herpesviruses 
Herpesviruses cause a range of clinical disorders in humans and are 
characterised by the establishment of latent infection. The virus is generally spread by 
direct contact between infected individuals and uninfected individuals, particularly at 
mucosal tissues. Herpesvirus infection has received a higher profile in recent times due 
to increased numbers of immunocompromised individuals. This is mainly through 
drug therapy, as in transplant patients, or as a result of AIDS. 
HSV-I is the most studied herpesvirus and is widespread with over 90% of 
western population seropositive by the age of sixty (Nahmias et ai., 1970). Infection of 
epithelial tissue generally causes vesicular lesions at mucosal membranes around the 
mouth, lips and nose. The distinction between the two serotypes HSV-l and HSV-2 
was historically on the basis that HSV -1 was responsible for the common 'cold-sore' 
and HSV-2 for genital lesions. However, it is noted that up to 50% of genital infections 
can be caused by HSV-l (Kinghorn, 1993) and inversely up to 20% of oral infections 
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by HSV-2, therefore this distinction is no longer clear cut (Wiedbrauk: & Johnston, 
1993). 
In general, HSV-l establishes latency in the trigeminal ganglia and HSV-2 in 
the sacral ganglia. Both serotypes can periodically reactivate causing recurrent lytic 
infection and leading to lesions at peripheral sites (reviewed by Nash & Lohr, 1992). 
Herpes simplex viruses can also cause conjunctivitis, herpetic whitlow and ocular 
keratitis, particularly in immunocompromised individuals. Clinically, the most severe 
situation is infection of the central nervous system (CNS) causing acute necrotising 
encephalitis (Corey & Spear, 1986). Neonatal infection also has a high mortality rate 
and is usually due to a primary HSV -2 infection in the mother where no maternal 
antibody is present for protection (Sullivan-Bolyai et at., 1983). 
VZV is the causative agent of chickenpox (varicella), a disease resulting from 
primary infection, generally in children. Following infection, the virus spreads through 
viraemia and ascends to the dorsal root ganglia of sensory nerves supplying the affected 
skin. Symptoms are in the form of a rash 14-15 days after infection and are often 
accompanied by fever. Reactivation of latent virus from neural ganglia in later life 
results in a localised vesicular condition known as shingles (herpes zoster). This 
condition is often accompanied by severe pain which can persist for months after the 
lesions have healed (Gelb, 1990). In contrast to HSV, VZV reactivation either does not 
occur in most individuals or is limited to a single recurrence of infection (Straus, 1989). 
HCMV affects the majority of the population asymptomatically although in 
certain cases HCMV infection results in the development of a mononucleosis 
syndrome. Primary infection is characterised by cytomegaly (the enlargement and 
fusion of macro phages). In immunocompromised individuals HCMV can cause a wide 
range of diseases in many organs including the lungs, gastrointestinal tract and CNS 
(Britt & Alford, 1993~ Gallant et at., 1992). HCMV respiratory infection in AIDS 
patients can lead to potentially fatal pneumonia (Meyers et aI., 1986). Retinitis is the 
most common HCMV disease of the nervous system and affects up to 20-25% of long-
lived AIDS patients. HCMV is also associated with neurological damage in neonates 
(Alford et at., 1990). 
EBV is usually acquired during childhood when it is generally asymptomatic, 
however primary infection in later life results in infectious mononucleosis, commonly 
known as glandular fever (Niederman et aI., 1968). EBV has a strong association with 
a variety of malignant diseases. Nasopharyngeal carcinoma (NPC) was first linked to 
EBV on the basis of epidemiological studies showing elevated levels of antiviral 
antibody titres in NPC patients (Old et at., 1966~ Mansoor et aI., 1997). There is also 
an association with Hodgkin's disease after the key finding that monoclonal viral 
genomes could be detected in tumour biopsies and that EBV DNA was localised to 
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malignant cells (Anagnostopoulos et al., 1989; Weiss et al., 1987). Burkitt's lymphoma 
has also been linked to EBV infection (Gunven et al., 1970; Khanna et al., 1997; 
Magrath et al., 1992). EBV is associated with various T cell and B cell lymphomas 
(Jones et al., 1988; Su et al., 1991). In AIDS patients, EBV infection can cause oral 
hairy leukoplakia (Greenspan et al., 1985). 
HHV -6 is known to affect up to 90% of the population although comparatively 
little is know about the virus. Primary infection generally occurs in infants and can be 
asymptomatic or cause the skin rash roseola (exanthem subitum) (Yamanishi et al., 
1990). The significance of HHV-6 as a pathogen is unclear but its tropism for CD4+ 
lymphocytes has led to speculation that it may have an adjunct role in AIDS (Takahashi 
et al., 1989; Levy et al., 1990). 
HHV-7 was isolated from peripheral blood lymphocytes (Frenkel et aI., 1990) 
and has been associated with roseola in infants (Ablashi et al., 1995). llliV-7 shows 
limited hybridisation with probes derived from llliV -6 but has significant antigenic 
dissimilarity to allow seroepidemiological discrimination between the two viruses 
(Wyatt et al., 1991). 
An eighth human herpesvirus, related to HVS and now classified as a y-
herpesvirus, has been associated with the neoplasm, Kaposi's sarcoma (Chang et al., 
1994; Chang & Moore, 1996; Moore et al., 1996). The virus has been given the trivial 
descriptive name KS-associated herpesvirus (KSHV) but is likely to be given the 
formal classification of human herpesvirus 8. 
1.2.3 Herpesvirus replication 
The lytic replication cycle of HSV -1 can be divided into attachment of the virus 
particle, entry into the host cell, DNA replication, and virion production. Initial events 
involve the attachment of the virus to the cell and fusion of the viral envelope to the 
plasma membrane. There have been ten surface glycoproteins identified in HSV-I, 
five of which are dispensable in cell culture. It is likely that HSV -1 can utilise more 
than one attachment pathway and there appears to be more than one viral protein-cell 
interaction. Studies have been complicated by the fact that in vivo HSV-I infects two 
very different cell types, epithelial and neuronal. Unlike the continuous cell lines used 
for many of the attachment studies, both of these cell types are polarised in vivo, 
sorting membrane and secreted proteins to different surfaces (Dotti & Simons, 1990; 
Rodriguez-Boulan & Pendergast, 1980). 
Heparan sulphate has been identified as a major component of HSV-l cell 
surface binding although even on removal of the molecule from cells there is still some 
infectivity (Shieh et al., 1992; Shieh & Spear, 1994). It is likely that heparan sulphate 
is one of a number of receptors or acts as a cofactor in glycoprotein binding. Following 
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attachment, entry into the cell is probably mediated by fusion of the viral envelope and 
the plasma membrane. Data from analysis of mutated viruses suggest that this process 
requires participation of several gene products (Brandimarti et al., 1994). Infection 
results in an immediate drop in host DNA and protein synthesis (Read & Frenkel, 1983; 
Roizman & Roane, 1964). Following entry, viral capsids are transported to the nuclear 
pore where viral DNA is released into the nucleus (Batterson et al., 1983). This 
process is thought to be mediated by the cellular cytoskeleton (Kristensson et a/., 
1986). 
HSV gene expression occurs in a coordinately regulated cascade with genes 
classified as immediate-early (IE), early (E) and late (L) (Clements et a/., 1977) or a, f3 
and y (Honess & Roizman, 1975). Genes are transcribed in the nucleus by the cellular 
RNA polymerase II with the participation of viral factors (Ben-Zeev & Becker, 1977; 
Costanzo et a/., 1977). The mRNAs that are produced are capped at the 5'-terminus, 
polyadenylated at the 3'-terminus and internally methylated (Bachenheimer & 
Roizman, 1972; Moss et al., 1977; Silverstein et a/., 1973). Translation occurs on both 
free and bound polyribosomes producing the viral proteins. Modifications to these 
proteins can then occur such as cleavage, poly(ADP) ribosylation, phosphorylation, 
sulphation and glycosylation (reviewed by Roizman & Sears, 1990). 
The HSV-l tegument protein, Vmw65, is necessary for the transactivation of 
the five IE genes (Campbell et al., 1984). In a cascade mechanism, at least three of 
these IE gene products are required for expression of E and L genes. The synthesis of 
the IE proteins reaches a peak at approximately 2 to 4 hours post infection although 
they continue to be produced at non-uniform rates until late on in infection 
(Ackermann et a/., 1984). The E polypeptides reach peak synthesis at about 5 to 7 
hours post infection and include most of the enzymes involved in nucleotide 
metabolism (Honess & Roizman, 1975). Viral DNA synthesis begins shortly after the 
E genes are expressed. The L genes have been further classified into leaky-late (Yl) and 
true-late (Y2) (Holland et a/., 1980). The Yl genes are expressed at a low level before 
the onset of viral DNA replication, reaching maximal levels after replication. The Y2 
genes are expressed exclusively after the onset of DNA replication. The process of 
DNA replication is discussed further in Section 1.3.1. 
The L genes code primarily for the structural proteins of the virion including the 
capsid. Much of the understanding of capsid assembly comes from the analysis of the 
three distinct capsid forms found in HSV-l infected cells (Gibson & Roizman, 1972). 
Current classification defines the capsid types as A, empty, B, intermediate, containing 
a proteinaceous scaffolding and C, containing DNA. B capsids are known to be the 
progenitors of A and C capsids. It is likely that A capsids are formed as the result of 
abortive packaging of DNA. Capsids, which are made from seven viral proteins, are 
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assembled in the infected cell nucleus (reviewed by Rixon, 1993). The replicated 
concatemeric DNA is cleaved at the 'a' sequence (Section 1.2.4) into genome length 
molecules which are then packaged into the pre-formed capsids. Studies with L gene 
mutant viruses indicate that the processes of cleavage and packaging are tightly 
coupled (reviewed by Roizman & Sears, 1990). 
The final events leading to the maturation and release of the virion are not well 
characterised. Two pathways relating to the formation of the tegument and envelope 
have been proposed (reviewed by Rixon, 1993). The capsids may bud through the 
inner nuclear membrane, fuse with the outer nuclear membrane and then enter the 
cytoplasm. This would allow the tegument to be assembled in the cytoplasm and the 
mature virion would be produced by budding through the plasma membrane. An 
alternative model has been described where the tegument is formed in the nucleus. 
This would require the capsid to bud through the inner nuclear membrane and enter the 
cytoplasm in a vacuole formed by the outer nuclear membrane. Fusion of the vacuole 
and plasma membrane would allow virion egress. Although the sites of tegumentation 
and envelopment have not been defined it is seems likely that the virion passes through 
Golgi derived cytoplasmic vesicles on the journey from the nucleus, through the 
cytoplasm and finally to the plasma membrane. 
1.2.4 Structure and content of herpesvirus genomes 
The herpesvirus genomes are diverse in a number of aspects. They vary in 
length (from about 125 to 240kbp), number of genes (from around 70 to 200) and base 
composition (from 31 to 75% G+C). The herpesvirus genomes also exhibit variation in 
the pattern of unique and repeated sequence elements. Figure 1.2 shows a 
diagrammatic representation of the human herpesvirus genome arrangements as 
described by McGeoch (1989). 
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Figure 1.2 Structure of the genomes of the human herpesviruses (not to scale). 
Unique regions are shown as horizontal lines and repeat regions as rectangles. The orientation of each 
repeat is shown by an arrow. The following abbreviations have been used: LTR (left terminal repeat), 
RTR (right terminal repeat), MIR (major internal repeat), DL (direct repeat left), DR (direct repeat right), 
T~ (terminal repeat long), UL (unique long), IRL (internal repeat long), IRs (internal repeat short), Us 
(unique short) and TRs (terminal repeat short). The orientations of the 4 possible isomers of the group 
(d) genome are represented below as long arrows. The four isomers are labelled P (prototype), IL 
(inversion of L), Is (inversion of S) and ILS (inversion of both L and S). Diagram was adapted from 
McGeoch (1989). 
The group (a) genome arrangement is the simplest consisting of a unique 
sequence flanked by large direct repeats. This type of genome structure has been 
described for HHV-6 and also for the non-human herpesviruses, CCV, EHV-2 and 
MCMV. The group (b) arrangement is characteristic of the VZV genome and consists 
of two unique regions with the UL region flanked by inverted repeats. VZV has four 
sequence-orientation isomers (not shown), two of which are 20-fold more abundant 
than the other two (Davison, 1984). Other a-herpesvirus such as PRY and EHV-l also 
have this arrangement. In these examples the two orientations of the Us region are 
present in equimolar amounts but the UL region is found completely (EHV -1) or 
predominately (VZV, PRY) in a single orientation. The group (c) arrangement 
represents the structure of the EBV genome where the DNA termini are formed by 
several direct repeats (TR). The genome also carries a set of major internal repeat 
elements (MIR) which vary in copy number. There are two other internal repeats, Dr-
and~, which are almost identical and lie in the same orientation. 
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The group (d) arrangement represents the genome structure ofHSV-l and HSV-
2 and is also found in BHV-2 and HCMV. Two unique sequences, UL and Us are 
flanked by pairs of oppositely orientated repeat elements (TRL and IRd and (IRs and 
TRs). The RL repeats and the Rs repeats are distinct apart from a short (400bp) direct 
repeat element at the genome termini named the 'a' sequence. In HSV-l this 'a' 
sequence is also found between the junction of the Land S segments in the opposite 
orientation to the genome termini copies (Wadsworth et ai., 1975; Wagner & Summers, 
1978). The recombination between the inverted repeats results in the formation of four 
sequence-orientation isomers. Each isomer is generated by inversion of the L and S 
components and are found in equimolar quantities in DNA preparations ofHSV-1. The 
direction of the unique sequences for each isomer is shown in the diagram. 
HSV -1 is the best studied of the herpesviruses and is the main focus of analysis 
in this thesis. The complete sequence of the HSV-l strain 17syn+ has been determined 
and the total size is 152261bp with a G+C content of68% (McGeoch, 1997; McGeoch 
et ai., 1988a). The total sequence length varies due to small reiterations and the 
presence of a variable copy number of the 'a' sequence. So far approximately two-
thirds of the ORFs have had functions assigned to their products (Table 1.2 and Figure 
1.3). 
The diagram in Figure 1.3 representing the HSV -1 genome was complied by 
McGeoch et al. (1988a). Since that time additional ORFs have been reported including 
UL26.5, UL49A, RLI and US8A. UL26.5 encodes an internal capsid protein required 
for the formation of the capsid shell around the scaffold (Liu & Roizman, 1991; 
Kennard et al., 1995). UL49A (also referred to as UL49.5) encodes an envelope 
protein (Barker & Roizman, 1992; Barnett et ai., 1992) and RLI encodes the 
neurovirulence factor, ICP34.5, first discovered in HSV-l strain F (Chou & Roizman, 
1986; 1990) then confirmed in strain 17 (Dolan et aI., 1992; McKie et aI., 1994). 
US8A lies between US8 and US9 and appears to be a y gene which is found in the 
nucleoli of HSV-l infected cells (Georgopoulou et aI., 1995). The position of these 
genes is given in Table 1.2. 
There have been further potential ORFs reported including ORF-P, UL8.5, 
UL9.5 and UL43.5 although these are much less validated. ORF-P lies antisense to 
gene RL I and although there have been experiments with over-producing virus 
mutants, the function is not clear (Lagunoff & Roizman, 1995; Lagunoff et ai., 1996). 
UL8.5 and UL9.5 ORFs were reported during a mapping study of HSV-l although no 
function has been attributed to either of the potential genes (Baradaran et aI., 1994). 
UL43.5 has been reported lying antisense to gene UL43 and encoding a protein 
dispensable in cell culture which colocalises with capsid proteins (Ward et aI., 1996). 
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Figure 1.3 The layout of genes in the genome of HSV -1. 
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The HSV-l genome is shown on four successive lines. Unique regions are represented by solid lines and 
major repeat elements as open boxes. The lower scale represents kilobases, numbered from the left 
terminus, and the upper scale represents fractional map units. The sizes and orientations of the proposed 
ORFs are shown by arrows. Overlaps of adjacent, similarly orientated ORFs are not shown explicitly. 
Locations of proposed transcriptional polyadenylation sites are indicated as short vertical bars. Locations 
of origins of DNA replication are shown as X. In the UL region, on the first three lines, genes UL 1 to 
UL56 are labelled. In the US region, on the bottom line, genes US} to US12 are labelled. The locations 
of introns in the coding regions of gene UL 15 and the two copies (TRL and IRd of the IE 11 0 gene are 
indicated. Copied from McGeoch et aJ. (1988a). 
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Table 1.2 
Gene Start Stop Codons Mr Status Function of Protein 
RLI 513 1256 248 26194 NE Neurovirulence factor (ICP34.5) 
RL2 775 78452 NE IE protein; modulator of cell state and gene 
expression 
exon 1 2261 2317 19 (lCPO, VmwllO) 
exon2 3083 3749 222 
exon 3 3886 5486 534 
LATC NE Latency-associated transcript; probably not 
protein-coding 
(UL starts at 9213) 
ULl 9337 10008 224 24932 E Glycoprotein L;complexes with glycoprotein H 
(UL22) 
UL2 9884 10885 334 36326 NE Uracil-DNA glycosylase 
UL3 10957 11661 235 25607 NE Function unknown 
UL4C 12422 11826 199 21516 NE Function unknown 
UL5C 15131 12486 882 98710 E Component of DNA helicase-primase complex; 
possesses helicase motifs 
UL6 15130 17157 676 74087 E Minor capsid protein 
UL7 17135 18022 296 33057 E? Function unknown 
ULSC 20476 18227 750 79921 E Component of DNA helicase-primase complex 
UL9C 23259 20707 851 94246 E Ori-binding protein essential for DNA replication 
ULlO 23204 24622 473 51389 NE Virion surface glycoprotein M 
ULll C 25091 24804 96 10486 NE Myristylated tegument protein; role in virion 
envelopment 
UL12 C 26887 25010 626 67503 (E) Deoxyribonuclease; role in maturation/packaging 
of DNA 
UL13 C 28502 26949 518 57193 NE Tegument protein; protein kinase 
UL14 C 28915 28259 219 23454 E Function unknown 
UL15 735 80918 E Role in DNA packaging; putative terminase 
component 
exon 1 29020 30048 343 
exon2 33635 34810 392 
ULl6 C 31295 30177 373 40440 NE Function unknown 
ULl7 C 33497 31389 703 74577 E Function unknown 
ULl8 C 36051 35098 318 34268 E Capsid protein (VP23); component of 
intercapsomeric triplex 
UL19 C 40528 36407 1374 149075 E Major capsid protein (VP5); forms hexons and 
pentons 
UL20 C 41488 40823 222 24229 EINE Integral membrane protein; role in egress of 
nascent virions; host range phenotype; syn locus 
UL21 42074 43678 535 57638 NE Tegument protein 
UL22 C 46382 43869 838 90361 E Virion surface glycoprotein H; complexes with 
glycoprotein L (UL 1); role in cell entry 
UL23 C 47802 46675 376 40918 NE Thymidine kinase 
UL24 47737 48543 269 29474 NE Function unknown; syn locus 
UL25 48813 50552 580 62664 E Capsid-associated tegument protein 
UL26 50809 52713 635 62466 E Protease, acts in virion maturation; N-terminal 
portion is capsid protein (VP24) 
UL26.5 51727 52713 329 33758 (E) Internal protein of immature capsids (VP22a); 
processed by UL26 protease 
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Table 1.2 continued. 
Gene Start Stop Codons Mr Status Function of Protein 
UL27 C 55794 53083 904 100287 E Virion surface glycoprotein B; role in cell entry; 
syn locus 
UL28 C 58159 55805 785 85573 E Role in DNA packaging 
UL29 C 62053 58466 1196 128342 E Single-stranded DNA-binding protein (ICP8) 
(Centre of oriL is at 62475/62476) 
ULJO 62807 66511 1235 136413 E Catalytic subunit of replicative DNA polymerase; 
complexes with UL42 protein 
UL31 C 67379 66462 306 33951 E Function unknown 
UL32 C 69162 67375 596 63946 E? Function unknown 
ULJ3 69161 69550 130 14436 E Role in DNA packaging 
ULJ4 69633 70457 275 29788 E? Membrane-associated phosphoprotein; substrate 
for US3 protein kinase 
ULJ5 70566 70901 112 12095 E? Capsid protein (VP26); located on tips ofhexons 
ULJ6 C 80543 71052 3164 335841 E Very large tegument protein 
ULJ7 C 84084 80716 1123 120549 E? Tegument protein 
ULJ8 84531 85925 465 50260 E Capsid protein (VPI9C); component of 
intercapsomeric triplex 
ULJ9 86444 89854 1137 124043 EINE Ribonucleotide reductase large subunit (ICP6, 
Vmw136, Rl) 
UL40 89926 90945 340 38017 E/NE Ribonucleotide reductase small subunit (Vmw38, 
R2) 
UL41 C 92637 91171 489 54914 NE Tegument protein; host shut-off factor 
UIA2 93113 94576 488 51156 E Subunit of replicative DNA polymerase; increases 
processivity; complexes with UL30 protein 
UL43 94748 96049 434 44905 NE Function unknown; probable integral membrane 
protein 
UL44 96311 97843 511 54995 NE Virion surface glycoprotein C; role in cell entry 
UL45 98032 98547 172 18178 NE Tegument/envelope protein 
UL46 C 100952 98799 718 78239 NE Tegument protein; modulates IE gene 
transactivation by UL48 protein 
UL47 C 103116 101038 693 73812 NE Tegument protein; modulates IE gene 
transactivation by UL48 protein 
UL48 C 105079 103610 490 54342 E Tegument protein; transactivates IE genes (VPI6, 
Vmw65, a-TIF) 
UL49 C 106391 105489 301 32252 NE? Tegument protein 
UL49A C 106993 106721 91 9201 NE? Envelope protein disulphide-linked to tegument 
UL50 107010 108122 371 39125 NE Deoxyuridine triphosphatase 
UL51 C 109011 108280 244 25468 (E) Function unknown 
UL52 109048 112221 1058 114416 E Component of DNA helicase-primase complex 
UL53 112179 113192 338 37570 (E) Glycoprotein K 
UL54 113734 115269 512 55249 E IE protein; post-translational regulator of gene 
expression (lCP27, Vmw63) 
UL55 115496 116053 186 20491 NE Function unknown 
UL56 C 116925 116224 234 25319 NE Function unknown 
(IRL starts at 117160) 
LAT NE Latency-associated transcript; probably not 
protein-coding 
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Table 1.2 continued. 
Gene Start Stop 
RL2 
Codons Mr Status Function of Protein 
775 78452 NE IE protein; modulator of cell state and gene 
expression (ICPO, Vmwll0) 
exon3 C 122485 120885 19 
exon2 C 123288 122622 222 
exonl C 124110 124054 534 
RLI C 125858 125115 248 26194 NE 
(Left end of a' sequence is at 125972) 
(Internal c sequence starts at 126373) 
RSI C 131128 127235 1298 132835 E 
(Centre of oris is at 131999) 
(US starts at 132605) 
US 1 132644 133903 420 
US2C 
US3 
US4 
US5 
US6 
US7 
US8 
134928 134056 291 
135222 136664 481 
136744 137457 238 
137731 138006 92 
138419 139600 394 
139785 140954 390 
141243 142892 550 
US8A 142744 143220 159 
US9 143313 143582 90 
USI0 C 145095 144160 312 
USl1 C 145246 144764 161 
US12C 145577 145314 88 
(TRs starts at 145585) 
(Centre of oris is at 146235) 
RSI 147105 150998 1298 
(Last nucleotide is 152261) 
46521 EINE 
32468 NE 
52831 NE 
25236 NE 
9555 NE 
43344 E 
41366 NE 
59090 NE 
16801 NE 
10026 NE 
34053 NE 
17756 NE 
9792 NE 
132835 E 
Neurovirulence factor (ICP34.5) 
IE protein; transcriptional regulator (lCP4, 
Vmw175) 
IE protein; function unknown (ICP22, Vmw68); 
host range phenotype 
Function unknown 
Protein kinase; phosphorylates UL34 protein 
Virion surface glycoprotein G 
Proposed glycoprotein J 
Virion surface glycoprotein D; role in cell entry 
Virion surface glycoprotein I; complexed with 
glycoprotein E (US8) in Fc receptor 
Virion surface glycoprotein E; complexed with 
glycoprotein I (US7) in Fc receptor 
Function unknown 
Tegument protein 
Virion protein 
Virion protein; ribosome-associated in infected 
cell 
IE protein; inhibitor of peptide transport by TAP 
and of antigen presentation(lCP47, Vmwl2) 
IE protein; transcriptional regulator (ICP4, 
Vmw175) 
Table 1.2 Features of the genes of herpes simplex virus type 1 (strain 17) 
Locations of protein-coding regions are given from the first residue of the translation initiation codon to 
the last residue of the last coding codon, omitting the stop codon. Leftward oriented genes are marked C. 
Bold genes are conserved in the three herpesvirus subfamilies. The status of each gene in cell culture is 
indicated: E = essential, NE = non-essential, E? = probably essential, NE? = probably non-essential, (E) = 
a mutant is viable, but very disabled, EINE = non-essential under certain conditions, ? = unknown. E 
genes are those for which mutants have been constructed that require complementing cell lines or those 
for which attempts to generate insertion mutants using the cosmid system have yielded only wild type. E? 
genes are those where attempts to derive a mutant by plasmid recombination have failed. NE? genes are 
those where data are available for aIphaherpesviruses other than HSV-l. IE = immediate early. 
This listing was compiled by A.J. Davison with help from C. MacLean and D.l McGeoch. The 
table was updated by A. Dolan in March 1997. 
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From Figure 1.3 it can be seen that the genes are arranged about equally on the 
two coding strands. There are a number of overlaps between coding regions in 
different reading frames. Genes are densely packed (89% ofUL codes for protein), and 
in many cases transcriptional control elements overlap with the coding regions of 
adjacent genes (Wagner, 1985). The majority of genes have their own promoters and 
are expressed as single exons although groups of adjacent genes in the same orientation 
may share a single polyadenylation site downstream of the most 3' gene (Wagner, 
1985). Genes contained in the repeat elements, such as IEIlO and IE175, are present in 
two copies in the genome (Perry et aI., 1986~ Rixon & Clements, 1982). The HSV-l 
genome has few spliced genes which include IEIlO (Perry et al., 1986), USI and USl2 
(Rixon & Clements, 1982) and UL15 (Costa et al., 1985~ McGeoch et al., 1988a). 
1.3 Replication of the herpesvirus genome 
1.3.1 HSV DNA replication 
Herpesviruses and other double stranded DNA viruses such as poxvlruses, 
adenoviruses, papovaviruses, and iridoviruses, all exploit replication mechanisms 
which are utilised by the host cell. This is in contrast to the RNA viruses whose 
replication requires processes not available in the uninfected cell. Despite this, most 
DNA viruses encode much of their own replication machinery even though many of 
these viruses (herpes-, adenoviruses) replicate in the nucleus where the cellular 
processes are localised. The dsDNA viruses have a wide range of genome sizes from 
about 5kbp in polyomaviruses up to 300kbp in poxviruses. The number of virally 
encoded proteins bears a direct relation to the dependence the virus has on the host 
cellular functions for successful replication. The herpesviruses are at the larger end of 
the dsDNA virus scale in terms of genome size, and encode a substantial number of 
their own functions (Table 1.2). 
There are two mechanisms by which the infecting virus can provide the 
functions required for its replication. The virus can utilise the host enzymes and impart 
a degree of regulation over them. However, even if there is a host enzyme supplying 
the basic function required, its properties may not be optimally adapted to the process 
of viral replication. Alternatively the virus can encode its own set of enzymes. A 
combination of regulating host enzymes and inducing viral enzymes ensures that the 
virus carries only those proteins which are advantageous for its own replication. The 
set of virally encoded enzymes is not constant throughout the Herpesviridae as shown 
in Table 1.3. We are principally concerned with the genes involved in DNA replication 
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and those required for nucleotide provision. Each of the enzymes listed in Table 1.3 
are dealt with in relation to HSV-l and the homologues in the other subfamilies. 
Enzyme/protein HSV-l (a) VZV(a) HCMV(6) EBV (y) 
Replication: 
DNA polymerase (catalytic) UL30 28 UL54 BALF5 
(accessory) UL42 16 UL44 BMRFI 
helicase/primase complex (I) UL5 55 UL105 BBLF4 
(II) UL8 52? UL102? BBLF3? 
(III) UL52 6 UL70 BSLFI 
DNase ULI2 48 UL98? BGLF5 
DNA repair: 
uracil DNA glycosylase UL2 59 UL114? BKRF3? 
Nucleotide provision: 
thymidine kinase UL23 36 none BXLFI 
ribonucleotide reductase (L) UL39 19 UL45 BORF2 
ribonucleotide reductase (S) UL40 18 none BaRF 1 
deoxyuridine triphosphatase UL50 8 UL72? BLLF2 
thymidylate synthase none l3 none none 
Table 1.3 Homologues of virally encoded enzymes between various herpesviruses. 
The HSV-l homologues in VZV, HCMV and EBV which show a low level of similarity are marked '?'. 
Details of each enzyme are given in the text below. Table was adapted from lM. Morrison (1991). 
1.3.1.1 DNA replication 
HSV-I DNA replication occurs by a rolling circle mechanism and head-to-tail 
concatemers accumulate in the nucleus (Roizman & Sears, 1990). There are two 
identical origins of replication, oriS1 and oriS2' which map to the Rs inverted repeat of 
the S segment of the genome (Stow, 1982; Stow & McMonagle, 1983) (Figure l.2). A 
third origin of replication, oriL, maps to the UL segment of the genome. Replication of 
the genome is dependent on seven major gene products as determined by the plasmid 
replication assay of Challberg (Challberg, 1986; McGeoch et aI., 1988b; Wu et aI., 
1988). The replication enzymes of HSV -I are generally the most highly characterised 
of all the Herpesviridae members. 
DNA polymerase 
HSV -I DNA polymerase was one of the first animal virus induced enzymes to 
be discovered (Keir & Gold, 1963) and has been studied extensively particularly in 
relation to antiviral therapy (see Section 1.4.5). The DNA polymerase is made up of a 
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catalytic subunit, the UL30 product, and an accessory subunit, the UL42 product 
(reviewed by Challberg, 1991). 
Sequence analysis of the UL30 gene predicted a protein product of 1235 
residues and approximately 136kDa (Gibbs et al., 1985; Quinn & McGeoch, 1985). 
The DNA polymerase activity from the UL30 ORF was found to be sufficient for 
catalysis when analysed by various methods (Dorsky & Crumpacker, 1988; Haffey et 
al., 1988). The UL30 protein also has a proof-reading 3'-5' exonuclease activity 
(Knopf, 1979) and a 5'-3' exonuclease activity. The later function can act as an RNase 
H presumably removing RNA primers (Crute et al., 1989). The product of the UL42 
gene, a dsDNA binding protein, acts as an accessory function and has been reported to 
stimulate the DNA polymerase activity (Gallo et al., 1988; Gottlieb et al., 1990). 
DNA polymerase activity as been described in other u-herpesviruses (including 
PRY, EHV-l and VZV), in the ~-herpesvirus, HCMV, and also in the y-herpesvirus 
EBV (reviewed by Morrison, 1991). 
Helicase/primase complex 
The helicase unwinds the dsDNA in an ATP-dependent reaction and the 
primase catalyses the synthesis of the oligoribonucleotide which initiates DNA 
replication on the lagging strand. The primase and helicase complex ofHSV-l is made 
up from the products ofUL5, UL8 and UL52 (Crute et aI., 1989). The presence of the 
UL8 protein appears to be unnecessary for either the helicase or A TPase activities 
although it may have a role in the nuclear localisation of the complex and the binding 
ofHSV-l DNA polymerase (Barnard et al., 1997; Calder & Stow, 1990; Marsden et al., 
1997). Specific binding to the origin is accomplished by the product of UL9 and the 
UL29 gene product binds single stranded DNA (Elias et aI., 1986; Powell et aI., 1981). 
Homologues of the HSV-l helicase/primase complex have been found in VZV although 
the UL8 homologue, gene 52, has homology of only 28% (Davison & Scott, 1986). 
HCMV homologues for UL5 and UL52 have been assigned to gene 105 and gene 70 
respectively (Chee et al., 1990). The homologue of HSV-l UL8, gene 102, is based on 
genome position only although it is similar in length. A similar situation exists with 
EBV where there are strong homologues of HSV -1 UL5 and UL52 but only a positional 
homologue ofUL8 (McGeoch, 1989). 
DNase 
The role of DNase in the viral life cycle was not well understood until recently. 
The enzyme is also referred to as an alkaline exonuclease due to its optimal activity at a 
high pH. The DNase of HSV -1 can hydrolyse both ssDNA and dsDNA and acts mainly 
on the 3'-terminus but can also act on the 5'-terminus. It was originally proposed that 
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the hydrolysis of cellular DNA helped provide the virus with a source of preformed 
nucleotides or had a role in the cleavage of viral DNA concatemers (Hoffmann, 1981). 
Subsequent analysis has shown that DNase has a role in HSV -I capsid egress. 
An HSV -I DNase deletion mutant was found to induce almost wild type levels of viral 
DNA but was deficient in the production of infectious virions (Shao et aI., 1993). 
HSV-I DNase has been shown to be essential in vivo and it has been proposed that it 
plays a role in the processing of complex DNA intermediates (Goldstein & Weller, 
1998). The HSV -1 DNase is encoded on gene UL 12 producing a protein of 626 amino 
acids and 67.5kDa (McGeoch et aI., 1986b). 
A ULI2 homologue with 29% sequence homology, gene 48, is induced in VZV 
(Cheng et aI., 1980). The UL98 gene of HCMV has only low sequence similarity to 
HSV-l but has recently been shown to allow functional complementation of the HSV-I 
UL121acZ deletion mutant in tissue culture (Gao et aI., 1998). EBV has been shown to 
induce a DNase which is similar to the HSV-l enzyme even though the EBV gene 
BGLF5 exhibits a low degree of sequence similarity to HSV-l UL12 (Baylis et al., 
1989; Cheng et al., 1980; McGeoch et aI., 1986b). 
1.3.1.2 DNA repair 
Uracil DNA glycosylase (UDGase) 
UDGase catalyses the removal of uracil from DNA. Its role in viral replication 
is described in Section 1.4.1. HSV-l gene UL2 encodes a UDGase which has been 
shown to be dispensable for growth in cell culture (Worrad & Caradonna, 1988; 
Mullaney et aI., 1989). VZV gene 59 has a 39% sequence homology with the HSV-I 
gene. No UDGase activity has been reported for HCMV or EBV although gene 114 and 
gene BKRF3 show limited homology to the HSV-I enzyme respectively (McGeoch, 
1989). 
1.3.1.3 Nucleotide provision 
Successful replication of the viral DNA in the host cell requires an additional 
group of virally encoded proteins involved in nucleotide metabolism. The substrates 
for the DNA polymerase reaction are the four deoxyribonucleoside triphosphates 
(dATP, dGTP, dCTP and dTTP) which must be supplied in sufficient quantity to allow 
efficient DNA synthesis, cell growth and metabolism (Reichard, 1988). In normal 
cellular DNA replication, small imbalances in the levels of each dNTP can lead to DNA 
mutation and fragmentation. Furthermore, cellular levels of dNTPs are cell-cycle 
regulated and only reach their maximal level during the S phase. The provision of 
virally encoded nucleotide metabolism enzymes may be necessary to allow 
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independence from the cell-cycle (Morrison, 1991). The role of each of the following 
enzymes in the de novo production of dNTPs can be seen in Figure 1.4. 
Thymidine kinase (TK) 
The TK of HSV -1 has been studied extensively due to its function as a gene 
transfer marker and its role in antiviral therapy (see Section 1.4.5). HSV-l TK, 
encoded on gene UL23, phosphorylates deoxycytidine and thymidylate in addition to 
thymidine (Jamieson & Subak-Sharpe, 1974). This enzyme is not essential for virus 
growth in tissue culture but virus mutants in the enzyme show significantly reduced 
pathogenicity (Field & Wildy, 1978). VZV gene 36 encodes an active TK with 28% 
sequence homology to the HSV-I enzyme (Cheng et aI., 1980). There appears to be no 
sequence homologue for the TK gene in HCMV although it may encode another type of 
nucleoside kinase and also appears to induce the cellular TK (Chee et al., 1989). It has 
been found that HCMV UL97 encodes a protein capable of phosphorylating 
ganciclovir, a function performed by TK in HSV-l (Littler et ai., 1992). In the y-
herpesvirus, EBV -encoded TK activity has been demonstrated in transformed 
mammalian cell lines (Littler et aI., 1986). 
Ribonucleotide reductase (RR) 
RR catalyses the reduction of all four ribonucleoside diphosphates to their 
corresponding deoxyribonucleoside diphosphates. The HSV-l enzyme is composed of 
two pairs of subunits (large and small) which are encoded by the neighbouring genes 
UL39 and UL40 (Cohen, 1972; Frame et aI., 1985; Ingemarsson & Lankinen, 1987; 
McLauchlan & Clements, 1983). Inhibition of the enzyme by peptide disruption of the 
subunit interaction has focused attention on the possibility of antiviral therapy (Dutia et 
al., 1986; McClements et al., 1988). The synthetic nonapeptide which was found to 
cause inhibition of HS V -1 RR (equivalent to the nine C-terminal residues of the small 
subunit) was also found to cause similar inhibition ofEHV-l RR (Conner et aI., 1993; 
Telford et aI., 1990). The two VZV genes, 18 and 19, show homology to the HSV-l 
genes UL40 and UL39 respectively. HCMV gene 45 has homology to the large subunit 
gene UL39 but no convincing homologue of UL40. It has been suggested that the 
cellular version of the small subunit may be utilised by HCMV to produce an active RR 
(Chee et al., 1989). Genes BaRFl and BORF2 show homology to HSV-I UL40 and 
UL39 respectively. 
Deoxyuridine triphosphatase (dUTPase) 
HSV-l specific dUTPase activity was discovered by Wohlrab and Francke 
(1980) and later mapped to gene UL50 by Preston and Fisher (1984). The enzyme 
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catalyses the hydrolysis of dUTP to dUMP and inorganic phosphate. The herpesvirus 
dUTPases are discussed separately in Section 1.4.8. It is noted here that the 13-
herpesvirus plus HHV6 and HHV7 do not contain a convincing homologue of the 
dUTPase enzyme (see Results Section 4.7). 
Thymidylate synthase (TS) 
In the generation of thymine, dUMP is methylated to dTMP by the enzyme TS 
(see Figure 1.4). The enzyme TS was discovered in HVS based on 70% homology with 
the human gene (Honess et aI., 1986). HSV-I, HCMV and EBV do not possess a TS 
however a copy was found during sequencing of the VZV genome (gene 13) and this 
was later shown to be active (Davison & Scott, 1986~ Thompson et al., 1987). It has 
been suggested that TS is only required by viruses with high A+T genomes (Honess et 
al., 1986). This is backed up by the relatively high A+T genomes ofHVS and VZV and 
the discovery of a TS in herpesvirus ateles (Richter et al., 1988). 
Dihydrofolate reductase (DHFR) 
Previous to 1988, possession of a DHFR had only been described in the T -even 
and T5 bacteriophages and not for any mammalian virus. Subsequently a virally 
encoded DHFR was described for HVS and herpesvirus ateles and more recently for 
HHV8 (Trimble et al., 1988; Nicholas et aI., 1998). The coding of a DHFR in HVS 
may be again related to the possession of an A + T rich genome although the reason for 
coding DHFR in HHV8 is still unclear. 
1.3.2 Nucleotide metabolism 
There are two pathways utilised by the mammalian cell for the production of 
RNA and DNA precursors (NTPs and dNTPs), the de novo and the salvage pathways. 
The de novo pathway is the main route where nucleotides are built up stepwise from 
small metabolic precursors such as ribose and amino acids. In the salvage pathway, 
free bases and nucleosides released from nucleic acid breakdown are recycled. 
Nucleosides can also be taken up from extracellular fluids by active transport across 
the cell membrane (Reichard, 1988). Specific kinases phosphorylate these nucleosides 
to yield nucleotides. 
We are principally concerned with pyrimidine metabolism and the role of 
dUTPase in this pathway. DNA differs from RNA in both the sugar moiety and the set 
of bases utilised. In DNA, uracil is replaced with thymine. This has direct 
consequences for nucleotide provision since dTTP has a more complex synthesis 
pathway compared to dATP, dGTP and dCTP (Figure 1.4). The de novo synthesis of 
NTP's and dNTP's is linked by the enzyme ribonucleotide reductase which acts on 
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ribonucleotides at the diphosphate level to produce deoxyribonucleotides (Reichard, 
1993). 
1 6 
ADP dADP .-.. ------.~ dATP 
1 6 
GDP dGDP .-. ------.~ dGTP 
1 6 
CDP -------.~ dCDP .... ----.~ dCTP 
~ 
dCMP 
Y 356 
dUMP ..... -__ --_ -_ -._~_d_T_M_P_.-.. _ -_-_-"':~ld_T_D_P _ ~"=--+~ dTTP 
-
UDP --------'--------+~ dUDP _~6,----.~ dUTP 
Figure 1.4 The later stages of the de novo pathway of pyrimidine deoxyribonucleotide 
synthesis in mammals. 
The enzymes are labelled as follows: (l) ribonucleotide reductase, (2) dCMP deaminase, (3) thyrnidylate 
(dTMP) synthase, (4) (d)CMP kinase, (5) thymidylate kinase, (6) nucleoside diphosphate kinase, (7) 
dUTPase. This diagram was adapted from (Reichard, 1988). 
The synthesis of dTTP occurs at great cost to the cell with enzymes encoded 
exclusively to deal with the replacement of uracil with thymine in DNA. A supply of 
dUMP is maintained by the action of two enzymes, dCMP deaminase and dUTPase. In 
mammals, the deamination of dCMP provides over 80% of the dUMP substrate for 
thymidylate synthase and the remaining amount arises from the activity of dUTPase 
(Nicander & Reichard, 1985~ Reichard & Nicander, 1985). In contrast, E.coli produces 
about 75% of dUMP for dTMP synthesis by the action of dUTPase. Unlike 
mammalian cells, E. coli possesses a deaminase which generates dUTP by the 
deamination of dCTP (Danielsen et al., 1992). 
Thymidylate synthase (TS) links dNTP synthesis to folate metabolism and is 
dependent on the activity of dihydrofolate reductase (Reichard & Nicander, 1985). TS 
catalyses the methylation of dUMP to dTMP. The methyl donor in this reaction is N5, 
NI0-methylenetetrahydrofolate which is oxidised to dihydrofolate. This molecule is 
recycled back to tetrahydrofolate by the enzyme dihydrofolate reductase using NADPH 
as the reductant. Phosphorylation of dTMP to dTDP is performed by thymidylate 
kinase which also phosphorylates dTDP, dUMP and dUDP (Pearl & Savva, 1996). The 
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final reaction in this pathway is carried out by the non-specific nucleoside diphosphate 
kinase which phosphorylates the dNDP's to their corresponding dNTP's. 
The maintenance of dNTP levels by these enzymes is crucial to the genetic 
stability of the cell. The results of an imbalance can have widespread effects including 
mutation, recombination, enhanced sensitivity to mutagens and carcinogens, 
chromosome breakage, exchange or loss, and oncogenic transformation (reviewed by 
Kunz et ai., 1994). 
1.4 The enzyme deoxyuridine triphosphatase (dUTPase) 
1.4.1 The function of dUTPase 
Deoxyuridine triphosphatase (EC 3.6.l.23) is also referred to as deoxyuridine 
triphosphate nucleotidohydrolase and dUTP pyrophosphatase in the literature. The 
position of dUTPase in the de novo pathway of nucleotide synthesis is shown in Figure 
1.4. The enzyme plays a crucial role in the regulation of dNTP synthesis by catalysing 
the hydrolysis of dUTP to form dUMP and pyrophosphate (Figure 1.5) (Bertani et ai., 
1961). 
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Figure 1.5 The dUTPase reaction. 
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This diagram was adapted from (Bergman, 1997). The number of protons released in the reaction 'n' is 
dependent on pH and Mg2+ concentration (Rogers et aI., 1997). 
The reaction mechanism of the E. coli dUTPase has been investigated and the 
substrate for the reaction appears to be a complex of dUTP with a divalent metal ion, 
preferably Mg2+ (Hoffmann et ai., 1987). The number of protons released in the 
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reaction has been shown to be determined by the concentration of metal ions and the 
pH of the reaction buffer (Rogers et aI., 1997). The enzyme has a high specificity for 
its substrates and discriminates efficiently between the base, sugar and phosphate 
moieties. This is a necessary capability for the enzyme since the hydrolysis of other 
nucleotides required for DNA and RNA synthesis would be highly detrimental. This is 
exemplified in the E.coli enzyme by discrimination against other highly structurally 
related molecules such as dUDP, UTP, dCTP and dTTP where phosphate, sugar and 
base are discriminated against with remarkable efficiency (Bjornberg & Nyman, 1996; 
Larsson et aI., 1996a). All dUTPases characterised to date show a high degree of 
specificity for dUTP although there are subtle differences between organisms 
(Bjornberg & Nyman, 1996). This may be a reflection of the evolutionary adaptation 
of the enzyme in different environments driven by a trade off between specificity and 
catalytic efficiency. 
The reactions involved in the provision of nucleotides must be controlled to 
ensure a balance is maintained. Disruption in this balance has direct consequences for 
DNA replication and the continued growth of the cell (Reichard, 1988). An increase in 
the ratio of dUTP compared to dUMP leads to large quantities of uracil being 
incorporated into the newly synthesised DNA chain. DNA polymerase, in contrast to 
dUTPase, does not distinguish between dUTP and dTTP (Shlomai & Kornberg, 1978; 
Focher et aI., 1990). Incorporation of uracil into DNA in place of thymine is not in 
itself mutagenic since both base pair with adenine. However, uracil also arises in DNA 
by the spontaneous deamination of cytosine which, if not corrected, will result in a 
point mutation in newly replicating DNA. Replacement of uracil for thymine in DNA 
can also disrupt sequence-specific DNA recognition by gene-regulatory proteins (Verri 
et at. 1990). 
I I 
G-C 
I I 
Deamination ~ I I G-U 
I I 
Replication 
I I 
G-C 
I I 
I I 
A-U 
I I 
Figure 1.6 Effect of unrepaired deamination of cytosine in replicating DNA 
The deamination of the cytosine residue in the G-C base pair results in an A-V base pair after replication. 
Further rounds of replication will result in the transition to an A-T base pair. 
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Cytosine is the most sensitive of the bases to nucleophilic attack even in 
physiological conditions and deamination is estimated to create about 100 uracil 
residues per day in an average sized mammalian genome (Lindahl, 1993). To cope 
with this potentially mutagenic situation an excision repair mechanism has evolved, 
utilising the enzyme uracil DNA glycosylase (UDGase) (Lindahl, 1982). The enzyme 
hydrolyses the glycosidic bond between the uracil and deoxyribose moiety in DNA 
creating an abasic site. An AP endonuclease (where AP represents an apurinic or 
apyrimidinic site) recognises the abasic site and nicks the phosphodiester backbone at 
an adjacent position. The residual deoxyribose phosphate is removed by an 
exonuclease and DNA polymerase I inserts the complementary base on the undamaged 
strand. DNA ligase completes the repair by rejoining the nicked backbone (reviewed 
by Friedberg et a/., 1995). 
The instability of cytosine may help to explain why thymine, and not uracil, is 
the standard constituent of DNA. UDGase specifically removes uracil and not thymine 
from DNA by discriminating against a single methyl group. The methyl group on 
thymine may therefore act as a tag to distinguish it from deaminated cytosine. In this 
context, it is likely that thymine is utilised in DNA to increase fidelity. RNA in 
comparison is a short lived genetic molecule where uracil, the less energetically 
expensive building block, is sufficient for information transfer. 
Excessive uracil incorporation as a consequence of an elevated dUTP/dTTP 
ratio results in excessive levels of UDGase mediated repair. Since this process 
involves a transient strand break in the DNA backbone, multiple repairs in close 
proximity can result in DNA fragmentation (Tye et a/., 1977; Ingraham et at., 1986). It 
has been suggested that the misincorporation of uracil into DNA has direct 
consequences for neuronal ageing (Mazzarello et at., 1990). Inhibitors of TS, such as 
fluorouracil, create a dramatic reduction in the dTTP pool and the resulting cytotoxic 
effect has been called 'thymineless death'. It has been proposed that the cytotoxic effect 
of these inhibitors is due to extensive uracil incorporation and excision repair 
(Ingraham et at., 1986). 
In summary dUTPase has two functions; 
1. As evident from the nucleotide pathway in Figure 1.2, dUTPase is a necessary 
component in the de novo synthesis of dTTP by supplying the substrate, dUMP, 
for dTMP synthase. 
2. The misincorporation of dUTP results in over stimulation of a natural repair 
mechanism which is highly detrimental to the cell. dUTPase must act to limit 
the amount of dUTP available to DNA polymerase and maintain the critical 
balance between dUTP and dTTP. 
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A further consideration concerns the physical organisation of dUTPase relative 
to other nucleotide metabolism enzymes (Wheeler et 01., 1992). In the bacteriophage 
T4 a non-covalently linked dNTP synthesising complex with a mass of l300kDa was 
isolated from infected E.coli cells. This complex contained at least ten enzymes, two 
of which were encoded by the host cell and the rest by the viral genome, and exhibited 
dUTPase activity (Mathews, 1993). It has been further suggested that this complex is 
in tum linked to the replication machinery, allowing dNTPs to be delivered directly to 
the replication fork (Mathews, 1993). The complex may be based on a common 
affinity of all proteins in the complex for the bacteriophage encoded gene 32 protein 
(Wheeler et ai., 1996). The perceived potential of such a complex is that physical 
connection of enzymes carrying out sequential steps in a metabolic sequence could 
allow significant kinetic advantage. Similar complexes have not been reported in other 
systems although the weak interactions involved would make this a difficult area of 
study. It would be interesting to discover if any eukaryotic viruses had evolved such a 
mechanism for the formation of complexes with both host and virally encoded 
enzymes. Such organisation would help to account for the variety of nucleotide 
metabolism enzymes which are specifically virally encoded since physical interaction 
with a host enzyme may overcome the requirement to encode a viral copy. 
1.4.2 Distribution and control of cellular dUTPases 
The enzyme dUTPase is ubiquitous in nature and many representatives have 
been substantially characterised. In prokaryotes examples include E.coli (Larsson et 
ai., 1996a) and Bacillus subtilis (Dunham & Price, 1974). In eukaryotes examples 
include Saccharomyces cerevisiae (Gadsden et al., 1993), Drosophila melanogaster 
(Nation et al., 1989), rat (Hokari & Sakagishi, 1987), human (Williams & Cheng, 
1979; Ladner et 01., 1996b), Allium cepa (onion) (Pardo & Gutierrez, 1990) and 
Lycopersicon esculentum (tomato) (Pri-Hadash et aI., 1992). Many viral dUTPases 
have also been characterised and are discussed separately in Section 1.4.3. With such a 
large range of organisms encoding an active dUTPase it has been suggested that this 
enzyme is indispensable to all cells (McIntosh et 01., 1992). The structural and 
functional relationships between dUTPases from diverse organisms provide an insight 
into the evolution of a cellular nucleotide metabolism enzyme. Representatives from 
distantly related organisms, such as those from E.coli and human cells, show 
remarkable structural similarity in terms of their trimeric arrangement and active site 
cavities (Mol et ai., 1996). 
The herpesvirus dUTPase proteins represent a distinct subset of the dUTPase 
enzymes as a whole. In order to easily distinguish between these two groups the 
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standard trimeric dUTPases (representing all those mentioned above) are referred to as 
class I dUTPases while the herpesvirus monomeric enzymes are referred to as class II 
dUTPases. This distinction addresses the structural differences between these two 
groups. It should be noted however that the dUTPase of the herpesvirus, CCV (and 
probably other fish herpesviruses) are clearly members of the class I group. The class 
II dUTPases are approximately double the chain length of their class I counterparts and 
are active as monomers as opposed to trimers (Caradonna & Adamkiewicz, 1984). The 
class II dUTPases are discussed separately in Section 1.4.8 and are the main subject of 
Chapter 4. Active dUTPases have also been discovered in Leishmania and 
Trypanosoma species which appear to show no sequence similarity to either the class I 
or class II enzymes. It appears likely that these examples represent an additional 
distinct subset of dUTPases (Camacho et al., 1997). Different organisms not only 
present different structural versions of the same enzyme but they also utilise the 
enzyme in subtly different ways. 
dUTPases have been found to be essential in E.coli (EI-Hajj et al., 1988) and 
yeast (Gadsden et al., 1993) although a viable double mutant of E.coli has been 
constructed which lacks both dUTPase and UDGase activities (Warner et aI., 1981). 
This mutant accumulates large amounts of uracil in its DNA but is presumed to survive 
due to the removal of the uracil extracting repair mechanism (Hochhauser & Weiss, 
1978). 
A conditional temperature sensitive dUTPase mutant (dut Ts) has been 
constructed in E.coli (EI-Hajj et al., 1992). It was found that phenotypic revertants of 
dut Ts restored viability without restoring the enzymatic activity of dUTPase. This 
secondary mutation was designated dus for dut suppressor. Further studies mapped, 
cloned, and identified the dus locus which was found to encode a dCTP deaminase 
(Wang & Weiss, 1992). As mentioned in Section 1.3.2., in E.coli, the major source of 
dUMP for dTTP synthesis is from the action of dUTPase (as opposed to the 
deamination of dCMP). The pathway utilised by E. coli involves the following 
intermediates: dCTP~dUTP~dUMP~dTMP. Mutation of the dCTP deaminase gene 
is likely to suppress the lethality of the dUTPase mutation by reducing the formation of 
dUTP. 
A multiple E.coli mutant with additional mutations to dut and dus including ung 
(UDGase), deoA (thymidine/deoxyuridine phosphorylase) and thyA (TS) has been 
created (EI-Hajj et al., 1992). It has been proposed that mutation in ung would prevent 
uracil excision from DNA, mutation in deoA would allow more efficient use of 
exogenous deoxyuridine and mutation in thyA would prevent synthesis of dTMP from 
any remaining dUMP. This multiple mutant displayed up to 93 to 96% substitution of 
uracil for thymine in new DNA. Growth of this mutant ceased after cellular DNA had 
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increased 1.6 to 1.9 fold and the cell mass had increased 1.7-2.7 fold suggesting an 
overall failure of macromolecular synthesis. 
From this evidence it may be suggested that dUTPase is a necessary enzyme 
which must be actively reducing the dUTP/dTTP ratio and supplying dUMP for dTTP 
synthesis at all times. However, it has been shown that the cell may regulate dUTPase 
activity to a high degree. In the root meristem cells of the plant Allium cepa, dUTPase 
activity has been shown to correlate closely with cellular proliferation (Pardo & 
Gutierrez, 1990). Activity is higher at optimal growth conditions and decreases as cells 
begin to differentiate. There is strong evidence for cell-cycle regulation in Allium cepa 
cells with a large increase in dUTPase activity at the G}/S boundary and continuing 
throughout the S phase. No activity could be detected at any other point in the cell 
cycle indicating a strong cellular control mechanism. A similar cell cycle dependent 
activity has been shown in Chinese hamster cell temperature sensitive mutants (Duker 
& Grant, 1980). 
In Drosophila melanogaster, cellular control of dUTPase activity has been 
attributed to a developmentally expressed protein inhibitor (Nation et al., 1989). 
dUTPase has been purified from Drosophila embryos and has been shown to be active 
only at early times in first-instar larvae (Giroir & Deutsch, 1987). A heat stable protein 
with a subunit molecular mass of 61kDa has been partially purified from the embryo 
and has been shown to be an active inhibitor of the embryonic dUTPase (Nation et aI., 
1989). This direct method of cellular control may be indicative of another utilisation of 
dUTPase. Controlled reduction in cellular dUTPase activity may result in uracil 
incorporation into DNA and UDGase mediated strand breakage. In the developing 
embryo this strategy could be used to increase DNA degradation during the 
histolysation process in the pupae where internal organs are dissolved before new 
growth of imaginal tissue. 
The role of dUTPase in the proliferation and maturation of human T cells has 
been investigated and it appears that the human enzyme is also dependent on the cell 
cycle (Strahler et al., 1993). There appears to be at least two forms of the human 
dUTPase, nuclear and mitochondrial. The mitochondrial form possesses an extended 
region at the amino terminus compared to the nuclear form (Ladner et al., 1996b). The 
nuclear form can be phosphorylated and a cyclin-dependent kinase phosphorylation site 
has been identified (Ladner et aI., 1996a). It has been suggested that the 
phosphorylation of the human dUTPase results in regulation of enzyme activity (Lirette 
& Caradonna, 1990). However, disruption of the phosphorylation site prevents 
phosphorylation but has no significant effect on enzyme activity in vivo (Ladner et al., 
1996a). Other possible roles for the phosphorylation of the human enzyme are 
multimerisation and cellular localisation (Ladner et al., 1996a). Whether the control 
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mechanism is translational, post-translational or mediated by a Drosophila-like 
inhibitor protein, it endows the human cell with regulation of dUTPase activity. 
1.4.3 The distribution of viral dUTPases 
Many, but not all viruses, encode a dUTPase. The discovery that a wide variety 
of viruses genomes encode a dUTPase was originally based on a number of sequence 
analysis studies. McClure et al. (1987) identified a supposedly protease-like gene 
segment specified in two distantly related groups, the lentiviruses and oncoviruses, 
although it was not present in all retroviruses. The gene segment was originally 
identified in the polymerase region of the lentiviruses, visna virus and equine infectious 
anaemia virus (EIA V). Homologous sequences were identified in a simian retrovirus 
type 1 (SRV-l) and its close relative, hamster intracisternal A particle (IAP-HI8) 
although these gene segments were located adjacent to the protease gene. On the basis 
of position and low level sequence homology, it was proposed that these gene segments 
originated by tandem duplication and subsequent divergence of the retroviral protease 
coding sequence (McClure et ai., 1987; McClure et ai., 1988). No function was 
ascribed to these polypeptides which were termed 'protease-like' domains. Subsequent 
studies found related genes in the poxviruses, vaccinia virus and orf virus (Slabaugh et 
al., 1989; Mercer et al., 1989). These related genes, termed 'pseudoproteases' were 
found to comprise an independent ORF and possess transcriptional control signals, 
rather than as a subunit of a larger polypeptide as in retroviruses. 
McGeoch (1990b) following on from these studies, correctly identified these so 
called 'protease-like' or 'pseudoprotease' genes as dUTPases. The gene segments 
identified from retroviruses and poxviruses were compared to the dUTPase sequences 
from E.coli and the herpesviruses, HSV-l, VZV and EBV. All sequences in the 
alignment were found to contain five highly conserved, short amino acid motifs. This 
work is discussed in detail in Section 1.4.8. This finding has allowed the subsequent 
identification of dUTPases from other viruses based on the conservation of these five 
motif regions. The viral dUTPases characterised to date include members of the 
Herpesviridae, Retroviridae, and Poxviridae (Table 1.4). 
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Family Virus Reference 
Herpesvirus Herpes simplex virus type 1 (HSV -1) (Wohlrab & Francke, 1980) 
Herpes simplex virus type 2 (HSV-2) (Wohlrab et aI., 1982) 
Epstein-Barr virus (EBV) (Williams et aI., 1985) 
Bovine herpesvirus 1 (BHV -) (Liang et aI., 1993) 
Pseudorabies virus (PRV) Ooos & Mettenleiter, 1996) 
Varicella-zoster virus (VZV) (Ross et ai, 1997) 
Poxvirus Vaccinia virus (Broyles, 1993) 
Retrovirus Mason-Pfizer monkey virus (MPMV) (Elder et aI., 1992) 
Simian type D retrovirus (SRV-l) (Elder et aI., 1992) 
Feline immunodeficiency virus(FIV) (Wagaman et al., 1993) 
Equine infectious anaemia virus (EIA V) (Threadgill et aI., 1993) 
Mouse mammary tumour virus (MMTV) (Koppe et aI., 1994) 
Caprine arthritis-encephalitis virus (CAEV) (Turelli et al., 1996) 
Visna virus (Turelli et aI., 1996) 
Table 1.4 Viral dUTPases which have been confirmed to be functional 
From Table 1.4 is evident that most of the current research in viral dUTPases is 
focused on members of the Herpesviridae and Retroviridae which are both discussed in 
later sections. Sequence homologues of dUTPase have also been found in the 
Adenoviridae, and the unclassified African swine fever virus (previously in the 
Iridoviridae family) but these have yet to be characterised. Many viruses which possess 
the dUTPase enzyme are sure to be identified in the near future from these families and 
others. 
1.4.4 The role of dUTPase in viral life cycles 
In this section a variety of viral life cycles are reviewed which exhibit different 
nucleotide metabolism pathways. These life cycles range from bacteriophages which 
utilise non-standard bases to those which encode a multiple array of enzymes to allow 
reversal of normal cellular functions. The retroviruses are also described here in 
relation to the possession of a dUTPase whereas the herpesviruses are described 
separately in Section 1.4.8. 
The replication mechanisms of many organisms differ with regard to nucleotide 
metabolism but none more so than bacteriophages of E.coli and B.subtilis. The cl>e 
bacteriophages of B.subtilis contain 5-hydroxymethyluracil (HMU) in place of thymine 
and possess dTTPase and dUTPase activities. Partial purification suggests that both 
activities are attributable to one, dual function enzyme. This dTTPase-dUTPase is 
thought to be responsible for excluding both uracil and thymine from phage DNA and 
39 
providing dUMP, the substrate for the cl>e-induced dUMP hydroxymethylase (Price & 
Warner, 1969). 
The T-even phages of E.coli replace cytosine with 5-hydroxymethylcytosine 
(HMC) in their DNA and encode a hydroxymethylase (Adams et al., 1981). They 
encode a dCTPase-dUTPase whose dCTPase activity prevents the incorporation of 
cytosine and produces dCMP, the substrate for dCMP hydroxymethylase. A kinase is 
encoded to phosphorylate the HMC to the diphosphate level and a host enzyme 
converts the diphosphate to the triphosphate. The return for encoding these extra 
enzymes is the advantage of promoting degradation of the host DNA by 
deoxyribonuclease. Specificity for the host DNA is attributed to the lack of cytosine 
clusters in the phage DNA due to replacement with HMC (Stryer, 1988). Another 
phage encoded enzyme catalyses the glycosylation ofHMC molecules which appears to 
further facilitate survival of the viral genome by reducing degradation by cellular 
enzymes (Cohen, 1968). 
The two examples above reveal how subtle changes to the chemical 
constituents of the viral DNA can be advantageous by allowing the replication and 
survival of viral DNA in preference to host DNA. Another replication mechanism 
variation is that of the PBS-2 phage of B.subtilis which has DNA containing uracil 
instead of thymine. To enable this phage to replicate in the host cell it must encode a 
number of proteins including a dTTPase (Price & Fogt, 1973). To allow accumulation 
of dUTP for incorporation into newly replicating DNA it encodes a dUTPase inhibitor 
protein (Price & Frato, 1975). PBS-2 must also encode a UDGase inhibitor to prevent 
purposely incorporated uracil molecules being excised (Wang & Mosbaugh, 1989). 
The UDGase inhibitor has been crystallised and characterised kinetically revealing that 
its mechanism of action is based on nucleotide mimicry (Bennet et al., 1993; Savva & 
Pearl, 1995). The purification and crystallisation of the dUTPase inhibitor protein to 
reveal its mechanism of action would be extremely interesting. The question as to 
what advantage can be gained from such a complex replication cycle remains unclear. 
Since the uracil rich DNA will be resistant to many restriction endonucleases this may 
have incurred an evolutionary advantage for this genome. 
Given the importance of dUTPase in general cellular metabolism it is not 
surprising that many viruses encode their own copy of the enzyme. It is interesting 
however that possession of a virally encoded dUTPase varies between viruses, even 
those closely related. One of the most striking examples of this variation is found in 
the Retroviridae where the lentivirus FIV encodes a dUTPase whereas its human 
counterpart mv does not. Existence of this gene in such a small, 10kb genome is 
indicative of its functional importance. It has been found that only distinct subsets of 
retroviruses encode a dUTPase gene (Elder et al., 1992) probably attributable to their 
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distinct life cycles. Retroviruses possess a single-stranded, RNA genome in the region 
of 8-10kb in length. The viral RNA is converted to DNA by virus encoded reverse 
transcriptase. Integrase, another virally encoded enzyme, performs integration of the 
viral DNA into the host cell chromosome. The retroviral genome is made up of three 
major genes, gag, pol and env. The gag region encodes structural proteins,pol encodes 
reverse transcriptase and integrase and env encodes a transmembrane glycoprotein 
which allows attachment and entry into the host cell. In the lentiviruses, the dUTPase 
gene is located in the pot gene between the reverse transcriptase and the integrase 
(McClure et al., 1987). In the type D retroviruses, MMTV, the dUTPase is expressed 
as an uncleaved transframe protein with the nucleocapsid protein (Bergman et at., 
1994; Koppe et at., 1994). 
Many of the retroviral dUTPase genes have been analysed by mutation studies 
and it is apparent that the replication of these dUTPase-deficient (dUTPase-) viruses is 
highly dependent on the state of the host cell. In many cases replication was close to 
wild type levels in certain dividing host cells. Studies with FIV dUTPase- mutants in 
vitro have shown that replication occurred with close to wild type levels in actively 
dividing host cells but was greatly reduced in non-dividing cells such as primary 
macrophages (Wagaman et at., 1993). A similar situation is seen with in vitro studies 
on EIA V (Threadgill et at., 1993), CAEV and visna virus (Turelli et at., 1996) where 
again there was reduced replication in primary macrophages but not in actively 
dividing cells. Studies with these mutants in vivo show that dUTPase does have an 
essential role in virus replication. Using FIV dUTPase- mutants in vivo, several key 
discoveries were made: 1) mutants infect their host with similar kinetics to wt, 2) 
mutants elicit a similar humoral antibody response to wt and 3) the virus burden is 
reduced in the mutants. Furthermore, it was found that the mutation rate of mutant 
FIVs integrated in the DNA of primary macrophages after 9 months was five fold 
greater than the mutation rate of mutant FlY's integrated in the DNA of T -lymphocytes. 
Comparative mutation rates of the wt virus between cell types were the same (Lerner et 
at., 1995). This is a clear indication that a virally encoded dUTPase becomes 
advantageous in non-dividing cells. This is backed up with similar in vivo data from 
studies with CAEV showing an increased mutation rate in dUTPase- mutants (Turelli 
et at., 1997). dUTPase- mutants of EIA V also shows increased incorporation of uracil 
into viral DNA (Steagall et aI., 1995) and replication deficiencies in macrophages 
(Lichtenstein et at., 1995). 
From these studies it is clear that dUTPase has a role in vivo in non-dividing 
cells where levels of host dUTPase activity may be low. The fact that HIV does not 
carry a dUTPase while other lentiviruses do may simply be because HIV does not 
encounter significantly high levels of dUTP during infection of the natural host. 
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However, since the FIV dUTPase is actually packaged into the virion (Elder el aI., 
1992) it has been suggested that mv may have developed a mechanism for the 
incorporation of the host dUTPase within its own mature virion (McIntosh et aI., 1992). 
Based on the discovery that human endogenous retrovirus-like elements (HERVs) also 
carry a gene with similarity to dUTPase (Cordonnier el aI., 1995) another possibility 
exists. If these viruses encode a functional copy of the dUTPase gene it may be 
possible for IDV to utilise this host-based source of the enzyme during replication 
(McIntosh et aI., 1992). 
1.4.5 dUTPase as an antiviral target 
There are relatively few successful antiviral therapies available at present. The 
main reason for this is that because viruses replicate in cells and employ much of the 
host's biosynthetic machinery, highly specific viral targets are hard to find. Many of the 
current antivirals suffer from low therapeutic indexes due to non-specific disruption of 
host cell components. The main areas of research into potential antiviral targets are 
historically nucleotide metabolism and DNA replication. As discussed previously, 
many viruses encode their own enzymes to allow efficient replication of viral DNA in 
the host cell. Identification and characterisation of these enzymes has allowed some 
success in the development of viral specific inhibitors. There are very few antiviral 
drugs licensed for use and most of them are nucleoside analogues (Table 1.5). The 
other antiviral drugs work in a variety of ways. 
Amantadine targets the process of endosome acidification and thus prevents 
release of the viral genome into the cytoplasm. Rimantadine has a similar mechanism 
and is less toxic than amantadine. Phosphonoformic acid, an analogue of 
pyrophosphate, inhibits DNA polymerase and viral reverse transcriptase (Blackburn & 
Gait, 1995). 
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Dru2 Virus 
Nucleoside analogues 
5-Iodo-2'-deoxyuridine HSV 
5-Trifluoromethyl-2'-deoxyuridine HSV 
Adenine arabinoside HSV 
5-Ethyl-2'deoxyuridine HSV (in Germany) 
5-Iodo-2'-deoxycytidine HSV (in France) 
Acyclovir (ACV, guanosine analogue) HSV,VZV 
(E)-5-(2-Bromovinyl)-2'-deoxyuridine HSV, VZV (in Germany) 
3'-Azido-2',3'-dideoxythymidine (AZT) HIV 
2',3'-Dideoxyinosine HIV 
2',3'-Dideoxycytidine HIV 
Ganciclovir (guanosine analogue) HCMV 
Ribavirin (purine nucleoside analogue) Respiratory syncytial virus 
Other 
Amantadine Influenza A 
Phosphonoformic acid HCMV 
Rimantadine Influenza A (in Russia) 
Table 1.5 Drugs approved for use against viral infection In humans In 1993 
(Blackburn & Gait, 1995) 
The most successful antiviral drugs in recent years include acyclovir (ACV) for 
herpesviruses and 3'-azido-2',3'-dideoxythymidine (AZT) for HIV-l. Referring to Table 
1.5 it can been seen that many of the licensed drugs are active against herpesvirus. The 
reason for this is twofold: Firstly, many of the herpesviruses enzymes have been 
substantially characterised allowing greater scope for directed drug development and 
secondly, many of the active drugs against herpesviruses are nucleoside analogues 
which are a by-product of extensive anti-cancer drug programs. 
The variation between the viral and host enzyme provides a basis for designing 
specific, non-toxic drugs. The majority of the herpesvirus antivirals rely on the virally 
encoded enzyme, thymidine kinase (TK). TK selectively phosphorylates nucleoside 
analogues, such as ACV, allowing conversion to the triphosphate state which is the 
active form. Since this reaction is not performed by the cellular host enzymes it 
provides a basis for specificity. Direct inhibition of the viral DNA polymerase has also 
been possible although the differences from the cellular version are limited (reviewed 
by Cohen, 1992). 
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ACV GCV 
Figure 1.7 Structure of Acyclovir (ACV) and Ganciclovir (GCV) 
ACV has the highest therapeutic index of any antiviral drug. Unlike many of 
the antivirals, the mechanism of action of acyclovir is well characterised. The structure 
of ACV is based on a deoxyguanosine which lacks part of the sugar ring (Figure 1.7). 
ACV is activated by the virally encoded TK which can phosphorylate a variety of 
nucleoside analogues. The mechanism of action is shown in Figure 1.8. 
ACV --. ACV-MP --. ACV-DP --.ACV-TP I Viral TK I I Cellular enzymes I 
Viral DNA polymerase 
Figure 1.8 The mechanism of Acyclovir action (Cohen, 1992) 
ACV is phosphorylated by the virally encoded TK converting it to ACV-
monophosphate. Subsequent conversion to ACV-diphosphate and -triphosphate is 
performed by cellular enzymes. The triphosphate form of ACV acts as a competitive 
inhibitor with dGTP and also as a substrate for the viral DNA polymerase which 
incorporates the analogue into the growing DNA chain. Because there is no 3'-
hydroxyl on the acyclo-GTP, the viral polymerase cannot add another dNTP. 
Furthermore, for reasons that are not yet clear, the polymerase becomes inactivated and 
viral DNA replication ceases. Non-infected mammalian cells do not phosphorylate 
ACV efficiently, imparting a high degree of specificity for HSV infected cells (Cohen, 
1992). Ganciclovir has a similar structure to ACV although by possessing the C-3' 
moiety on the sugar ring it is closer to the natural substrate. This may account for the 
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fact this is more toxic than ACV. Ganciclovir has the same basic mechanism of action 
as ACV and is commonly used to treat HCMV infection. 
The first report of ACV resistance in an immunocompromised HSV-infected 
patient was in 1982 (Crumpacker et al., 1982). Cases of resistance have been 
particularly common in patients suffering from AIDS or undergoing transplants. It is 
thought that the increased viral burden, characteristic of severely immunocompromised 
patients, increases the likelihood of resistance (Chatis & Crumpacker, 1992). There 
are three mechanisms of resistance including the selection of TK deficient mutants 
which lack the enzyme (Schmipper et al., 1980) and selection of mutants which 
produce an TK with a substrate specificity excluding ACV (Darby et al., 1981). 
Alternatively a mutated polymerase is selected for which is capable of elongating DNA 
in the presence of high concentrations of ACV (Knopf et al., 1981). Ganciclovir 
suffers from a similar set of resistance mechanisms (Chatis & Crumpacker, 1992). 
It is clear that there is a very limited number of selective antivirals available to 
treat herpesvirus infections and there are resistance problems with those in common 
use. There are, however, ongoing studies with other approaches such as disruption of 
viral or viral-cellular protein interactions and inhibition of proteases to block viral 
assembly. Antisense oligonucleotides are being developed to inhibit viral gene 
expression and work is continuing in the production of soluble receptors which block 
herpesvirus attachment and entry. 
It is possible to disrupt specific protein subunit interactions by peptide 
inhibition (reviewed by Marsden, 1992). The peptide is engineered to correspond to 
one of the two subunits, whether it is of viral or cellular origin. The best studied 
peptide inhibition of a viral protein subunit interaction is that of HSV ribonucleotide 
reductase (RR) (Outia et al., 1986). RR is a functionally important enzyme in viral 
replication and is discussed in Section 1.3.1. The HSV RR is a heterodimer composed 
of two molecules of a large subunit and two molecules of a small subunit (Ingemarsson 
& Lankinen, 1987). A nonapeptide was synthesised, corresponding to the carboxy-
terminal region of the large subunit. This nonapeptide was able to specifically inhibit 
the viral RR by competing with the binding site on the large subunit to which the small 
subunit normally associates (Outia et at., 1986). The specificity for the viral enzyme 
appears to be from the difference in amino acid sequence at this binding region 
between the viral and mammalian RRs. The approach has also had some success in 
other herpesvirus protein interaction such as that between the polymerase (UL30) and 
the dsONA binding protein (UU2) (Marsden et at., 1994). 
Although these studies have proved to be useful in vitro, there are obstacles to 
overcome before they become clinically useful, such as delivery of the peptide into the 
target cell and degradation by cellular enzymes. Antisense oligonucleotides have 
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similar problems to peptides in terms of clinical use. The strategy involves the design 
of oligonucleotides that are complementary to a unique viral sequence. These 
molecules then hybridise to the viral DNA or RNA and interfere with the target 
sequence (reviewed by Bischofberger & Wagner, 1992). 
A relatively new target for a herpesvirus drug is the virally encoded dUTPase. 
Evidence suggesting an important role for the enzyme plus structural studies on related 
dUTPases has generated further interest. The herpesvirus encoded dUTPases are 
substantially different from the mammalian versions yielding the potential of selective 
inhibition of the viral enzyme. Elucidation of the active site region of the herpesvirus 
dUTPases may allow analogues to be developed that act specifically against the viral 
enzyme. HSV and EBV dUTPases have now been accepted as serious contenders for 
novel drug design (Williams, 1988~ Sommer et af., 1996). Sequence analysis studies 
have identified a conserved motif present in the herpesvirus dUTPases but not in other 
dUTPases (McGeoch, unpublished work). This is discussed fully in the Results 
(Section 4.7). Clearly, if a function can be attributed to this conserved region of the 
viral enzyme, it may be possible to design drugs targeted at this area. To adequately 
design selective inhibitors for the herpesvirus dUTPase it is first necessary to 
characterise the enzyme thoroughly both structurally and functionally. This thesis deals 
with the preliminary results of this characterisation. 
A substrate analogue has been developed which is a potent inhibitor of both the 
E.coli and the HSV-l dUTPases (Bergman et aI., 1997; Persson et aI., 1996). The 
dUDP analogue, 2'-deoxyuridine 5'-( a,f3-imido )diphosphate (dUPNPP) was chemically 
synthesised and the active triphosphate was prepared enzymatically using the enzyme 
pyruvate kinase and phosphoenolpyruvate as a phosphate donor. This method was also 
used to phosphorylate the imidodiphosphate analogue of 2'-deoxythymidine to 2'-
deoxythymidine 5'-( a,f3-imido )triphosphate (dTPNPP). Replacement of the a,f3-
bridging oxygen in dUTP with an imido group results in a non-hydrolysable substrate 
analogue (Figure 1.9). 
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Figure 1.9 Structure of pyrimidine analogues 
The chemical structures of the following compunds are shown: (A) dUPNPP, (B) dTPNPP, (C) dUTPaS 
and (D) BM-dUTP. 
Both dUPNPP and dTPNPP compounds were developed for use in 
crystallisation experiments but also demonstrate that inhibitors can be readily 
produced. The structure of analogue benzyl-(2'-deoxy-5'-uridinyl-hydroxyphosphinyl-
methylenyl-hydroxyphosphinyl-oxo )-phosphonate (BM-dUTP) is also shown in Figure 
1.9. This substrate analogue has been synthesised and found to be a useful inhibitor of 
dUTPase in cancer cell lines (see Section 1.4.6). The molecule dUTPa.S has two 
enantiomers of which only one is hydrolysed by dUTPase in the presence of Mg2+. 
The non-hydrolysable enantiomer can be hydrolysed upon the addition of C02+ thus 
providing evidence for the participation of the a-phosphate with a metal ion in the 
reaction mechanism (Bergman, 1997). 
1.4.6 Human dUTPase and chemotherapy 
It is clear that dUTPase plays a key role in many viral replication cycles. It is 
also clear that dUTPase is an essential enzyme to mammalian cells specifically those 
cells which are actively growing or dividing. The variation in requirement for cellular 
dUTPase appears to be dependent on the cell state, with actively dividing cells 
producing much larger quantities of the enzyme than resting cells (Nation et ai., 1989). 
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This makes dUTPase a useful target for cancer therapy since its inactivation may 
selectively inhibit rapidly dividing cells (McIntosh et aI., 1992). 
It was widely considered that cell death due to inhibition of thymidylate 
synthase (TS) was a direct result of low levels of intracellular dTTP. It was not, 
however, understood why such a transient nucleotide imbalance could result in 
irreversible cell damage and death. It has been found that induction of cell death by 
inhibition of TS involves an increase of intracellular dUTP resulting in 
misincorporation into DNA and fragmentation due to excision repair (Curtin et al., 
1991 ). This enzyme is a key target for cancer chemotherapy and several inhibitory 
drugs have been developed including methotrexate and fluorodeoxyuridine (FdUrd). 
FdUrd gives a significant benefit to cancer patients but a large percentage of tumours 
exhibit intrinsic or acquired resistance. Many of the mechanisms of resistance of the 
group of fluoropyrimidine drugs have been identified as mutations of the cellular TS 
resulting in reduced inhibition. Further studies with FdUrd have implicated dUTPase 
in the resistance mechanism of the drug (Canman et aJ., 1993). It appears that in 
response to high dUTP levels induced by FdUrd the cell can increase dUTPase activity 
to compensate (Lirette & Caradonna, 1990). This increase in dUTPase activity allows 
the intracellular dUTP levels to be reduced thereby lowering the potentially cytotoxic 
misincorporation of uracil into DNA (Beck et al., 1984). This is backed up by older 
studies which show that inhibition of dUTPase with nucleoside analogues increases 
the cytotoxicity of methotrexate in cell culture (Beck et al., 1985 ~ 1986). 
The role of dUTPase in resistance to FdUrd induced cytotoxicity has been 
confirmed by expressing E.coli dUTPase in a mammalian cell line prior to drug 
treatment (Canman et aJ., 1994). Cells expressing the recombinant E.coli enzyme 
showed a 4-5 fold increase in overall dUTPase activity. These cells were found to be 
protected against the action of FdUrd compared to cells expressing standard levels of 
dUTPase activity (Canman et al., 1994). Although the in vivo situation has not been 
investigated, these results support the theory that the action of anti-tumour drugs such 
as FdUrd may be enhanced by combining them with dUTPase inhibitors thus 
maximising uracil incorporation into DNA and the consequent strand breakage. In 
terms of resistance to drugs such as FdUrd, dUTPase inhibitors may become extremely 
useful. Studies on the human enzyme indicate that there are at least two distinct 
versions of the enzyme of which one may be activated by phosphorylation (Section 
1.4.2). Further characterisation of the human dUTPase will allow greater potential to 
regulate the enzyme in tumour cells and may provide a degree of specificity. 
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1.4.7 The dUTPase of Escherichia coli 
The E.coli enzyme is the most highly characterised dUTPase to date in terms of 
both structure and function. After large scale purification was successful, E.coli 
dUTPase was the first to be crystallised (Hoffmann et al., 1987; Cedergren-Zeppezauer 
et aI., 1992). The E.coli enzyme is used as a working model for a typical class I 
dUTPase and as a basis for the molecular modelling of the class II HSV-l dUTPase in 
this thesis. There are now four class I enzymes for which a crystal structure has been 
solved: E.coli (Cedergren-Zeppezauer et al., 1992), FIV (Prasad et aI., 1996), EIA V 
(Persson et aI., 1997) and a human (Larsson et aI., 1996b; Mol et al., 1996) dUTPase. 
The crystal structure of the E.coli enzyme with bound dUDP has also been solved 
allowing identification of functionally important residues within the structure (Larsson 
et al., 1996c). 
The E.coli dUTPase was originally described as a tetramer (Shlomai & 
Kornberg, 1978) but in the course of crystallographic analysis was found to be a homo-
trimer (Cedergren-Zeppezauer et al., 1992). The structure of the E.coli dUTPase is 
presented in Figure 1.10(a) with each of the three subunits coloured individually. Each 
subunit comprises a globular region with an extended tail which is formed by the C-
terminal region of the protein. The extended arm of each subunit crosses the adjacent 
subunit. In the E.coli crystal structure the last 16 residues of this arm are not visible in 
the electron density map even when dUDP is bound and it has been proposed that the 
arm is flexible (Larsson et al., 1996c). Subsequent studies using non-hydrolyzable 
substrate analogues have demonstrated that the E.coli arm closes over the active site 
following the binding of 2'-deoxyuridine 5'-(a.,j3-imido)triphosphate (diphosphate 
shown in Figure 1.9A) in complex with Mg2+ and then opens after catalytic cleavage 
(Vertessy et al., 1998). 
Primary sequence comparisons of the class I and class II dUTPases revealed 
five distinct regions of local sequence similarity which have been named motifs 1-5 
(McGeoch, 1990b). These conserved regions are dealt with in detail in Chapter 4. 
Analysis of the E.coli dUTPase-dUDP co-crystal demonstrated that at least four of 
these motifs regions condense to form an active site pocket (Figure 1. lOb and c). The 
trimer has three such active sites, with each one positioned at the interface region 
between adjacent subunits (Larsson et al., 1996c). Motif 5 is positioned at the end of 
the C-terminal tail and is not visible even in the dUDP co-crystal structure. 
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(a) 
(b) (e) 
Figure 1.10 Structure of the E.coli trimer (top) and active site region (bottom). 
(a) The E.coli trimer. Each of the three identical subunits is coloured: 'A ', cyan, ' B', red and 'C', 
yellow. There are three active sites in the trimer positioned at the interface between adjacent subunits. 
An arrow indicates the position of one of the three active sites. (b) Side view of the trimer looking in the 
direction of the arrow in (a). (c) Active site region. View as in (b) with all three subunits coloured white 
and the motif regions highlighted. Subunit 'A' contributes motif 3 (red). Subunit 'B' contributes motifs 
1 (green), 2 (blue) and 4 (pink). Motif 5 is not visible in this structure but is proposed to be contributed 
by subunit 'c' at the end of the C-terminaI arm. The last visible residues, 134-136, of the 'c' subunit 
(yellow) can be seen approaching the active site area in figure (b). 
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Figure 1.11 The secondary structure of the E.coli trimer (Bergman, 1997). 
Each subunit is composed of 10 J3-strands and one short a-helix (see Section 
4.4.2 for a detailed description). The 7 main J3-strands from one subunit plus an eighth 
extended J3-strand from a neighbouring subunit form a secondary structure resembling 
the Jelly-roll' often found in viral coat proteins. Three such folds condense to fonn the 
trimer depicted in Figure 1.11. The last visible residue of the enzyme, Phe-136, lies at 
the end of the ann and points in the direction of the active site. The structure of the 
human dUTPase trimer reveals that motif 5 also participates in the active site area and 
it is likely that a similar situation exists in the E.coli enzyme (Mol et aI. , 1996). It has 
been suggested that this region becomes ordered only upon binding a nucleoside 
triphosphate in complex with a metal ion (Larsson et ai., 1996c). Motif 5 is rich in 
glycine residues and has similarity to phosphate binding sequences in other nucleotide 
binding proteins (Moller & Amons, 1985; Bossemeyer, 1994). 
One of the most interesting discoveries is that with the participation of motif 5, 
each active site is made up from motifs from all three subunits. This can be visualised 
in Figure 1.10 where subunit 'A' contributes motif 3, subunit 'B' contributes motifs 1, 2 
and 4, and subunit 'C' is likely to contribute motif 5 at the end of the arm structure. 
This has important implications in the modelling of the HSV -1 enzyme and will be 
discussed in some detail in the Results Chapter 4. 
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The most important residues involved in the specificity for dUTP are contained 
in motif 3. This region may be a general uridine binding motif since homologues have 
been found in both dCTP deaminases and pseudouridine synthases (Koonin, 1996). 
There are, however, no structural data to determine if these homologous sequences are 
in fact involved in uridine binding. Motif 3 has a p-hairpin loop structure with 
discrimination against ribose achieved by a tyrosine (Tyr-93) which lies at the comer of 
this loop. This residue is highly conserved between dUTPases and is also found in the 
majority of class II enzymes. There is chemical evidence that acetylation or nitration 
of this residue in E.coli inactivates the enzyme (Vertessy et al., 1996; Vertessy et aI., 
1994; Vertessy & Zeppezauer, 1994). The structure of the active site and the 
mechanism employed for discrimination against sugar, base and phosphate are 
discussed in Section 4.2. 
Kinetic studies with the E.coli enzyme and other dUTPases have resulted in 
widely different values even for the most standard measurements. The KM for the 
E.coli enzyme has been reported as 1.5J,tM (Bertani et al., 1961), 12J,tM (Shlomai & 
Kornberg, 1978), 22J,tM (Hoffmann et al., 1987) and recently as 0.2J,tM (Rogers et al., 
1997). The most recent measurement, carried out by stopped-flow analysis, has shown 
that by excluding Mg2+ from the reaction, an almost 100-fold higher KM was obtained 
and metal-free dUTP was shown to be an inhibitor of the reaction (Larsson et aI., 
1996a). It is possible that Mg2+ concentration was not taken into account in earlier 
experiments. It is also possible that the discontinuous measurement of dUTPase 
activity (as measured by reaction product quantification using TLC separation) is not 
accurate enough to measure KM in the submicromolar range. 
The stopped-flow technique measures the release of protons and subsequent pH 
change in a weakly buffered solution containing a pH indicator dye. This system 
allows real-time measurement of the hydrolysis reaction and was utilised for a detailed 
kinetic analysis of the E.coli enzyme (Larsson et aI., 1996a). It was found that the 
enzyme was highly specific for its substrate dUTP, with the next best substrate, dCTP, 
hydrolysed 105 times less efficiently (by comparison of specificity constants, kcatfKM). 
This vast difference is mainly attributable to a higher KM for dCTP. A catalytic 
mechanism has been interpreted from these data and involves the magnesium binding 
to the a-phosphate, rate-limiting hydrolysis by an activated water molecule and fast 
ordered desorption of the products. The turnover (kcat) for the E.coli dUTPase, in the 
range of 6 to 9 s-l, is considered to be slow and it has been suggested that this is a 
consequence of the high specificity the enzyme has for dUTP. 
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1.4.8 The dUTPases of herpesviruses 
The dUTPase ofHSV-l is the focal enzyme in this thesis. It is encoded by gene 
UL50, a rightward oriented ORF of 371 codons. The position of the gene in the HSV-I 
genome was correctly identified by (Preston & Fisher, 1984) although there were 
earlier reports describing a different location (Williams & Parris, 1987; Wohlrab et aI., 
1982). It lies head to head with UL49A and tail to tail with UL51. The close proximity 
ofUL50 and UL49A means that they overlap their respective promoter regions. 
Fisher & Preston (1986) generated the HSV-l mutant dufl218 which contains 
an insertion of 12 base pairs at the KpnJ site within the UL50 ORF (see Section 5.3.2 & 
5.3.3). Inactivation of the HSV-l dUTPase gene had no effect on growth of the virus in 
tissue culture and demonstrated that the virally encoded dUTPase was non-essential in 
vitro (Fisher & Preston, 1986; Barker & Roizman, 1990). This is not surprising since 
the natural cellular hosts of HSV-l include nondividing cells such as neurons. It has 
been reported that infection with HSV -1 down regulates the host cell dUTPase whereas 
infection with a dUTPase- mutant does not (Lirette & Caradonna, 1990). In the latter 
case it is likely that the virus can rely on the host dUTPase in cell culture. Again, this 
study was carried out with actively dividing HeLa cells and therefore does not represent 
the true picture in vivo. 
Later studies using the mouse model indicated that infection with HSV-l 
dUTPase- mutants results in a marked reduction in neurovirulence, neuroinvasiveness 
and reactivation from latency (Pyles et al., 1992). This gives a better perspective of the 
role of the enzyme in neural tissue. The HSV-l insertion mutant, dufl218 (Fisher & 
Preston, 1986) and a deletion mutant, 17Bl, were tested in vivo (Pyles et aI., 1992). 
Neuroinvasiveness, as measured by footpad inoculation, was over 1,000 fold less than 
wt HSV-l. A complication results from the deletion of the UL49A promoter in mutant 
17B 1. This mutant was constructed with a deletion between base pairs 107028 and 
107956 (UL50 represents bp 107010 to 108123) which includes the promoter region for 
UL49A. Analysis of this mutant demonstrated that UL49A was not transcribed. This 
may have had an effect on invasion and replication in the CNS since UL49A has been 
reported to be a virion membrane protein (Barnett et al., 1992; Jons et at., 1996). 
Furthermore, the restoration of the dUTPase gene in mutant 17B 1 did not restore 
neuroinvasiveness in some isolates suggesting that a second mutation may have been 
inadvertently selected. The insertion mutant dufl 218 was also shown to be over 1,000 
fold less neuroinvasive following footpad inoculation as compared to the wt 17 syn + 
virus. Restoration of the dUTPase gene to this mutant resulted in fully wt viruses. 
Concern that the small, four residue, in-frame insertion may be leaky is unlikely given 
that it disrupts the highly conserved motif 3 which is crucial to substrate binding 
(Section 4.2.5). Further confidence is given in that several groups have not found any 
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HSV -1 specific dUTPase activity in mutant dun 218 (Fisher & Preston, 1986; 
Williams, 1988). 
Even with the reservations in the in vivo study by Pyles et al. (1992) it is likely 
that the virally encoded dUTPase has a role in allowing reactivation from latency and 
viral replication in neuronal cells. HSV-l mutants in thymidine kinase and 
ribonucleotide reductase show reduced replication in neuronal tissue as well as a 
reduction in the capacity to establish latency (Katz et al., 1990; Kosz-Vnenchaak et al., 
1990). It is possible that in adult neurons HSV-l requires dUTPase to redress the 
nucleotide balance before initiating its own DNA replication. 
One of the distinct characteristics of herpesviruses is their ability to establish 
latent infection. EBV has been shown to encode an active dUTPase during infection 
and this enzyme may be required for reactivation and replication in resting epithelial 
tissue or resting B cells (Sommer et aI., 1996). Just as mammalian cells may switch off 
dUTPase to promote nucleotide imbalance and apoptosis (Section 1.4.2), viruses may 
switch on dUTPase to push dTTP synthesis from dUMP thus allowing viral replication 
in otherwise resting cells (Pyles et al., 1992). Studies with PRY and BHV-l indicate 
the presence of active dUTPases and mutants have been constructed and tested in cell 
culture (Jons & Mettenleiter, 1996; Liang et aI., 1993). As expected, in both cases 
dUTPase is dispensable in cell culture. In vivo studies utilising these mutant viruses is 
likely to result in reduced replication and/or reactivation from latency. 
The herpesvirus dUTPases vary in length particularly between the three 
subfamilies of herpesviruses. The longest polypeptide chains are found in the u-
herpesvirus with VZV the largest at 396 residues. The y-herpesviruses include shorter 
chains with EBV at 278 residues and HVS at 287 residues. The f3-herpesvirus, HCMV, 
has been suggested to carry a dUTPase (UL 72) on the basis of its location in the 
genome compared to the other herpesviruses (Chee et al., 1990). There are no 
convincing homologues of the five motifs found in other dUTPases although it 
possesses a herpesvirus exclusive motif (McGeoch, unpublished). This protein is the 
subject of further discussion in the Results section. 
All dUTPases which have been characterised to date (excluding the dUTPase of 
Leishmania major), share five short regions of amino acid similarity termed motifs 1-5 
(Figure 1.12) (McGeoch, 1990b). Excluding the herpesvirus enzymes, all dUTPases 
contain these five motifs in the same order over a roughly similar length protein chain 
around 150 residues. The only major variation from this primary structure in the class I 
enzymes is found in the retrovirus MMTV where the nucleocapsid domain is fused to 
the N-terminus of the dUTPase (Bergman et al., 1994). The herpesvirus dUTPases, or 
class IT dUTPases, share the five common motifs found in class I dUTPases but in a 
different linear order on the polypeptide chain. Motif 3 is displaced to the N-terminal 
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half of the class II protein with regard to the other four motifs. The class II dUTPases 
are approximately double the protein chain length of the class I enzymes and exhibit 
greater length variation. The distance been motifs 4 and 5 is also enlarged compared to 
the class I enzymes (Figure 1.12). 
Figure 1.12 Comparison of the order of the five motifs in a subset of class I (MMTV, 
EIA V, Human and E.coli) and class II (HSV-1 and EBV) dUTPases. 
HSV -1 dUTPase is the best studied of the class II enzymes and unlike the 
trimeric class I enzymes has been shown to be active as a monomer (Caradonna & 
Adamkiewicz, 1984; Persson, 1999, personal communication). EBV dUTPase has also 
been shown to be a monomer and it is likely that the other class II enzymes which share 
this primary structure arrangement are also monomers (Persson et al., 1999). It has 
been suggested that the class II enzymes have arisen by an intragenic duplication of a 
class I enzyme (McGeoch, 1990b). The proposed evolutionary process linking the two 
classes of dUTPase is depicted in Figure l.13. The top figure represents a typical class 
I dUTPase, such as that of E.coli, with five conserved motifs in the class I linear order. 
Intragenic duplication of this gene creates a double length protein chain with two 
copies of the conserved motif regions 1-5. Subsequent loss of motifs 1,2,4 and 5 from 
the N-tenninal half plus motif 3 from the C-tenninal half results in the motif 
arrangement found in the class II dUTPases. 
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Figure 1.13 Schematic representation of a class I intragenic duplication. 
(a) represents the standard class I dUTPase with its conserved motifs 1-5. (b) represents a duplication of 
the class I gene resulting in a double length protein, possessing two copies of motifs 1-5. (c) represents 
the genuine arrangement of the class II dUTPases. The transition from (b) to (c) requires the loss of 
motifs 1,2,4 and 5 in the N-terminal half of the protein and motif 3 in the C-terminal half There must also 
be an insertion of novel sequence between motifs 4 and 5 to account for the extension. 
A model accounting for the observed motif rearrangement in the class II 
enzymes was proposed by (McGeoch, 1990b). This model was based on the 
assumption that the E.coli dUTPase class I enzyme was a tetramer (Shlomai & 
Kornberg, 1978). As described in Section 1.4.7. it is now clear that the E.coli dUTPase 
is, in fact, a trimer. This does not, however, affect the basic idea of the original model 
since the principles are easily transposed onto a trimeric class I molecule. 
A NI1 2 3 4 5 Ie Nt 3 1 2 4 5 Ie 
B 
Figure 1.14 Arrangement of motifs and model for dUTPase quaternary structure. 
A. Linear arrangement of the motifs of class I (left) and class II dUTPases (right). 
B. The left cartoon represents the model ofMcGeoch (1990b), assuming a tetrameric structure for the 
class I dUTPase. The proposed motif positions are shown on two of the four subunits. Each of the two 
active site regions depicted is composed of motifs 1, 2, 4, and 5 from one subunit and motif 3 from the 
other. The right cartoon represents a class II dUTPase monomer, with the C-terminal region in white and 
the N-terminal region shaded. Diagram from McGeoch (1990b). 
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In this model (Figure 1.14), it is proposed that the motifs from each of the class 
I subunits condense to fonn an active site region, creating two active sites per dimer 
(equivalent to four active sites per tetramer). It is proposed that an equivalent 
condensation of the five motifs would result in the fonnation of two active sites in the 
monomer. Loss of one of these active site regions, and subsequent loss of one set of 
motifs would result in the observed class II arrangement. The structural modelling and 
molecular analysis presented in the Results section of this thesis provide insight into 
how the transition from a class I to a class II enzyme could be achieved. This is based 
on the current knowledge that the E. coli and other class I enzymes are trimeric and 
each of their three active sites is composed of motifs from all three subunits. 
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Chapter 2 - Materials 
2.1 Chemicals and reagents 
All chemicals and reagents were purchased from BDH Chemicals UK or Sigma with 
the exception of those listed below and referred to specifically in the Methods section. 
Amersham Life Science 
Beecham Research 
Bio-Rad Laboratories 
Boehringer Mannheim 
Fluka 
FMC Bioproducts 
Gibco BRL Life 
Technologies 
Melford Laboratories 
National Diagnostics 
Pharmacia Biotech 
Prolabo 
Rainbow coloured protein MW markers 
Ampicillin sodium B.P. (Penbritin) 
Ammonium persulphate, Coomassie brilliant blue R250, 
TEMED 
leupeptin, pepstatin, PMSF, agarose MP, 
Tris (2-amino-2(hydroxymethyl )-1 ,3-propanediol) 
Formamide 
NewSieve GTG agarose 
IPTG 
CsCI 
Ecoscint A scintillation fluid 
7-deaza-dGTP, dNTPs, ddNTPs 
Boric acid, butanol, chloroform, ethanol, glacial acetic 
acid, glycerol, hydrochloric acid, isopropanol, methanol 
United States Biochemical Glycerol tolerant gel buffer 
Whatman International Pll cellulose phosphate 
2.2 Solutions 
2.2.1 Standard solutions 
Coomassie stain 
Destain 
DF dyes 
dNTPs 
Formamide dyes 
Kinase buffer (5X) 
Ligation butTer (5X) 
0.2% (w/v) Coomassie Brilliant Blue R250 in 
methanol:water:acetic acid in a 50:50:7 ratio 
5% (v/v) methanol, 7% (v/v) acetic acid in water 
50% (v/v) TBE, 50% (v/v) glycerol, 0.1 % (w/v) 
bromophenol blue 
1.25mM stock (312.5 !JM of each of dATP, dCTP, dGTP, 
dTTP) 
10mM EDT A, 1 mg/ml xylene cyanol FF, 1 mg/ml 
bromophenol blue, 80% (v/v) formamide, pH 8.0 
350mM Tris-HCI (pH 7.5), 50mM MgC12, 25mM DTT 
250mM Tris-HCI (pH 7.6), 50mM MgC12, 5mM DTT, 
5mM ATP, 25% (w/v) PEG 8000 
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PCR buffer (lOX) 
PBS(A) 
PBS-complete 
SEQ buffer (SX) 
Sequencing buffer 
(for Sequenase) 
TAE (SOX) 
TBE (lOX) 
TE 
TFB 
100mM Tris-HCI, ISmM MgCI2, SOOmM KCI, pH 8.3 
170mM NaCl, 3.4mM KCI, 10mM Na2HP04, 
1.8mM KH2P04, pH 7.2 
PBS(A) plus CaC12.2H20 and MgC12.6H20 at 19l1 
200mM Tris-HCI, 80mM MgCI2, pH 7.S 
200mM Tris-HCI, 100mM MgCI2, pH 7.S, 2S0mM NaCl 
0.2M Tris, O.OS EDTA (pH8.0), pH to 8.0 with glacial 
acetic acid 
0.8M Tris, 0.3M boric acid, 0.2mM, EDT A 
lOmM Tris-HCI, ImM EDTA, pH 8.0 
lOmM MES, 100mM RbCI, 4SmM MnCI2.4H20, 
lOmM CaCI2.2H20, 3mM hexammine cobaltic chloride, 
pH6.3 
2.2.2 Glycine SDS PAGE buffers: 
Loading buffer (3X) 29% (v/v) SGB, 6% (w/v) SDS, 2M J3-mecaptoethanol, 
29% (v/v) glycerol, Imglml bromophenol blue 
Resolving gel buffer (RGB) I.5M Tris-HCI, 0.4% (w/v) SDS, pH 8.9 
Stacking gel buffer (SGB) O.SM Tris-HCI, 0.4% (w/v) SDS, pH 6.7 
Tank buffer O.OSM Tris, O.OSM glycine, 0.1% (w/v) SDS 
2.2.3 Lysis Buffers for plasmid sequencing 
Lysozyme solution 0.4% (w/v) Lysozyme, 50mM sucrose, 25mM Tris, 
pH 8.0 
NaOHlSDS 0.2MNaOH, 1% (w/v) SDS 
Potassium acetate solution 3M KAc, 2M acetic acid 
STET 8% sucrose, O.S% triton x-toO, 50mM EDTA (pH 8.0), 
SOmM Tris-HCI, pH 8.0 
2.2.4 Extraction / purification buffers 
illI extraction buffer A SOmM Tris-HCl (pH 8.0), SmM EDTA, 0.2Smg/ml 
lysozyme, SOJ,lg/ml sodium azide 
illI extraction buffer B l.SM NaCI, O.IM CaCI2, O.IM MgC12, 
0.02 mg/ml DNAse I, SOJ,lg/ml sodium azide 
illI periplasmic EB O.SM sucrose, 0.03M Tris, ImM EDTA at a final 
pH of 8.0 after resuspension 
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pET extraction buffer 
FPLC buffer I 
(Phosphocellulose) 
FPLC buffer IT 
(Mono S) 
2.3 Plasmids 
20mM Hepes(pH 7.3), 50mM NaCI, lO%(v/v) glycerol, 
ImM EDTA, ImM EGTA, ImM DTT, ImM PMSF, 
2Jlg/mlleupeptin, 2Jlg/ml pepstatin A, 
O. 1 % polyoxyethylene-l O-tridecyl ether 
20mM Hepes(pH 7.3), 50mM NaCl, lO%(v/v) 
glycerol, ImM EDTA, ImM EGTA, ImM DTT, 
ImM PMSF, 2Jlg/mlleupeptin, 2Jlg/ml pepstatin A, 
0.01 % polyoxyethyiene-IO-tridecyl ether 
50mM MES(pH 6.5), 100mM NaCl, lO%(v/v) 
glycerol, ImMEDTA, ImMEGTA, ImMDTT, 
ImM PMSF, 2Jlg/mlleupeptin, 2Jlg/ml pepstatin A, 
0.01% polyoxyethyiene-IO-tridecyl ether 
Commercially available plasmid, pFLAG.A TS, was used in the Kodak IBI 
expression system and plasmids, pET3a and pET23a, in the Novagen pET expression 
system. The plasmid construct pET3a1UL50, containing the HSV-I dUTPase ORF, was 
a kind gift from 0. BjOmberg, Dept. Biochemistry, University of Lund, Sweden. 
Details of this construct are given in Section 5.1.3.2. 
2.4 Enzymes 
Restriction enzymes were obtained from Boehringer Mannheim or New England 
Biolabs. DNase I and lysozyme were purchased from Sigma. T4 DNA ligase, T4 
polynucleotide kinase, calf intestinal phosphatase, DNA polymerase I (Klenow 
fragment) T7 DNA polymerase and Taq polymerase were purchased from Boehringer 
Mannheim. Gene 32 protein was purchased from Pharmacia. 
2.5 Synthetic oligonucleotides 
Oligonucleotides were synthesised for PCR, sequencing and mutagenesis on a 
Cruachem PS250 automated synthesiser mainly by myself but also by Mr R. Van 
Deursen and Mr R. Reid. A detailed description of their synthesis is given in section 
3.l.l. 
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2.6 Peptides 
Peptides were prepared by Mrs K. McAulay and Miss G. McVey using a 
Shimadzu PSSM-8 peptide synthesiser. Peptides with purities below 70% were purified 
by HPLC (Beckman System Gold). 
2.7 Bacteria 
E. coli strains 
DHSa [F-,supE44 AlacUI69 (q,80lacZ AMIS) hsdRI7 recAI endAI gyrA96 fhi-l 
relAI] 
Used for maintenance and propagation of plasmid DNA 
BL2I(DE3)pLysS [hsdS gal (AcIts8S7 indl sam7 ninS lacUVS-T7 gene 1)] 
Used for expression of recombinant proteins using the pET T7 system 
(Novagen, Inc.) T7 RNA polymerase is carried on bacteriophage ",DE3 which 
is integrated into the chromosome ofBL21 (Studier et aI., 1990). 
CHS26 DAM- [F-, araB/(lac pro) thi, strA] 
Used for propagation of plasm ids with DAM methylation sites allowing efficient 
restiction digestion. 
NMS22 [recA+, supE, thi, A(lac-proAB), hsdS(F',proAB, lacIQ, lacZAMI5)] 
Used as a recipient host for mutagenic plasmids during Kunkel mutagenesis. 
BW313 [dur, ung-, recAI, thi-I, relA spoTIIF'lysA, Hfr KLI6(P04S)] 
Used for the production of uracil enriched plasmid DNA during Kunkel 
mutagenesis and as a dUTPase negative host and control strain. 
2.8 Bacteria Culture Media 
L-Broth 
2YT Broth 
IOgll NaCI, IOgil Difco Bactotryptone, Sg/l yeast extract, pH 7.S 
5g1l NaCI, 16g/1 Difco Bactotryptone, 109/I yeast extract, pH 7.0 
L-Broth Agar 1.5% (w/v) agar in L-broth 
Antibiotics were used at the following concentrations as required~ 
Ampicillin IOOJlg/ml for bacteria containing pFLAG.ATS and pET plasmids 
Chloramphenicol 25Jlglml for strain BL2I(DE3) harbouring the pLysS plasmid 
Kanamycin 70Jlg/ml was used for propagation of the K07 helper phage 
Tetracycline 20Jlg/ml was used for VZV dUTPase donor plasmid KpnC29 
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2.9 Radiochemicals 
Radiochemicals were purchased from Amersham International pIc. with the 
following specific activities: 
Seguencing label: 
[a-35S] deoxyadenosine thiotriphosphate, 1000Cilmmol (lOJ.!CilJ.!l) 
[a-35S] deoxycytosine thiotriphosphate, 1000Cilmmoi (lOJ.!Ci/J.!l) 
Terminator cycle sequencing labels: 
[a_33p] ddGTP 1 
[a_33p] ddA TP I all at 1500Ci/mmol, 450J.!Ci/ml 
[a_33p] ddTTP I 
[a_33p] ddCTP J 
dUTPase assay label: 
deoxy[5-3H] uridine 5'triphosphate, 19Cilmmol (lJ.!Ci/J.!l) 
2.10 Other materials 
DNA purification 
Pharmacia Biotech Sephaglas Band Prep Kit 
DNA seguencing 
Amersham Life Science, United States Biochemical (USB) 
-Sequenase Version 2.0 DNA Sequencing Kit 
-Sequenase Quick-Denature Plasmid Sequencing Kit 
Amersham Life Science 
-Thermo Sequenase Cycle Sequencing Kit 
-Thermo Sequenase Radiolabelled Terminator Cycle Sequencing Kit 
High efficiency ligation 
Amersham T 4 Ligation Kit 
Preparation of plasmid DNA 
Qiagen QIAprep Spin Plasmid Mini-Prep Kit (small scale) 
Promega Wizard DNA Maxi-Prep Kit (large scale) 
Protein concentration 
Amicon Centriplus Concentrators 
Spectrum SpectraIPor 3 dialysis membrane 
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Chapter 3 - Methods 
3.1 DNA manipulation 
3.1.1 Oligonucleotide synthesis and purification 
Chemical Synthesis 
Synthesis was by cyanoethyl phosphoramidite chemistry on controlled pore 
glass (CPG) columns. The first nucleoside which forms the 3' end of the synthetic DNA 
is attached to the CPG surface via an ester linkage and a hydrocarbon spacer. To allow 
the correct polarity of chemical synthesis (3' --+ 5') the 5'OH is protected with a 
dimethoxytrityl group (DMT). Mononucleotides are added sequentially using the 
following method: 
1. Deprotection - the 5' DMT acid labile protecting group is removed producing the 
5' OH to react with the next base. 
2. Coupling - phosphoramidite is activated by tetrazole and covalent bond formed 
3. Capping - chains with failed additions are capped 
4. Oxidation - the phosphite internucleotide bond is oxidised. 
Steps 1-4 are repeated for each base addition. 
The ester linkage to the CPG can then be cleaved with ammonium hydroxide (0.88 
specific gravity) leaving the DNA with a free 3' OH. The protecting groups of A, G and 
C are removed by incubation for 5hr at 55°C and the DNA is lyophilised under vacuum. 
For standard sequencing reactions, oligonucleotides were resuspended in water and 
used directly. For more stringent applications such as mutagenesis, oligonucleotides 
were resuspended in deionised formamide and TBE then gel purified. 
Oligonucleotide purification 
Purification was performed by denaturing polyacrylamide gel electrophoresis on 
a 12% gel (acrylamide:bisacrylamide 19:1) with 8M urea, and IX TBE. Polymerisation 
was by addition of O.Olvol 10% APS and O.OOlvol TEMED. Samples were heated at 
100°C for Imin with an equal volume of formamide before loading. Formamide dyes 
were loaded in adjacent wells. Samples were electrophoresed in gels (1.5mm thick x 
25cm long) at 250 V for 3-5hr in IX TBE running buffer. Bands were visualised under 
short wave UV light by shadowing with an intensifying screen and excised from the gel. 
Urea was removed from the slices by washing for 2min in 3ml of water. DNA was 
passively eluted by washing the slice in 3ml TE buffer overnight at 37°C with shaking. 
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Fragments of acrylamide were removed from the solution by spinning for 5min in a 
microfuge and transferring the supernatant to a 30ml siliconised glass Corex tube. 
DNA was precipitated with 2.5vol of 100% ethanol plus O.Ivol of 3M sodium acetate 
(pH 4.6), incubated on dry ice for Ihr and spun at 10K (Sorvall, SS34 rotor) for 10m in. 
Pellet was recovered in IOOJ.lI of water and diluted accordingly based on the absorbance 
at 260nm. 
3.1.2 Polymerase chain reaction (peR) amplification of DNA 
PCR was carried out using various primer pairs designed to amplify the chosen 
target sequence, give restriction sites for cloning and introduce stop codons in the target 
open reading frame. Taq DNA polymerase was employed in the majority of PCR 
reactions. Pfu DNA polymerase, which lacks terminal transferase activity, was used 
occasionally depending on the cloning protocol. A standard 50J.lI reaction was as 
follows: 
Reagent 
Buffer (lOX) 
Template DNA 
Primers 
dNTPs 
Taq DNA polymerase 
H20 
Final concentration 
IX 
< IJ.lg/100ml 
O.1-1.0J.lM each 
20-200J.lM each 
0.5-2.5U 
up to 50J.lI 
The standard lOX PCR buffer supplied by Boehringer Mannheim contains 15mM 
MgC12. PCR buffer was prepared from stock chemicals when titrating Mg2+ levels 
down to ImM. All samples were overlaid with 50J.ll mineral oil to prevent evaporation. 
A standard set of cycling temperatures is as follows: 
(95°C, 4min / 55°C, 2min / 72°C, 3min) x 1 
(95°C, Imin / 55°C, 2min / 72°C, 3min) x 25 
These reaction concentrations and cycling conditions were varied for each template / 
primer set in order to obtain a good product yield without non-specific primer 
annealing. Titration of template DNA, primers, and Mg2+ concentrations proved to be 
the most useful. 
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3.1.3 Agarose gel electrophoresis 
DNA fragments generated by PCR or restriction digests were analysed on 0.8-
1.5% agarose gels containing 0.5J..1.g/ml ethidium bromide in IX TBE. Samples were 
prepared in loading buffer (DF dyes) and electrophoresis was performed at 100V for 1-3 
hr. DNA bands were visualised using short wave UV light and photographed with 
either Polaroid film (type 667) or using a digital camera. 
3.1.4 Purification of DNA fragments 
DNA fragments were separated by electrophoresis using 3% NuSieve GTG 
Agarose to allow good separation and easy melting of the gel. Fragments were 
visualised under long wave UV light for very short periods to minimise DNA damage. 
Appropriate bands were excised and purified using the Sephaglas Band Prep kit 
(Pharmacia). In this method DNA was bound to a silica matrix in the presence of a 
high concentration of sodium iodide (Vogel stein & Gillespie, 1979). 
Excised agarose blocks were dissolved with IJ.lI of gel solubiliser (NaI solution) 
per mg of agarose. The Sephaglas (silica matrix) was added (5J.lI per J..I.g DNA), 
vortexed and left to bind at room temperature for 5min. Three rounds of brief 
centrifugation and washing with wash buffer (8X volume of Sephaglas added) were 
performed before a final elution in 20J..l.l (or 4X volume of Sephaglas) of elution buffer 
at RT for 5min. The matrix was then pelleted by a brief centrifugation and the 
supernatant, containing the purified DNA, was recovered and stored at -20°C. 
3.1.5 DNA restriction digests 
Restriction enzyme digestion was carried out in 20J.lI volumes at 37°C (or 
temperature specified by the supplier). Samples were digested in the appropriate buffer 
(Boehringer Mannheim system) using approximately 1 unit of enzyme per 0.5J..1.g DNA 
for I-3hr. Generally 0.5J..1.g of DNA was digested for agarose gel analysis and up to 
IOJ..l.g for the isolation of specific restriction fragments. Samples prepared using the 
miniprep method (section 3.1.10) were digested in the presence of RNaseA at I o J..I.g/m I. 
Digestion with the restriction enzyme KpnI was performed with the addition of 
100J..l.g/ml BSA. 
3.1.6 DNA cloning 
Plasmid DNA was linearised for cloning using the appropriate restriction 
enzymes. Double digestion was monitored by checking the efficiency of each 
restriction enzyme separately and also testing for the re-ligation of double digested 
vectors. End repair (phosphate removal from 5' ends) was performed as necessary using 
calf intestinal phosphatase (30min, 37°C) followed by phenoVchloroform extraction 
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and ethanol precipitation. Restriction fragments generated by enzymes that produce 5' 
extensions were made blunt ended by incubating with 50JJM of each dNTP and 0.5 unit! 
J..lg of Klenow polymerase for 30min at room temperature. Again, samples were 
extracted with phenoUchloroform and ethanol precipitated. Ligation was performed in 
20J..lI volumes at 16°C for 3hr using 2 units of T4 DNA ligase in ligation buffer with 
various ratios of vector:insert. Alternatively the Amersham T4 Ligation system was 
employed allowing higher ligation efficiency with an incubation time of approximately 
30min (Hayashi et ai., 1986). 
3.1.7 Transformation for growth and maintenance of plasmid DNA 
The method of Hanahan (1983) was used to make competent E.coli giving up to 
100 times the number of recombinants obtained compared to standard calcium chloride 
methods. An individual colony from a streaked plate of bacteria was picked into 10ml 
of 2YT broth and grown up overnight at 37°C with shaking. 100m I of 2YT was 
inoculated with 1 ml of the overnight culture and grown at 37°C, with shaking, to an 
OD600 of 0.4-0.6. 30ml of culture was spun at 2K rpm (Sorvall SS34 rotor) for 10min 
at 4°C. The pellet was gently resuspended in 2.5ml cold TFB and incubated on ice. 
100J..l1 of DMSO was added after 15min, followed by 100J..l1 DTTlKAc solution after a 
further 10m in. A final 100J..lI aliquot of DMSO was added after a further 5min. Cells 
were used directly and not stored. Generally 10J..lI of the ligation mix, about lOng 
plasmid (section 3.1.6), was added to 200J..lI of competent cells and incubated on ice for 
45min. Cells were heat shocked for 3min at 42°C before spreading on L-broth agar 
plates containing appropriate antibiotics. Plates were incubated overnight at 37°C and 
screening was performed by picking single colonies and extracting DNA by the 
miniprep method (section 3.1.10). Clones were then analysed by mobility change or 
restriction profile using agarose gel electrophoresis (section 3.1.3). Positive clones 
were sequenced to determine the correct positioning of the insert in the vector and to 
check for the absence of mutations. 
3.1.8 Transformation for protein expression 
A modification to the protocol in 3. 1.7 was used when transforming bacteria for 
expression of recombinant proteins in the pET system. Glycerol stocks of 
BL21(DE3)pLysS were streaked to single colonies on LB-agar plates with antibiotics 
and grown overnight at 37°C. One isolated single colony was picked and streaked on 
another LB-agar plate and grown at 37°C overnight. This step was repeated again. 
Several single colonies were picked into 200J..l1 cold TFB and incubated for 30min 
before addition of the transforming plasmid. No DMSO or DTTlKAc solutions were 
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used. Transformation was as in section 3.1.7. Repeated streaking of bacteria to single 
colonies improved expression and reduced variation between different cultures. 
3.1.9 Glycerol stocks 
Glycerol stocks were prepared by inoculating 10ml of L-broth containing 
appropriate antibiotics with a single bacterial colony and incubating overnight at 37DC 
in an orbital shaker. Aliquots of 1.5ml were spun briefly in a microfuge and pellets 
were resuspended in 0.75ml of 2% Bactopeptone plus 0.75ml of 80% glycerol. Stocks 
were kept at _20DC and -70DC. All glycerol stocks were streaked to single colonies 
before use. 
3.1.10 Miniprep plasmid DNA preparation 
Small scale preparation of plasmid DNA was performed using three methods 
depending on the final quality of DNA required. 
Method 1 - for bulk screening 
lOml of bacteria were grown up at 37°C with shaking overnight. A 1.5ml 
aliquot was pelleted by spinning in a microfuge for 20sec at 13,000 rpm and 
resuspended in 350J.11 of STET buffer plus 25J.11 (lOmg/ml) of freshly prepared 
lysozyme solution. Tubes were vortexed and then placed in a boiling water bath for 
40sec. Cell debris was pelleted by centrifugation for 15min. Pellets were removed with 
a toothpick and discarded. DNA was precipitated by addition of 40J.11 2.5M NaOAc 
plus 420J.11 isopropanol and samples were incubated on dry ice for 30min. The solution 
was then spun at 13K in a microfuge for 10min and pellets were recovered, air dried 
and dissolved in 1O-20J.11 of IX TE or water. Approximately 25% of sample was 
electrophoresed and visualised on an agarose gel. 
Method 2 - for sequencing 
15ml of bacteria were grown up at 37°C with shaking overnight. Bacteria were 
spun at 10K rpm (Sorvall SS34 rotor) for 15min, resuspended in lmllysozyme solution 
and left at room temperature for 5min. 2ml of NaOHlSDS solution was added and 
incubated for 5min on ice. The solution was neutralised by the addition of 1.5ml KAc 
solution, left on ice for 5min then spun at 10K for 15min at 4°C. The supernatant was 
extracted with phenol/chloroform then precipitated for 30min after the addition of two 
volumes of ethanol. The sample was spun at 10K for IOmin at 4°C and the pellet was 
washed with 70% ethanol, dried and dissolved in 100J.11 TE. 2J.11 of IOmg/ml RNase A 
was added and incubated at 37DC for 30min. DNA was precipitated by the addition of 
60J.1120% PEG/2.5M NaCI and left on ice for Ihr. Sample was spun in a microfuge for 
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5min then washed with 70% ethanol and dried. Pellet was resuspended in 18J.1.1 TE and 
DNA was denatured by adding 2).l1 of 2M NaOH and incubating at room temperature 
for 5min. Solution was neutralised by the addition of 8).l1 5M ammonium acetate and 
precipitated with 100J.l.I of ethanol on dry ice for 5min. The sample was spun in a 
microfuge for 10min then washed again with 70% ethanol and dried. The pellet was 
dissolved in 20).l1 TE and 2).l1 were used per sequence reaction. 
Method 3 - for sequencing 
Plasmid DNA was also prepared using Qiagen mini-columns using the 
manufacturer's standard protocol. Basically overnight cultures were pelleted, 
resuspended and lysed with NaOHlSDS. The cleared lysate containing the DNA was 
then adsorbed to a silica-gel membrane which was washed and eluted. In the case of 
low copy number plasmids the starting culture was increased from the standard 1.5ml 
up to 10ml to increase the yield of plasmid DNA. DNA produced from these columns 
was suitably clean to allow sequencing after denaturation. 
3.1.11 Large scale plasmid DNA purification 
Most large scale preparations of plasmid DNA were done using the Promega 
Wizard kit which has the advantage of speed and reproducibility and does not involve 
the large quantity of ethidium bromide used in CsCI purification. The Qiagen large 
scale plasmid purification system was also tried but was slower and produced a 
significantly lower yield (lOX) of plasmid DNA per litre of bacterial culture. 
Purification by Wizard Maxipreps 
Method was performed using the standard commercial protocol. Briefly: 
A 500ml culture was grown up at 37°C overnight with shaking. Cells were pelleted by 
centrifugation at 8K rpm (Sorvall GSA rotor) for 10min, 4°C and resuspended in 15ml 
of resuspension buffer containing 100).lglml RNase A. Cells were lysed with 15ml lysis 
solution (O.2M NaOH, 1% SDS) for up to 20min until solution was clear and viscous. 
15ml neutralisation solution was added (l.32M KAc, pH 4.8) and the sample was 
centrifuged at 8K rpm (Sorvall GSA rotor) for 15min, 4°C. The supernatant was 
decanted and O.6vol isopropanol were added. Sample was centrifuged at 8K rpm 
(Sorvall SS34 rotor) for 15min, 4°C and the DNA pellet resuspended in 2ml TE. The 
DNA solution was then bound to lOml of the Wizard DNA binding resin and poured 
into a column. The bound DNA was washed several times with ethanol solution before 
elution with 1.5ml of preheated (65-70°C) TE. Up to Img of plasmid DNA was 
obtained from 500ml of bacterial culture. 
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3.1.12 Preparation of ssDNA by phage rescue 
The basic method involves infecting a culture with single stranded phage and 
allowing replication of the plasmid carrying a single stranded origin of replication. 
Phage is then recovered, precipitated and ssDNA extracted. 
A single bacterial colony was inoculated into 5ml 2YT broth with antibiotics 
and K07 helper phage at 108pfu/ml. The culture was grown for 1-2hr at 37°C with 
vigorous shaking. Kanamycin was added to a final concentration of 70J..Lglml and the 
culture was grown at 37°C for a further 16-24hr. 1.5ml aliquots of bacterial culture 
were centrifuged for 10min and 1 ml supernatant collected in a fresh Eppendorf Phage 
particles were precipitated by the addition of300J..L1 of 20% (w/v) PEG / 2.5M NaCI and 
incubation on ice for 15min. Samples were microfuged for 5min at 9K rpm and 
supernatant discarded. This step was repeated to remove all traces of PEG which can 
produce background smearing during sequencing. The pellet was resuspended in 400J..LI 
0.3M sodium acetate, pH 6.0 / ImM EDTA and vortexed. DNA was extracted with one 
vol phenol/chloroform for 1-2min, ethanol precipitated and resuspended in 10J..L1. 
Generally 5J..LI was used per sequence reaction. 
3.1.13 DNA sequencing 
Sequencing of DNA was performed using several different commercial kits all 
based on the dideoxy chain termination method of Sanger et al. (1977). 
Sequenase 2.0 kits (United States Biochemical) 
This method is split into four sections: template preparation, annealing, labelling and 
termination. 
Template preparation: 
Single stranded template DNA was prepared either as in section (3.1.10) or in one of 
the following ways: 
1. NaOH denaturation 
Purified plasmid DNA (0.5-3J..Lg) was denatured at 37°C for IOmin in an IIJ.lI 
reaction volume containing IJ..Ll primer (5pmol) and 2J..LI 1.0M NaOH. The sample was 
then cooled on ice and neutralised by the addition of2J..L1 1.0M HCI. 
2. Glycol heat denaturation 
Purified plasmid DNA (0.5-3J..Lg) was combined with primer (5pmol) and a 
denaturing mix (IOmM Tris-HCI, pH 7.5, ImM EDTA, 50% glycerol, 50% ethylene 
glycol) up to a total volume of 13J..L1. Samples were incubated at 90-100°C for 5mins 
then cooled on ice. 
3. Preparation of ssDNA using bacteriophage (See section 3.1.12) 
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Annealing: 
Plasmid reaction buffer (400mM Tris-HCI, pH 7.5, 100mM MgCh, 250mM NaCl) was 
added to a total volume of 15J.lI and the primer/template/buffer mix was annealed at 
37°C for 10min. 
Labelling: 
The commercial labelling mix was diluted to 1.5J.1M 7-deaza-dGTP, 1.5J.1M dCTP, 
1.5J.1M dTTP and the following solution was made up: 
Ice cold annealed DNA mixture 
DTT,O.IM 
Diluted labelling mix 2J.lI 
5J.lCi [a._35S]-dATP 0.5J.lI 
Sequenase T7 DNA Polymerase 2J.lI (3U) 
Solution was mixed and incubated for 2-5min (5-lOmin for glycol denatured plasmid) 
atRT. 
Termination: 
Four aliquots of 4.5J.11 from the labelling reaction were transferred into 2.5J.lI of each of 
the four termination reactions (containing 3 dNTPs and one ddNTP) and incubated at 
37°C for 5min. Termination solutions contain: 80J..lM of three dNTPs, 8J.lM of the 
remaining ddNTP and 50mM NaCl. Reactions were stopped by the addition of 4J.11 of 
stop solution (95% formamide, 20mM EDTA, 0.05% bromophenol blue, 0.05% xylene 
cyanol FF) or freezing at -20°C before subsequent loading. 
Thermo Sequeoase 
Thermo Sequenase is a thermostable DNA polymerase used with the cycle 
sequencing method. This method uses repeated cycles of thermal denaturation, 
annealing and extension/termination for increased signal levels relative to standard 
sequencing. Advantages include the very small amount of template required and the 
complete denaturing afforded at each cycle allows greater readability of high G+C 
areas. Two different kits were used. 
1. Standard cycle sequencing 
Labelling: 
An oligonucleotide primer is designed which will allow a brief extension in a reaction 
mix containing one labelled dNTP and only two non-labelled dNTPs. This results in 
termination of the labelling step when the missing base is reached in the template. The 
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reaction is thermally cycled (typically 60°C-90°C, 30-50 times) and results in the 
production of labelled, extended primer whose length is dependant on the template 
sequence. 
Chain termination: 
In the second step the concentration of all the dNTPs is increased and the reaction is 
split into four tubes each with a different ddNTP. The reactions are thermally cycled 
(typically 95°C-72°C, 30-60 times) until all the growing DNA chains are terminated by 
a ddNTP. The final products are denatured with formamide and heating before 
subsequent loading. 
2. Radiolabelled terminator cycle sequencing 
The methodology behind this technique is based on standard cycle sequencing with the 
exception that label is incorporated into the sequencing reaction by the use of four 
[a-33P]ddNTP terminators in a one-step reaction. Four reactions are set up containing 
all four dNTPs with a lower concentration of one of the four labelled ddNTPs. 
Reactions are thermally cycled until all chains have terminated. Efficiency is greater 
than other methods because only terminated chains are labelled therefore there are no 
stop artifacts and a there is a reduction of background bands. There is also a greater 
flexibility as there is no constraints on the primer sequence as in the standard cycle 
sequencmg. 
Visualisation of sequenced products 
Denaturing electrophoresis for all sequencmg methods was performed 
essentially as in section 3.1.1 with the following modifications. Sequencing gels 
(0.35mm thick and 35cm long) were prepared using 6% acrylamide and 0.5X TBE. 
Samples were heated at 100°C in formamide dyes and loaded on a pre-run gel (20m in) 
and then electophoresed at lOOW for Ihr. This is a higher wattage than most protocols 
recommend as it was found that the subsequent increase in temperature in the gel 
allowed better denaturation and elucidation of compressions. Glycerol tolerant gel 
buffer (taurine replaces boric acid) was used when the glycol method of plasmid 
denaturation was performed. Plates were separated and gel was washed on one plate 
with 10% acetic acid (X3) thus removing the urea. Gels were transferred onto paper 
and dried under vacuum at 80°C for 1 hr. Gels were exposed to film from between 1 
and 5 days depending on the intensity of the signal. Autoradiographs were developed 
for reading using an automatic X-Omat machine. 
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3.1.14 Kunkel mutagenesis 
This method is a version of that of Kunkel (1985; 1987). Uracil enriched DNA 
was made by transforming the E.coli strain BW313 with a recombinant pET-23a 
plasmid carrying a single stranded origin of replication. BW313 lacks dUTPase and 
uracil DNA glycosylase allowing incorporation of uracil into newly replicated plasmid. 
Single stranded uracil enriched DNA is produced by infection and precipitation of the 
M13 R408 helper phage. A mutagenic olionucleotide was annealed to the recovered 
plasmid DNA and a new strand was synthesised in vitro. This double stranded plasmid 
was transformed into the E.coli strain NM522 which carries an active uracil DNA 
glycosylase (Mead et ai., 1985). This enzyme catalyses the destruction of the uracil 
containing strand leaving the synthesised mutagenic strand to act as a template for 
replication. dsDNA plasmid mutants were then recovered from the bacteria using the 
miniprep method (section 3.1.10). 
Preparation of uracil enriched ssDNA: 
10mi of2YT broth plus 100J.1g/ml ampicillin and IOOJ.1g/ml uridine was inoculated with 
50J.11 glycerol stock of E.coli BW313 and grown overnight at 37°C with shaking. The 
overnight culture was added to 200ml 2YT plus lOOJ..1g/ml uridine in a 21 baffled flask. 
The culture was grown at 37°C to an OD600 of 0.3 prior to addition of M13 R408 
helper phage to 5.04x109 pfulml. Growth was continued for 8hr at 37°C with shaking. 
The culture was centrifuged for 20min at 7K rpm (Sorvall GSA rotor), 4°C. 
Supernatant was collected and the spin was repeated. Supernatant was collected in a 
300ml glass bottle and stored at 4°C overnight. Phage was precipitated by addition of 
0.25vol 3.75M ammonium acetate / 20% PEG and incubation on ice for 30min. Sample 
was centrifuged at 9K rpm (Sorvall GSA rotor) for 30min, supernatant discarded and 
the pellet resuspended in 200ui TE. DNA was recovered by two chloroform 
extractions, six phenol/chloroform extractions and one final chloroform extraction. The 
aqueous layer was removed and DNA precipitated with 0.36vol 7.5M ammonium 
acetate and 2.5vol ethanol and incubated on ice for 20min. Sample was spun for 20m in 
at full speed in a microfuge, and pellet was washed with 70% ethanol and dried before 
resuspension in 50J..11 water. DNA was visualised by agarose gel electrophoresis and 
concentration determined by measuring the OD at 260nm. 
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Mutagenic strand synthesis: 
Mutagenic oligonucleotides were kinased at 37°C for 30min, followed by 15min at 
65°C to stop the reaction. A typical reaction with final concentrations was as follows: 
Oligonucleotide 
Ligation buffer 
T4 Kinase 
H20 
500pmol 
IX 
IOU 
up to 20J..lI 
80J..lI of water was added to the stopped reaction to give a kinased oligonucleotide stock 
of5pmoVJ..l1. 0.1 pmoVJ..l1 of the prepared uracil enriched ssDNA was annealed to IJ..lI of 
the kinased oligonucleotide stock with 2J..lI TM buffer in a lOJ..lI total volume. Samples 
were annealed at 37°C for 30min. T7 DNA polymerase was found to be the most 
efficient enzyme for second strand synthesis. A typical reaction is as follows: 
Annealing mix (above) lOJ..lI 
SEQ buffer (5X) 2J..lI 
dNTPs(5mM) lJ..l1 
ATP(5mM) 1 J..lI 
DTT(lOOmM) IJ..lI 
Acetylated BSA (lJ..lglul) 2J..lI 
Gene 32 protein 0.51l1 
T4 DNA ligase 31ll (3U) 
T4 kinase 0.51l1 (5U) 
T7 DNA polymerase IJ..lI (lU) 
The reactions were incubated at 37°C for Ihr then stored at -20°C before transformation 
into the E.coli strain NM522. Single colonies were picked and screened by the 
miniprep method (Section 3.1.10). Initial mutations were designed to allow screening 
by restriction digest allowing optimisation of the technique. Subsequent mutations 
were screened by single track sequencing. 
3.2 Polypeptide analysis 
3.2.1 Expression of recombinant proteins 
It was found that the quality of the bacteria carrying the recombinant expression 
plasmid was vital to maintain consistent and stable expression of recombinant protein. 
Care was taken to streak host strain several times after recovery from glycerol stocks. 
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Plasmids were transformed immediately before expression and overnight cultures were 
avoided as much as possible. Two bacterial expression systems were utilised: 
(a)Kodak mI system 
The initial system for the production of recombinant proteins was the Kodak illI 
FLAG system. This system was based on a tac promotor (a hybrid between the trp 
promoter and the lac operator) allowing induction of expression under the standard lac 
system via IPTG. Transcripts were generated as fusion proteins to the FLAG peptide. 
This octapeptide marker was designed to allow detection and purification of the 
recombinant fusion protein with specific FLAG monoclonal antibodies. This peptide 
had an enterokinase cleavage site for removal of the fusion to yield the native protein. 
The OmpA signal peptide could also be fused to the protein to allow secretion of the 
protein to the peri plasmic space (see Section 5.1.2). 
(b) pET system 
The majority of proteins were expressed in the pET vector system originally 
constructed by Studier (1990) and now sold by Novagen Inc. This system utilises the 
strong bacteriophage T7 promoter. Expression was induced by providing a source of 
T7 RNA polymerase which is not present in the normal host cell. This allowed 
propagation of recombinant plasmids without the selective pressure associated with low 
levels of uninduced expression in other systems. Plasmids were then transferred into 
the BL21(DE3)pLysS strain which carries a chromosomal copy of the T7 RNA 
polymerase under lacUV5 control. Induction was then performed with the addition of 
IPTG. 
General protocol for expressing recombinant dUTPase 
Ampicillin was used at 150J.!g/ml to maintain the pET construct and 
chloramphenicol was used at 25J.!glml to maintain the pLysS plasmid. A 10ml culture 
was prepared by inoculation with a single colony of freshly transformed 
BL21(DE3)pLysS bacteria containing the appropriate pET construct. This culture was 
then used to inoculate 300ml ofL-broth containing the above antibiotics. Cultures were 
grown at 30-37°C until they reached an OD of 0.7 at 600nm. Induction of recombinant 
protein synthesis was performed by the addition of IPTG at concentrations ranging 
from 0.1-1.0mM. Cultures were grown at temperatures ranging from 20-37°C 
depending on the construct used. Lower temperatures were found to increase protein 
solubility in some cases. 
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3.2.2 Protein extraction 
Proteins were extracted in buffers appropriate to the expression system being 
used. Generally 250ml aliquots of culture were chilled on ice for 10min and then 
centrifuged for 15min at 10K rpm (Sorvall GSA rotor), 4°C. Supernatant was discarded 
and the pellet resuspended in 50ml extraction buffer. In the Kodak mI system, lysis 
was performed by the incorporation of lysozyme and detergent in the extraction buffer 
(section 2.2). In the pET system, detergent and freeze thawing (X3) was sufficient to 
disrupt the cell membrane releasing the indigenous lysozyme of the BL21 (DE3 )pLys 
E.coli strain resulting in efficient lysis. Variations on the constituents of the extraction 
buffers and their effects are discussed in the Results section. The viscosity of the lysed 
solutions was reduced by passing through a thin syringe needle (X3) before 
centrifugation for 60-90min at 10K rpm (Sorvall SS34 rotor), 4°C. Supernatants 
containing the soluble protein fraction were stored at -20°e. Samples were centrifuged 
again immediately prior to purification by FPLC. Protease inhibitors were maintained 
throughout the extraction process. 
3.2.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
For analysis of proteins single concentration slab gels between 9-12.5% 
acrylamide were used. Stock solutions of 30% acrylamide were prepared using a ratio 
of 39: 1 acrylamide to N,N'-methylene bisacrylamide in water, filtered through 
Whatman No. 1 filter paper and stored at 4°C. Gels were prepared at the appropriate 
concentration from this stock solution with freshly made buffer to a final concentration 
of 375mM Tris-Hel (pH 8.9) and 0.1 % sodium dodecylsulphate (SDS). Polymerisation 
was instigated with the addition of freshly made ammonium persulphate and TEMED 
to a final concentration of 0.06% and 0.04% respectively. 
For large gels (20 x 22cm) the gel solution was poured between two thoroughly 
washed glass plates separated by 1.5mm thick spacers and sealed with rubber tubing. 
The gel was left to polymerise at room temperature under a thin layer of butan-2-01. 
The butan-2-01 was removed and the stacking gel was poured consisting of 5% 
acrylamide in 122mM Tris-Hel (pH 6.7), 0.1 % SDS with wells formed using a teflon 
comb. 
SDS-PAGE was also performed using the Bio-Rad miniprotean II apparatus 
allowing faster resolving times and smaller volumes. These gels were not appropriate 
for the resolution of some recombinantly expressed proteins in a background of closely 
migrating E. coli proteins. 
Samples were boiled for 5min in denaturing buffer with sufficient bromophenol 
blue to visualise the dye front. Electrophoresis was carried out in a buffer containing 
52mM Tris, 53mM glycine and 0.1% SDS. Gels were run at 100V until dye front had 
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reached the bottom, approximately 3hr for large gels and Ihr for mini gels. Proteins 
were visualised by fixing and staining in Coomassie brilliant blue R250 solution and 
destained with several washes in 5% methanol and 7% acetic acid. 
3.2.4 Purification by FPLC 
Samples prepared as in section 3.2.2 were purified by phosphocellulose and 
Mono S chromatography using the Pharmacia FPLC system. Phosphocellulose 
(Whatman Pll) columns were prepared fresh according to the manufacturers 
instructions. Phosphocellulose was pretreated with 25vol 1M NaOH for 5min and 
washed 3 times with water. The phosphocellulose was then washed with 25vol 1M HCI 
and washed three times in IX PBS before packing into the columns. Equilibration was 
performed overnight in the appropriate buffer. Mono S cation exchange columns were 
from Pharmacia LKB and were used according to the manufacturers instructions. 
Columns were washed thoroughly and equilibrated before use. 
Generally 10-50ml of sample was applied to the phosphocellulose column at a 
flow rate of ImUmin. A gradient ofO-1.0M NaCI was used to separate protein species 
by ion-exchange chromatography and fractions of 1.5ml were collected and analysed 
for activity. 4ml of the most active fractions were diluted 1/10 in Mono S loading 
buffer and loaded directly onto the Mono S columns. A gradient of 0-1. OM NaCI was 
used to separate proteins and fractions of 1-1.5ml were collected. Samples were 
analysed for activity by enzyme assay (section 3.2.6) and purity by SDS-PAGE (section 
3.2.3). 
3.2.5 Protein quantification 
The total protein concentration was measured using the Bradford assay with 
BSA as a standard (Bradford, 1976). Reactions were performed in flat bottom 
microwell plates with a Labtech Anthos HT2 plate reader. This equipment allows 
instant determination of a standard curve by absorbance at 620nm and calculates the 
protein concentration of the samples. To quantitate the amount of soluble dUTPase in 
each purified sample it was necessary to use SDS-PAGE (section 3.2.3). A dilution 
series of each purified sample was examined by SDS-PAGE and compared with other 
samples and to standard dilutions of BSA. As each sample contained a different 
proportion of dUTPase protein compared to the total protein, this allowed quantitation 
of the dUTPase enzyme specifically. This method was also used as a measure of 
relative enzyme purity. 
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3.2.6 Analysis of enzyme activity 
Analysis of dUTPase activity was performed using two methods, both utilising 
tritiated dUTP as a substrate marker. TLC was the preferred method as both substrate 
(dUTP) and reaction product (dUMP) could both be measured. 
dUTPase reaction 
A typical reaction solution was as follows: 
Potassium phosphate, pH 6.5 
MgCl2 
DTT 
dUTP 
[3H]dUTP 
H20 
0.4M 
20mM 
20mM 
2mM 
0.5J.lCi 
up to 10J.lI 
Reaction mix was preheated to 37°C and 10J.lI enzyme sample is added. Note that the 
final dUTP concentration was ImM. Reaction was stopped after lOmin by the addition 
of 2J.ll 80% formic acid. 
Filter disk assay 
This is a version of the method by Williams and Cheng (1979). Samples were spotted 
onto Whatman DE81 paper disks and washed thoroughly in 4M formic acid / ImM 
ammonium formate three times with a final wash in 95% ethanol. Disks were then 
dried and the bound, non-decomposed [3H]dUTP was quantified by scintillation 
counting. 
TLCAssay 
This is essentially the method of Tye et al. (1977). Polyethyleneimine-cellulose sheets 
(Polygram, Machery-Nagel, Germany) were pre-washed with 1M formic acid and dried. 
Samples were spotted (4x 0.5J.lI) onto the sheets with markers (dUTP and dUMP) and 
TLC was performed in a tank with 1M formic acid and O.5M LiCl. Plates were dried 
and spots were visualised under short wave UV light. Spots were excised and 
quantified by scintillation counting. 
Scintillation counting 
Quantification of radiolabeled samples was performed by immersing either the DE81 
disks or the PEl spots in Ecoscint A. Samples were counted on either a Packard 
1600TR or Beckman LS 5000CE liquid scintilation counter. 
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3.3 Computer-based analysis 
3.3.1 Sequence analysis programs 
Amino acid primary sequence data was examined using various programs in the 
GCG program set running under V AXlVMS. Sequences of dUTPases were obtained 
from the Swiss-Prot database except HSV-2 dUTPase which was sequenced in the 
MRC Virology Unit. Sequence alignments were performed using Pileup, a 
simplification of the method of Feng and Doolittle (1987). The program SAGA was 
also used for alignment comparisons (Notredame et al., 1996). TBALSTX (Altschul el 
al., 1990), available online at the National Centre for Biotechnology Information 
(NCBI), was used for primary sequence searches in the Brookhaven Protein Databank 
(Bernstein et al., 1977). This server can be accessed at www.ncbi.nlm.nih.gov. 
3.3.2 Structure prediction 
Secondary structure prediction was performed using the PredictProtein server at 
the Protein Design Group, EMBL (www.embl-heidelberg.de/predictprotein).This 
server can automatically generate sequence alignments using the MaxHolm method 
(Sander & Schneider, 1991) although most sequences were pre-aligned using the 
programs above (section 3.3.1). The program PHDsec (Rost & Sander, 1993 ~ Rost & 
Sander, 1994~ Rost, 1996) was employed to predict secondary structure. 
Threading based analysis of specific sequences was performed using the 
program Threader available at the Biomolecular Structure and Modelling Unit at 
University College London (Jones et al., 1992). The program Threading Analyst 
(encompassing the front-end graphical interface, tan.tel) was used for interpretation of 
the Threading data (Miller & Thornton, 1995). 
Generation of 3D models based on the HSV-l dUTPase primary amino acid 
sequence was performed using the ProMod program at the Swiss-Model Protein 
Modelling Server (peitsch, 1995; Peitsch, 1996). This server is available online at 
www.expasy.ch!swissmod/SWISS-MODEL.html. 
The calculation of molecular surfaces was performed using the programs 
NewArea (Lee & Richards, 1971) and Sleuth (Dudek & Ponder, 1995) available at 
Washington University (ftp://dasher. wustl.edu/pub/sleuth!). Secondary structure 
assignment based on PDB structural coordinates was performed using the program 
STRIDE (Frishman & Argos, 1995) with details at the EMBL website, (www.embl-
heidelberg. de/argos/stride ), available at ftp.ebi.uk/pub/software/unixlstride. 
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3.3.3 Molecular visualisation tools 
The programs that were used in order to generate diagrammatic representations 
of the molecules analysed in this thesis are listed below. Both the programs Insight II 
and '0' were run on a Silicon Graphics Workstation under the Unix operating system. 
All other viewing programs were run in the PC Windows environment. 
- Insight n by BIOSYM / MSI 
(www.msi.com) 
- WebLab ViewerPro by Molecular Simulation Inc. 
( www.msi.comlweblab/) 
- Swiss-PdbViewer by Glaxo Wellcome Experimental Research 
(www.expasy.ch./spdbv/mainpage.html) 
- Rasmol by R. Sayle (1994) 
(ftp.dcs.ed.ac. uk:/pub/rasmol) 
- CN3D by NCBI 
(www.ncbi.nlm.nih.gov/Structure/cn3d.html) 
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Chapter 4 - Results of Computer Modelling 
4.1 General Introduction 
The main goal of the work presented in this chapter was the construction of a 
model for the HSV-l dUTPase. The main reason for embarking on such a project was 
the absence of structural data for any of the class II dUTPases. Since the primary 
objective of this study was to characterise a member of this group, the HSV-l dUTPase, 
a working model was considered to be an important parallel to complement 
mutagenesis studies. Section 1.4.8 introduced the five motif regions found in both 
class I and class II dUTPases and the intragenic duplication model proposed by DJ. 
McGeoch (1990b). This study, based on primary amino acid sequence analysis, 
constitutes the starting point for modelling of the HSV-l dUTPase. Crystallographic 
data became available for E.coli dUTPase and was used as the original template for the 
class II model. 
In order to construct this model it was necessary to follow a set of logical steps 
which are set out in this chapter as individual sections. Compilation of the available 
information revealed a wealth of primary sequence data for both class I and class II 
dUTPases. The first step was therefore to utilise the class I primary sequences to 
determine common elements within this group. This in turn was used to identify key 
structural elements in the E.coli structure that were likely to be consistent throughout 
the class I group. During the course of this study additional class I structures of FIV, 
human and EIAV dUTPases were solved by X-ray crystallography and allowed 
subsequent refmement of these data. 
The next step was to use extensive alignments with primary sequence data to 
identify areas of homology and variance within the class II group. Finally the data from 
both the class I and class II groups were compiled utilising the set of defined 
hypotheses detailed in Section 4.3.3. 
The primary sequence work was expanded to include secondary structure 
predictions and homology modelling between the two dUTPase classes. Using this 
basis it was possible to model distinct structural elements of the class II group enzymes 
from solved crystallographic data from the class I group. 
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4.2 Class I dUTPases 
4.2.1 Introduction 
The key to creating a model for the HSV-l dUTPase was the understanding of 
the class I enzymes and how they relate to the class II group. To do this, it was first 
necessary to defme the areas of consistent homology within the class I group. 
4.2.2 Comparison of class I primary sequences 
Class I dUTPases from a wide variety of both prokaryotic and eukaryotic 
organisms share remarkably distinct homologous features. The most obvious of these 
features is the presence of the five motif regions identified by OJ. McGeoch (1 990b ). 
These regions of localised homology allow diverse class I sequences to be lined up 
effectively. Figure 4.1 shows an alignment of a selection of class I sequences including 
mammalian, yeast, plant, poxvirus, retrovirus and bacterial species. The Swiss-Prot 
protein database contains many more homologous class I sequences which have yet to 
be validated as functional dUTPases. 
There are several key observations which are apparent from class I sequence 
alignments. The first is the presence of extremely homologous copies of all five motifs 
in the same order. In Figure 4.1, comparison of the highlighted motifs (34 residues in 
total) between the tomato plant, Lyeopersieon eseulentum and the yeast, Candida 
albieans yields a sequence identity of 94%. Even more distantly related species such as 
E. coli and human share 79% identity over these motif regions. The high conservation 
of these loci suggest that not only do they playa vital role in dUTPase functionality but 
that all class I dUTPases operate by a homologous mechanism. This is supported by the 
structural data available so far. 
The second observation is the overall conservation of protein chain length. 
There is some variation at the sequence termini with the retroviruses possessing the 
smallest sequences. The exact N-terminus for some of these dUTPases is not clear and 
is consistent with the retrovirus dUTPases being translated as a polyprotein and 
subsequently cleaved. What is important to note is the variation between the start of 
motif I and the end of motif 5. In this selection of sequences this core distance varies 
by a maximum of 10% between species. This is consistent with all the class I 
sequences analysed. 
Finally it is apparent that although the interlying regions between the motifs are 
substantially divergent between species at the sequence level, the distance between each 
motif is highly conserved. Structural data demonstrate that the active site consists 
almost exclusively of motif residues. 
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Mpmv .....•........ SLWGSQ ......... .. LCSSQQKQPlSKLTRATPGS 
Srv1 . . ...•........ SLWGGQ ..... . ... . . LCSSQQKQPlSKLTRATPGS 
J.rv .... . •..... . .. MLWG .............. NTAGSKRTIADLCRATRGS 
Mmtv .....•..... . .. GVKGSG . . ... . ..... LNPEAPffPlHDLPRGTPGS 
fi v .....•................... . ......... . MIIEGDGILDKRSED 
Omv. . ....•.......................... SEl fLAREGSGlLPKRAED 
Visn . ..... .. .. . .. .. .. . ... . .. .. ...... SEl fLAKEGRGlLQKRAED 
Caev .....•... .. ..................... SElFLAKEGEGILPKREE 
Eiav .....•.......................... . .. MLAYQGTQlKEKRDE 
Coxb .......... . .. MTHSVQLK ........ . . lLDKRLGSEFPLPAYATTGS 
Eeo1 .....•...... MMKKIDVK ..... . ..... ILDPRVGKEfPLPTYATSGS 
Vaccc ............ MfNMNINSP .......... VRfVKETNRAKSPTRQSP 
VarY ... . . . . .. .. . MfNMNlNSP ....... .. . VRfVKETNRAKSPTRQSPY 
Human .....•......... MQ .............. LRfARLSEHATAPTRGS 
Orfv ............. MEfCHTET .......... LQVVRLSQNATIPARGSP 
fadv .......... MDPfGSSSVPPCSTSDLPEPKLYfVRLSPHAVPPVRATH 
Ca1b ............. MTSEDQSLKKQKLESTQSLKVYLRSPKGKVPTKGS 
Seer ......... . ... MTATSDKV . .. ....... LNlQLRSASATVPTKGSAT 
Lyees MAENQlNSPElTEPSPKVQKLDHPENGNVPffRVKKLSENAVLPSRASS 
Cev MDfNTDRGSAlPTGDDRGYQCGVIGDSVRfSVFTGYDAADVSlPKISSPGS 
DL .. CSTSHTVLTPEMGPQALSTGIYGPLPPNTfG.LlLG 
DL .. SSTSHTVLTPEMGPQALSTGlYGPLPPNTfG.LILG 
DL .. CATSYTVLTPEMGVQTLATGVfGPLPPGTVG.LLLG 
DL . . SSQKDLILSLEDGVSLVPTLVKGTLPEGTTG.LllG 
DL . . LAAKElHLL.PGEVKVIPTGVKLMLPKGYWG.LIIG 
DL .. ICPQEVCIP.AGQVRKIPINLRINLKEDQWA.MVGT 
DL . . ICPQEISlP.AGQVKRIAlDLKINLKKDQWA.MIGT 
DL . . ICPEEVTIE.PGQVKCIPIELRLNLKKSQWA.MIAT 
FDL .. CVPYDIMlP.VSDTKIIPTDVKIQVPPNSfG.WVTG 
DLRACLDEPLKIE.PDETCLISTGLAIYLGHSNVAATILP 
DLRACLNDAVELA.PGDTTLVPTGLAIHIADPSLAAMMLP 
DL .. YSAYDYTIP.PGERQLIKTDISMSMPKICYG.RIAP 
DL .. YSAYDYTIP.PGERQLIKTDlSMSMPKFCYG.RIAP 
DL .. YSAYDYTlP.PMEKAVVKTDlQ1ALPSGCYG.RVAP 
DL .. CSAYDCVlP.SHCSRVVFTDLLIKPPSGCYG.RIAP 
DL .. fSAYDIKVP.ARGRALVPTDLVFQfPPGCYG.RI AP 
DL .. YSAEAATlP .AHGQGLVSTDlSIIVPIGTYG. RVAP 
D1 .. YASQDITlP. AMGQGMVSTDISFTVPVGTYG. RIAP 
DL .. SSAAETKVP.ARGKALVPTDLSIAVPQGTYA.RIAP 
fDL .. SVLEDREfI.RGCHYRLPTGLAIAVPRGYVG.IITP 
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Motif 1 Motif 2 
101 197 
Mpmv K.GLQVYP .. GEIKlMA.KAVNNIVTVSQGNR l LLPLlETDNKV .... . .. QQPYRGQGSfGSSDl .................. . 
Srv1 K.GLQVYP .. GEIKlMA.KAVNNIVTVPQGNR I LLPLlETDNKV ....... QQPYRGQGSfGSSDlYW . ............... . 
Jsrv K.GILIHP .. GEIKlLA . SAPNKIIVl NAGQR LLVPLVIQGKTI. .. . .... NRDRQDKGfGSSDAYW . .. .. ...•...• .. .. 
Mmtv KKGLEVLP .. ElKVMV. KAAKNAVIIHKGERl LLLPYLKLPNPVl ....... KEERGSEGfGS PSHVHW .. . .. . ........•. 
Fiv K.GLDVLG .. GEIGVIMINVSRKSITLMERQK l lLPCKH.EVLEQG . . KVVMDSERGDNG¥GSTGVFSSW ......•. . .. .. .. 
Omvs K.GVFVQG .. GI I IQVVVYNSNDKEVI I PQGRKF I LMPLIH.EDLEAW .. GETRRTERGNQGfGSTGAY . ................ . 
Visn NKGVFVQG .. GI TIQVVIYNSNNKEVVI PQGRKF l LMPLIH.EELEPW . . GETRKTERGEQGfGSTGMYW ..... .. ......•... 
Caev K.GVFTQG .. Gl lQVlMYNSNKlAVVl PQGRKF l LMDKKH.GKLEPW .. GESRKTERGEKGfGSTGMY ... . ............. . 
Eiav KQGLLlNG .. G GElQVlCTNlGKSNlKLl EGQKF l lLQHHS . NSRQPW .. DENKlSQRGDKGfGSTGVFW .. . ............. . 
Coxb KHGlVLGNLVG PLMVSCWNRGKEPYTlNPGDR VVLPILK. AQfAVV .. EEFELTERGAGGfGSSGQN .. . ......••. . •• . .. 
Ecol KHGIVLGNLVG LMlSVWNRGQDSFTlQPGER I FVPVVQ.AEfNLV .. EDFDATDRGEGGFGHSGRQ . ......... . ... . .. . 
Vaccc K.GIDIGG .. GNIGVlLINNGKCTFNVNTGDR I YQRlYY.PELEEV .. QSLDSTNRGDQGFGSTGLR ......•... . ....... 
VarY K.GIDIGG .. GNlGVlLlNNGKYTFNVNTGDR I YQRlYY.PELKEV .. QSLDSTDRGDQGFGSTGLR .......... . ...... . 
Human KHfIDVGA .. GNVGVVLfNfGKEKfEVKKGDRI l CERlfY.PElEEA .. QALDDTERGSGGFGSTGKN ................. . 
Orfv KHFIDVGA .. GNVGVVLfNfGNSDFEVKKGDRl l CERlSC. PAVQEV .. NCLDNTDRGDSGFGSTGSGACGGRDTAWnS ..... . 
Fadv KFFIDVGA .. GNVSVVLfNFSESSfNlRRGDRV I LERIMV.PELSEL .. TQLGETDRGASGFGFTGMGAVDRNQRSVLEWLTPGSR 
ca1b KHGlSTGA .. GEVKVVLfNHSEKDFElKEGDRl VLEQlVN .ADIKEISLEELDNTERGEGGFGSTGKN .......... . ...... . 
Seer KNGlQTGA .. GEVKVVLfNHSQRDfAlKKGDRV ILEKlVDDAQlVVV .. DSLEESARGAGGFGSTGN ... . ... .. ......... . 
Lyees KYSIDVGA .. GPVGVVLfNHSEVDfEVKVGDR IVQKlVT. PEVEQV .. DDLDSTVRGSGGFGSTGV .................. . 
Ccv KNFVST . ... Gl GHlHIMV .. SAlADfSVKKNQRl VVT PCLTQSEVVPY .. ETLERTRRGTGGFGSSGQ .................. . 
---------
Motif 3 Motif 4 Motif 5 
Figure 4.1 Alignment of class I sequences 
Over 100 dUTPase homologues are produced from a blastp search of the Swiss-Prot database probed 
with the E.coli sequence. A standard alignment using a selection of 19 class I sequences is shown. Motif 
regions are highlighted in yellow. Green highlights refer to those residues which make contact directly or 
indirectly with the substrate in the E.coli-dUDP structure (see Section 4.2.5). The following sequences 
were used: Mpmv (Mason-Pfizer monkey virus), Srv! (Simian type D retrovirus), Jsrv (Sheep 
pulmonary adenomatosis virus, Lentivirus), Mmtv (Mouse mammary tumor virus), Fiv (Feline 
immunodeficiency virus), Omvs (Ovine lentivirus), Visn (Visna lentivirus), Caev (Caprine arthritis-
encephalitis virus), Eiav (Equine infectious anaemia virus), Coxb (Coxiella burnetii, Eubacteria), Ecol 
(E.coli), Vaccc (Vaccinia virus), Vary (Variola virus), Human (Human), Orfv (Orf virus), Fadv 
(AvianlFowl adenovirus CELO), Calb (Candida albicans), Scer (Saccharomyces cerevisiae), Lyces 
(Lycopersicon esculentum, Tomato), Ccv (Channel catfish virus). 
4.2.3 Comparison of trimeric class I structures 
There are presently structures available for four class I dUTPases: E.coli 
(lDUP), FlV (1 DUT), EIA V (lDUC) and human (not yet in Brookhaven PDB 
database). The main features of the E.coli dUTPase structure are described in the 
introduction (Section 1.4.7). This section deals with the comparison of overall 
structures between these four class I dUTPases. 
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(a) E.coli (b) FIV 
(c) human (d) EIAV 
Figure 4.2 Comparison of class I trim eric structures 
The four class I trimers are rendered as ribbons using the Swiss-PDB Viewer. Each trimer is orientated 
approximately down the three fold axis of symmetry. In the human structure the extended tail is shown 
on two subunits (blue and green) and removed from the other (red) for comparison to the other trimers. 
From Figure 4.2 it is clear that the structure detailed for E.coli dUTPase in 
Section 1.4.7 is repeated in other distantly related class I species. Each subunit 
structure shows an almost identical a-carbon backbone trace allowing the generation of 
almost identical trimers. Not only is the globular region conserved but also the visible 
region of the extended C-terminal arm. 
Figure 4.2 shows these four structures positioned approximately down the 3-
fold axis of symmetry. Each subunit is represented by a different colour. It is clear that 
in terms of overall quaternary structure these dUTPases are highly homologous. This is 
an important observation for the modelling of a class II structure. Given that the only 
areas of primary sequence conservation lie within the motif regions it suggests that 
inter-motif chain length is an important factor in the overall structure. Interestingly the 
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final tail residues which were found to be disordered in the E. coli structure are also 
disordered in FIV and EIAV. This was found even with the co-crystallisation of dUDP 
with the E. coli and EIA V structures. 
In the human structure however the C-terminal tail is visible. It is shown for 
two of the three subunits in the figure. From the structure shown it can be seen that the 
tail region curls round to cap the active site. A more detailed investigation of this 
region is given in Section 5.8.2 in relation to mutational analysis and demonstrates that 
motif 5 is in intimate contact with the substrate. Given the conservation of motif 5 in 
the class I sequence alignment and the similarity in chain length between motifs 4 and 5 
(Figure 4.1) it is proposed that the other class I trimers all share the extended arm fold 
visible in the human dUTPase. 
4.2.4 Substrate docking model of the E.coli active site 
Preceding publication of the structure of E.coli dUTPase with dUDP, I made 
attempts to identity the major components of the active site region by substrate docking 
experiments. This was done in collaboration with L. Pearl at University College, 
London, who had experience in the crystallisation and active site modelling of 
UDGases. This proved to be a fruitful exercise demonstrating a close relationship 
between the proposed active site interactions and those seen by subsequent co-
crystallisation. These docking experiments had the advantage of modelling the natural 
substrate as opposed to the non-hydrolyzable inhibitor, dUDP. 
The method was to identity the key residues in motif areas which were likely to 
interact with dUTP. Residues were graded on importance by assessing their 
conservation between the class I species, their relative position in the E. coli structure 
and their properties such as hydrophobicity and charge. Figure 4.3 shows the proposed 
position of dUTP in a solvent surface and wireframe representation of the E.coli active 
site. The key residues are highlighted with their respective sequence numbers and the 
wireframe is colour coded in relation to charge. Blue represents positive charge, red is 
negative and yellow is neutral. 
The observations on this model are discussed with reference to the following 
section (4.2.5) which details the crystal structure of E.coli dUTPase with dUDP. One 
of the major difficulties with the modelling exercise was the inherent flexibility of the 
natural dUTP substrate molecule. It was realised that the various torsion angles of the 
dUTP molecule could be significantly altered if the active site produced an 
energetically favourable environment. 
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(a) 
(b) 
Figure 4.3 Active site docking model of dUTP and E.coli dUTPase 
Figure (a) shows the wireframe and dot surface representation of E.coli dUTPase active site which was 
created using the molecular graphics program '0' . The dUTP substrate was positioned in the active site 
cavity with respect to residues of stabilising charge (numbered). The uracil ring is shown stacking on the 
highly conserved residue tyro ine 93. Figure (b) shows the actual position of dUDP in the E.coli co-
crystal . A solvent surface was created using the WebLab molecular viewer. Residues are coloured by 
charge: positive in blue and negative in red. 
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Figure 4.3 shows the docking model prediction of dUTP in the E.coli active site 
(a) compared to the actual structural data from bound dUDP in the E.coli dUTPase co-
crystal (b). Both diagrams show the active site cavity in the same orientation to allow 
direct comparison. Charged residues shown as coloured wireframe representations in 
(a) can be seen as correspondingly coloured molecular surfaces in (b). The cavity area 
which can be seen in both diagrams was proposed to be the substrate binding area based 
solely on the condensation of the conserved motif regions in this area. The subsequent 
co-crystal of E.coli dUTPase with bound dUDP demonstrated that this was predicted 
correctly. The overall shape of this cavity constrained the number of possible substrate 
orientations in the docking model. The deepest area of the cavity (on the left of the 
diagrams) was predicted to accommodate the nucleoside portion of the substrate which 
generated an overall predicted orientation close to the real structure. 
The substrate was aligned within the active site cavity with the phosphate 
groups close to areas of neutralising charge. The ring of Tyr 93 was proposed to 
generate a stable stacking conformation with the pyrimidine ring of dUTP and was 
positioned accordingly. It was later found in the crystal structure that Tyr 93 does 
indeed form a parallel stacking structure but with the sugar moiety of dUDP and not 
with the pyrimidine as proposed by the docking model. This can be more clearly 
visualised in Figure 4.5 in the following section. Apart from this error the overall 
position of the substrate in the proposed active site was reasonable. The sugar ring and 
a-phosphate was correctly located close to negatively charged Asp 90. This residue 
interacts directly with the hydroxyl group on the sugar and through a water molecule, 
indirectly with the a-phosphate. The a-phosphate was also correctly positioned close 
to Ser 72 (on the upper side of dUTP in the model). This residue was shown to interact 
with the a-phosphate through a second water molecule in the crystal structure. 
In the crystal structure the ~-phosphate is highly mobile and the stabilising 
interactions are not clear. In the proposed model the ~- and y-phosphates are positioned 
towards the conserved residues Arg71 and Argl16 which, being positively charged, 
would have the ability to neutralise the phosphate groups directly without the 
interaction on further water molecules. This area of positive charge can be seen in both 
diagrams in Figure 4.3 by comparing the position of the blue wireframe residues Arg71 
and Argl16 in (a) and the corresponding blue surfaces in (b). It is likely that this area 
of the model will not be resolved until a non-hydrolyzable substrate containing the a-, 
~-, and y-phosphates is co-crystallised with the enzyme. This type of docking analysis 
is useful at providing a constrained set of possible residue-substrate interactions which 
can then be tested by mutagenesis studies. 
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4.2.5 Interactions of the E.coli active site with bound dUDP 
Two properties of the active site area were highlighted by the docking model: 
the accommodation of the pyrimidine and sugar rings in a visible cavity and the 
accommodation of the phosphate tail by neutralising charge. There are however 
additional attributes necessary for functionality. For modelling purposes it is useful to 
identify the specific residues involved in substrate specificity and those involved in 
catalysis. This information became available with the co-crystallisation of E.coli 
dUTPase with dUDP. The main interactions are shown in Figure 4.4 and 4.5. 
Seven of the residues in Figure 4.4 appear to be of key functional importance to 
the enzyme. Four residues (He 89, Asp 90, Tyr 93, Gin 119) make direct contact with 
dUDP in the active site and three residues (Gly 30, Ser 72, Met 98) make indirect 
contact mediated through water molecules. These residues are almost completely 
conserved throughout the class I group (highlighted in green in alignment Figure 4.1) 
with the exception of Met 98. Since this residue hydrogen bonds to the uracil ring of 
dUDP through main chain atoms it is likely that the conservation of its position is of 
more consequence than conservation of its side chain. This main chain interaction can 
be seen in the motif 3 loop shown in Figure 4.5. The water molecule responsible for 
nucleophilic attack of the a.-phosphate has not been determined but it is likely that the 
conserved residues (Ser 72, Asp 90, Gin 119) play a role by contributing to the 
hydrogen bonding pattern around the phosphorus atom. 
Figure 4.4 Interactions of the E.coli active site with bound dUDP. 
A diagram of the main interactions of dUDP with the active site in the E.coli co-crystal structure is 
shown (from Larsson et ai., 1996). Hydrogen bonds are shown as dashed lines and distances are given 
(in A). Residues from different subunits are marked as 'a' or 'c' respectively. 
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E. coli dUTPase is highly discriminatory with respect to base, sugar and 
phosphate and does not significantly hydrolyse dCTP, dTIP, UTP or any of the 
diphosphate relatives. This specificity is accomplished almost entirely by the l3-hairpin 
formed by the highly conserved motif 3 (Figure 4.5). In terms of base specificity it is 
likely that the main chain of Met 98 provides discrimination between cytosine and 
uracil. Discrimination against thymine is proposed to be steric given the lack of space 
available to accommodate a C5 methyl group. Specificity for the sugar is achieved by 
the positioning of the pentose ring between the conserved residues Ile 89 and Tyr 93 
thus removing space to accommodate a 2' OH. The mechanism for triphosphate 
specificity is not clear at present. The key residues identified as interacting with dUDP 
are highly conserved within the class I group and are highlighted in the sequence 
alignment in Figure 4.1. 
Figure 4.5 Interactions of E.coli l3-hairpin loop with bound dUDP 
The structure of the E.coli ~-hairpin loop with bound dUDP is shown. The ~-hairpin loop structure is 
formed by the conserved motif 3 region. The main residues involved in the specific recognition of the 
substrate are indicated in addition to the structurally bound water molecule (Wat). Hydrogen bonds are 
shown as black lines. Uracil recognition is accomplished by hydrogen bonding to the main chain (Met-
98) and the bound water molecule through the side chain of Asn-84 and backbone of Ser-IOO. 
Discrimination against ribose is provided by Tyr-93 which faces the deoxyribose moiety. The 3' -
hydroxyl group of the sugar donates a proton to the side chain of Asp-90. Graphic representation was 
generated using the Insight II molecular viewer. 
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4.2.6 Comparison of class I active sites 
Since data became available for the EIAV, FlV and human dUTPases it was of 
interest to compare the active site regions to identify areas of homology. The 
condensation of the 4 motif regions visible in Figure 4.6 is remarkably consistent 
between species. Motif 3 forms the main interaction platform and, as seen in the 
previous section, forms the ~-hairpin loop allowing high substrate specificity. All four 
active sites shown expose this motif 3 region (red) and utilise motifs 1, 2 and 4 to create 
the other 3 sides of the active site cavity. The interacting residues of the E.coU 
dUTPase with dUDP depicted in diagram 4.5 represent only one third of the total 
residues contained in motifs 1-4. Although there are few interactions from motifs 1, 2 
and 4, it is clear from these diagrams that they have a role in creating a specific active 
site environment. 
This is a key observation for interpretation of the class II model. Although 
specific residues have been identified as interacting with the substrate, for this to be 
achieved it is necessary to conserve surrounding residues. Although only a small 
minority of the motif residues interact directly with the substrate (see Figure 4.1) it is 
the motif regions as a whole that produce the architectural design. It appears that 
conservation of non-interacting motif residues is just as important as interacting 
residues in order to create an efficient, discriminating active site. It will be shown that 
the class II molecules contain highly conserved versions of both types of motif residue. 
Again this is an indication that the class II active site is structurally homologous to the 
class I active site. 
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(a) E.coli (b) FIV 
(c) Human (d) EIAV 
Motifs 
Species 1 2 3 4 5 
E.coli 29-33 71-77 87-100 114-121 141-150 
FlV 16-20 55-61 68-81 95-102 122-131 
Human 23-27 62-68 76-89 103-110 130-139 
EIAV 17-21 56-61 69-82 96-103 123-132 
Figure 4.6 Comparison of class I proposed active site regions 
For each molecular species an enlarged view of a single active site is shown. The following colour 
coding has been used for the motif regions composing the active site area: I-blue, 2-purple, 3-red and 4-
green. The spacefilling representations were created using RasMol. Note that the C-terminal tail has 
been removed from the human structure to allow an unimpeded view of the active site. The table 
indicates the residue numbers which constitute the motifs in each species. 
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4.2.7 Discussion 
In summary it is clear that in tenns of overall structure and active site 
confonnation, the class I dUTPases are highly similar. The motif regions condense to 
fonn an active site cavity with conserved residues providing key functional roles. The 
conservation of inter-motif distances, observed in the class I alignments, is likely to 
help defme the position of the 5 motifs. Structural comparison of the four available 
structures highlighted that the inter-motif regions can generate similar confonnations 
even with low sequence conservation. It will be shown in the forthcoming sections that 
these inter-motif regions possess more homology than is first evident with primary 
sequence analysis. Although there is only a relatively small percentage of the molecule 
that actually achieves substrate binding and catalysis, the active site confonnation is 
dependant on the secondary and tertiary structure of the entire molecule. This is an 
important observation for the class II modelling since there is almost no primary 
sequence homology out with the motif regions. 
Modelling of the E.coli active site helped to identify the key residues now 
apparent in the dUDP co-crystal structure. Comparison of active sites from diverse 
class I species shows a remarkable conservation of structural elements. Homologous 
cavities are visible in all the structures with key residues being similarly positioned. 
The attribution of function and high conservation of these residues provide an ideal 
probe for investigating the class II enzymes. 
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4.3 Class I dUTPases as a basis for modelling class II dUTPases 
4.3.1 Introduction 
In terms of motif arrangement, gene size and general structural arrangement, the 
class I dUTPases are highly homologous. The class II dUTPases however are a much 
more heterogeneous group. Members share a common motif arrangement but vary 
considerably in motif spacing and gene size. It is predicted that this group share a 
similar structural arrangement although these genetic variations will provide some 
variations and will be considered with respect to the class II model. This section 
tackles the class II dUTPases and how to best utilise the data from the class I enzymes 
for comparison. 
4.3.2 Comparison of class II primary sequences 
Alignment of the class II sequences was more difficult than the class I relatives 
due to the heterogeneity outside the motif regions. The motifs themselves are highly 
conserved throughout the class II group and provide a starting point for sequence 
alignments. In order to achieve a non biased set of alignments different programs were 
utilised. 
Initially class II sequence alignments were performed using GCG Pileup, a 
simplification of the method of Feng and Doolittle (1987). This is a very quick and 
reasonably efficient alignment program and is commonly used. It performs well on 
sequences with reasonable conservation but is less efficient at aligning multiple 
sequences with significant variation. Variability in sequence length for example, can be 
potentially difficult for the program to judge, especially if it occurs in areas of low 
sequence conservation. The program itself aligns the two most conserved sequences 
first and subsequently adds additional sequences to the lineup one by one. This means 
that if there are any significant mistakes in the initial or intermediate alignments they 
cannot be corrected later as further sequences are added. 
In the context of the class II alignments this was thought to pose a potential 
problem. As will be shown, the C-terminal halves of the class II enzymes are 
reasonably conserved relative to motif sequence and inter-motif distance. Conversely 
the N-terminal halves are significantly divergent within class II group. Since this half 
contains only one motif region (motif 3) this variability is judged by measuring two 
direct variables: the distance from the N-terminus to the beginning of motif 3 and 
secondly, the distance between motif 3 and motif I (the first motif in the C-terminal 
half). Figure 4.7 shows such a measurement. 
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Distance A '" Distance B ... 
" 0 
::< 
EBV 72 50 
EHV-2 77 
HVS 74 49 
HSV-l 93 116 
HSV-2 93 114 
EHV-l 104 64 
EHV-4 104 64 
BHV-l 
PRY 
VZV 
Figure 4.7 Determination of class II variability by inter-motif distances 
Two sequence lengths have been calculated for each species: "A", the distance between motif 3 and the 
N-terminus and "B", the distance between motif 3 and motif 1. The N-terminus is represented as a 
vertical line, motif 3 by a red box and motif 1 as a blue box. The lines are drawn to scale to allow a 
graphical as well as numerical visualisation. Sequences are arranged in the same order as Figure 4.8 for 
comparison. 
The fIrst measurement "A", from the N-termini to motif 3, shows a general 
variability between dissimilar species. Closely related pairs such as HSV-IIHSV-2 and 
EHV -llEHV -4 have identical distances. The largest "A" distance is that of VZV while 
EBVIEHV-2IHVS have the smallest. This overall pattern is mimicked in the second 
distance "B" between motif 3 and motif 1. Similar species have closely related "B" 
distances while more distant species show wide variability. HSV-l and HSV-2 have 
the longest "B" distance closely followed by VZV. 
The key point to note is that distance "A" is not predictive of distance "B". For 
example, EHV-l and EHV-2 have a long "A" and a short "B" while EBV and HVS 
have a short "A" and a short "B". Furthermore, these distances are not conserved 
between species. For example, HSV-l and EHV-l differ by only 11 residues in "A" 
but differ by 52 residues in "B". A very simple conclusion can be drawn from this data, 
namely that there is variability with respect to insertions in both regions "A" and "B". 
However, in terms of sequence alignment this is not a simple problem. As can be seen 
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from the following alignments, there is almost no sequence conservation ill the N-
termini outwith motif 3. In any alignment therefore, there will have to be extensive use 
of padding characters in the N-terminal half. What is difficult to predict is the exact 
position of these gaps in this half of the alignment. 
The results from using the Feng and Doolittle program on the class II sequences 
is shown in Figure 4.8. Although there is a low background use of padding characters 
throughout the alignment, there are four main areas of extensive gaps. These variable 
regions, labelled Var 1-4, are highlighted in blue text. 
EBV 
EHV-2 
HVS 
HSV-l 
HSV-2 
EHV- l 
EHV-4 
BHV-l 
PRY 
VZV 
EBV 
EHV-2 
HVS 
HSV-l 
HSV-2 
EHV-l 
EHV-4 
BHV- l 
PRY 
VZV 
1 100 
· . .. . ....... MEACPHIRYAFQNDKLLL. QQASVGRLTLVNKTTILLRPMKTTT . . ..•.. . ... . .. . ... . .. .. . . . .. . . .. VDLGLYARPPE. 
. . ..... . . MTLRKQRQEIYYEFTSSSFEITSPPESSKITLTNLYPILVRPYVPAV . . . . .... . . ..... . . .. . .. .. ..... . .. IPLGIRIIYGNK 
· ... . .. . ... MPYKVPEIYYRFEPQTITITSPARASNLQLINHNNILVKAGQVTI ... .. ... .. .. . .... ... . .. . . . . . . . . . VSTGI . I FPKET 
... MSQWGSGAILVQPDSLGRGYDGDWHTAVATRGGGVVQLNLVNRRAVAFMPKVSGDSGWAVG . . . . .. . . . . . ... . .. . .. . . . RVSLDLRMAMPA. 
· .. MSQWGPRAI LVQTDSTNRNADGDWQAAVAI RGGGVVQLNMVNKRAVDFTPAECGDS EWAVG . ...... . . . ..... . .. . .... RVSLGLRMAMPR. 
... . .... MASVTNLVDSIVVVECGERWRARAEAAGRLLVLINNHTVELSGEHGSAGEFYSVL . . .. . ........... . .. .. . . .. TDVGVRVACSS. 
· .. . .. . . MASATNLADNIVVVECSNGWEARAEADGRLL VLINNHTVELSAGLGSAGE FYSVL ....... . ........ . .. . ... . . TDVGVRVACSS . 
MANSAAATTATMSGDRGILVVELNAEAAPWRLESCCEPDSLALWGPIAPAAKRDETAPSGSLLYSR .. .. . ...... ... . .. .. . . LINLNMKAAAPG. 
MEESAGATSA . .. .. . .. . ... . . QSAATSVSESPAE . ...... ETILVCASEPVTVDGGRLLVCRSPGPEGF . .. . . ..... ... YKVPLGLKVALPT. 
. .. MNEAVIDPILETAVNTGDMFCSQTIPNRCLKDTILIEVQPECADTLQCVLDDKVSRHQPLLLRNHKKLELPSEKSVTRGGFYMQQLELLVKSAPPN. 
VAR 1 
101 200 
GHGLMLWGSTSRPVTSH . ...... . .... .. .. .. .. VGIIDPGYTGELRLILQNQRRYNSTLRPSELKIHLAAFRYATPQMEEDKGPINH .. . . . .. . . 
GQGFILAGSSQKKVFCH . ....... . .... . .... . . TGLIDPGYRGEI KLIVLNTTKYNVTLFAGELRVSLFSFFFSTPII . YDYDLLNR .... . . . . . 
SFAFILYGKSAKSIFCH .. .. ... .. . . .. ... . ... TGLIDPGFQGELKLIVLNKTEDDITLFENDLRVSVTAFVYGVPKL. HDYSDLCP . . . ..... . 
DFCAIIHAPALASPGHH ..... .. . ... . . . . . .. VILGLIDSGYRGTVMAVVVAPKR . TREFAPGTLRVDVTFLDILATPPALTEPISLRQF . . . PQLA 
DFCAIIHAPAVSGPGPH . ... . .. . ..... . . . .. VMLGLVDSGYRGTVLAVVVAPNG.TRGFAPGALRVDVTFLDlRATPPTLTEPSSLHRF .. . PQLA 
GYAIVL TQI SGLLPVEPEPGN FSNVT FPENSAKYYTAYG IVDSGYRGVVKA VQFAPGI . NTSVPPGQMSLGL VL VKLARKS I HVTS IGSTRDG . . . RTSE 
GYAIVLAQISGLPHVGREPGNFSNITFTGNLANYYTAYGIVDSGYRGVVKAVQFANGV.NTVVPPGCMSLGLVLVKLSTETINVTNINLTENG . . . RSPR 
GYAIIMSQMRSGDTHMPRPPAVAV .... . . .. . ..... GIVDSGYSGILRAIVWAPES.AAAAPPAGL . .. ALRLTLARLTTTLPRLIAVDDD . .. ANAG 
GYAMLVAQRGGGRT . ... . . . . TN . . ..... . ..... . GIVDAGFRGEVQAIV ...... APGRPRAQFYCTPLRL .... .. . . . . ..... . . . . . . . .. A 
EYALLLIQCKDTALADED . . . . . .. . . . . . . . NFFVANGVIDAGYRGVISALLYYRPG . VTVILPGHLTIYLFPVKLRQSRLLPKNVLKHLDPIFKSIQV 
VAR 2 MOTIF 3 VAR 3 . .. 
201 300 
EBV . ... . ...• . .... .. . . . .. . .. . . ... .. . . ........ . . . • .. . ... . . . .. .. ... PQYPGDVGLDVSLPKDLALFPHQTVSVTLTV .. P. PPSI 
EHV- 2 ... . ... . ... . .. ... .... . ... . . .... . .. . ....... . . . . . . .. . .. .. . .... . PQYSDDAGYDLYLQEDLMLFPQASTTVTIDS . . RVPTTT 
HVS ... . .. ... ......... . .. ... .. . .... . ... . .... . . .... . .... . .•. .... . . PRYSKDAGFDLYLPTDVTVKPRVPNRYSVN1. . CCPAQL 
HSV-1 PPPPTGAGlREDPWLEGALGAPSVTTALPARRRGRSLVYAGELTPVQTEHGDGVREAIAFL PKREEDAGFDIVVRRPVTVPANGTTWQPS. LRMLHADA 
HSV- 2 PSPL . . AGLREDPWLDGALATAGGAVALPARRRGGSLVYAGELTQVTTEHGDCVHEAPAFLPKREEDAGFDI LI HRAVTVPANGATVIQPS . LRVLRAAD 
EHV-1 ANL . . .. . FYD ...... .. .. . .. .. . . .. . . . . . •.. . . . . .... . ........ . .. YFAPKRVEDAGYDISAPEDATIDPDESHFVDLP. 1. VFANSN 
EHV- 4 VNI ... .. FYD .. . . .. . . . . . .. .. ... . ........ . . . .. . ...... .. ... . .. YFAPKRDE YD1SAQTNATIEPDESYFVELP. I. VFSSSN 
BHV- l TEAGVEVPFFA ............ . .. . ... . . . . .. .... . . .. . . . ... .. . .. ... TFAPKRDEDAGYDIAMPYTAVLAPGENLHVRLP.V.AYAADA 
PRY PG1ATDVPFFE . . . . . .. . .. . .. . ...... . ...... . . .. ... . .... . .... .. . VFAPKRDE DAGYDIPCPRELVLPPGGAETVTLP.V.HRTDGR 
wz QPLSNSPSNYEKPVIPEFADISTVQQGQPLHRDSAEYHIDVPLT .. . . .. .... . YKHIINPKRQEDAGYDICVPYNLYLKRNEFIKIVLPIIRDWDLQH 
VAR 3 continued MOTIF 1 
301 400 
EBV PHHRPTI FGRSGLAMQGlLVKPCRWRRGGV. DVSLTNFSDQTVFLNKYRRFCQLVYLHKHHLTSFYSPHSDAGVLGPRSLFRWASCTFEEVPSLAM .... 
EHV-2 KFFKPWFGRSGLATRGVWDVVKWTHSPL .TLKIYNFTDNTLRYSAGTRICQWFVHRRHFPSKLKHFFTY lNLNSKTSFYWANVSFVDCQNDAYRSLV 
HVS KSYKPVL FGRSGLAAKGLT I KVS RW . QNQL . Q1 I FYNYTKSQITYTARTRIAQWFMHKKHLPTTLTRLKPTMHLSEN I KYSWARVS FODl KT FPVQDEK 
HSV- l GPAACYVLGRSSLHARGLLWPTRWLPGHVCAFVVYNLTGVPVTLEAGAKVAQLLVAGADALPWl . .. . PPDNFHGTKALRNYPRGVPDSTAEPRNPPLL 
HSV-2 GPEACYVLGRSSLNARGLLVMPTRWPSGHACAFVVCNLTGVPVTLQAGSKVAQLLVAGTHALPW1 .... PPDNIHEDGAFRAYPRGVPDATATPRDPP1L 
EHV- l PAVTPC1 FGRSSMNRRGLlVLPTRWVAGRTCCFFILNVNKYPVSITKGQRVAQLLLTEDlDDAL1 . ... PP .TVNYDNPFPTYSPS .. ESTKAPQSPVLW 
EHV- 4 PAVTPCI FGRSSMNRRGLlVLPTRWVTGRTCCFFILNINKYPVYITKGQRVAQLVLTEDIDEALI . .. . PT. NVNYNTPFPTYSPT . . GAVKHNPTPILW 
BHV-1 HAAAPYV FGRSSCNLRGLIVLPTAWPPGEPCRFVLRNVTQEPLVAAAGQ RVAQLLLLARRLE.WL .. . . PS .GLNDREPFPTSPRA .. APPAPGAPRLRW 
PRY HWA .. YVFGRSSLNLRGIWFPTPWESG. PCRFRlQNRGAHPVTLESGQRVAQLVLTREPLG. WI . .. . T . .... GRSPFPATPRA .. PMQHRPAWLFAR 
VZV PSINAYI FGRSSKSRSGIIVCPTAWPAGEHCKFYVYNLTGDDIRIKTGDRLAQVLLIDHNTQIHL . .. . . KH NVLSNIAFPYAIRGKCGIPG ... . . VQW 
MOTIF 2 MOTIF 4 VAR 4 
401 436 
EBV ... GDSGLSEALEGRQGRGFGSSGQ . ......... . 
EHV-2 TLPCQEDTDRG .. YRGDSGFGSSGMR ......... . 
HVS LYSSSKDTSDSQMSRGDAGLGSSGLM . . ... .. .. . 
HSV-l VFTNEFDAEAPPSERGTGGFGSTG1. .... .. ...• 
HSV- 2 VFTNEFDADAPPSKRGAGGFGSTG1. ....... . . . 
EHV- 1 KFTTDFDREAPSSLRADGGFGSTGL .... .. ....• 
EHV-4 KFTEAFDHDAPSSARSEGGFGSTGL . ... . . . ... . 
BHV-1 RRVADLAAAVPPSARGPRGFGSTGL ....•.. ... . 
PRY DFVA . ... .. PSSARGARGFGSTGL . ... • . .. . .. 
VZV YFTKTLDLIATPSERGTRGFGSTDKETNDVDFLLKH 
MOTIF 5 
Figure 4.8 Class II sequence alignment by Feng and Doolittle method 
This alignment was generated by GCG Pileup using the method of Feng and Doolittle with standard 
default values (gap weight: 3.0, gap length weight: 0.1). Motif regions are highlighted in yellow. 
Variable regions are shown as blue text. 
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To allow a more objective approach to the class II alignments a different 
program was used to process identical input data. A multitude of alignment programs 
are available but many of them utilise similar progressive methods to that of Feng and 
Doolittle (FD). The program SAGA (sequence alignment by genetic algorithm) was 
chosen since it employed a novel approach to sequence alignment. 
The program works on an evolutionary basis, generating a large population of 
alignments and gradually improving them by measuring their quality. The calibre of 
each alignment is measured by an objective function which is generated by assigning a 
cost for each column of aligned residues and a cost for each gap. Using this objective 
function it is then possible to apply a selection process to the population of alignment 
solutions. Parental alignments which score highly generate more children than 
alignments of poor quality. The overall size of the population is kept constant creating 
a selection pressure for better alignments. Over many generations the regions of high 
quality are conserved until the alignment can no longer be improved. The results of 
such an alignment is shown in Figure 4.9. 
The alignment generated by SAGA has been highlighted in the same way as the 
original alignment of FD to allow direct comparison. In overall terms the alignments 
were generally similar despite using two different methods. This was encouraging and 
gave some assurance that the alignments were close to optimal. 
The C-terminal half of the alignments, from motif 1 to motif 5, was aligned 
efficiently by both methods. Although the inter-motif regions share only scarce 
sequence conservation, their lengths are highly conserved. Once motifs 1, 2, 4 and 5 
are aligned, there are few gapped regions necessary to generate a reasonable alignment 
in the C-terminal half. 
As was shown graphically in Figure 4.7, there is considerable variation in 
sequence length in the N-terminal half of the alignments. Both programs readily 
recognised motif 3 but had difficulty with the regions to either side. There is very little 
sequence homology in these regions which is complicated by the fact that some 
individual species have substantial deletions and insertions. The two methods used 
generated similar alignments for the N-terminal half in terms of overall structure. There 
were however distinct differences. 
The main difference was the splitting of variable region I into two parts in the 
SAGA alignment. This is interesting in terms of how these two methods interpret 
overall conservation. The key feature of this region is that both programs are obviously 
constrained by the excessive length of the VZV sequence compared to the others. In 
both cases the VZV sequence is run almost straight through this region with very few 
gaps. In the FD alignment it can be seen that additional gaps were added to each 
additional species from top to bottom in order to accommodate the VZV sequence. The 
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SAGA program has allowed refmement of this region providing a greater number of 
paired alignments. This can be measured in terms of the quantity of gaps inserted 
within the bounds of variable region 1. The FD program created 221 gaps compared to 
162 from SAGA. Even with these differences, the overall consensus for this region is 
reasonably high between the two alignments. 
EHV-2 
HVS 
EBV 
EHV-1 
EHV-4 
BHV-1 
HSV-1 
HSV-2 
PRV 
vzv 
1 100 
......• . ..• . ... MTLRKQRQEIYYEFTSSSFEITSPPESS . . . KITLTN .... LYPILVRPYVPA . ................ VIPLGIRIIYGNKGQ 
.. . ... . . . ..... .. . MPYKVPEIYYRFEPQTFYITSPARAS ... NLQLIN .... HNNILVKAGQVT . ................ IVSTGIIFP.KETSF 
.. . ............... MEACPHIRYAFQNDKLLLOQASVGR .... LTLVN .... KTTILLRPMKTT .... . ............ TVDLGLYAR.PPEGH 
· ... ... .. .. ... MASVTNLVDSIVVVECGERWRARAEAAGR . .. LLVLIN .... NHTVELSGEHGSAGEFYSV ... .. . . ... LTDVGVRVA. CSSGY 
· ..... . ....... MASATNLADNIVVVECSNGWEARAEADGR ... LLVLIN .... NHTVELSAGLGSAGEFYSV .......... LTDVGVRVA.CSSGY 
............... MANSAAATTATMSGDRGILVVELNAEAA ... PWRLES.CCEPDSLALWGPIAPAAKRDETAPSGSLLYSRLINLNMKAA.APGGY 
· •• .. ..... HSQWGSGAILVQPDSLGRGYDGDWHTAVATRGGGWQLNLVN .... RRAVAFMPKVSGDSGWAVG .......... RVSLDLRMA. MPADF 
.. . ....... HSQWGPRAILVQTDSTNRNADGDWQAAVAIRGGGWQLNMVN .... KRAVDFTPAECGDSEWAVG .......... RVSLGLRMA.MPRDF 
· ......... MEESAGATSAQSAATSVSESPAEETILVCASEP . . .. VTVDG ... . GRLLVCRSPGPEGFY ..... . ........ KVPLGLKVA.LPTGY 
MNEA VI DP I LETA VNTGDMFCSQT I PNRCLKDTILI EVQPECADTLQCVLDDKVSRHQPLLLRNHKKLELPSEKSVTRGG FYMQ . QLELLVKSA. P PNEY 
VAR 1A VAR 1B 
101 200 
EHV-2 GFlLAGSSQKKV . ............ . ... . .. FCHTGLIDPGYRGEIKLIVLNTTKYNVTLFAGELRVSLFSFFFSTPIIY .......•........... 
HVS AFILYGKSAKSI . ................ .. . FCHTGLIDPGFOGELKLIVLNKTEDDITLFENDLRVSVTAfVYGVPKLH .... . . ....... . .... . 
EBV GLMLWGSTSRPV . .. ................. TSHVGIIDPGYTGELRLILQNQRRYNSTLRPSELKIHLAAFRYATPQME .................. . 
EHV-1 AIVLTQISGLLPVEPEPGNFSNVTFPENSAKYYTAYGIVDSGYRGVVKAVQFAPGI.NTSVPPGQMSLGLVLVKLARKSIH . ............•..... 
EHV- 4 AIVLAQISGLPHVGREPGNFSNITFTGNLANYYTAYGIVDSGYRGVVKAVQFANGV . NTVVPPGCMSLGLVLVKLSTETIN . ................. . 
BHV-1 AIIMSQMRSGDTHMPRPP .... . ....... . . AVAVGIVDSGYSGILRAIVWAPES.AAAAPPAGLALRLTLARLTTTLPR . .. . ..... . ........ . 
HSV-1 CAIlHAPALASPGH .................. HVILGLIDSGYRGTVMAVVVAPKR.TREFAPGTLRVDVTFLDlLATPPALTEPISLRQFPQLAPPPPT 
HSV-2 CAIIHAPAVSGPGP ............•... . . HVMLGLVDSGYRGTVLAVVVAPNG. TRGFAPGALRVDVTFLDIRATPPTLTEPSSLHRFPQLAP .. SP 
PRV AMLVAQRGGG ..... . ...... . ... . ... . . RTTNGIVDAGFRGEVQAIVAPGRP.RAQFYCTPLRLA . . . ... PGIATD . . . . .............. . 
VZV ALLLIQCKDTALADEDNF ............ . . FVANGVlDAGYRGVISALLYYRPG . VTVILPGHLTIYLFPVKLRQSRLL . .. . .... PKNVLKHLDPI 
VAR 2 MOTIF 3 VAR 3 .•• 
201 300 
EHV-2 .... . .. . ... . ....... . .... . .. . ............. . ....... DYDLLNRPQYSDDAGYDLYLQEDLMLFPQASTTVTIDSRV .. PTTTKfFKP 
HVS ... . ..... . . . ...... . .... . ....... . ..... . ........... D'lSDLCPPR'lSKDAG FDL'lLPTDVTVKPRVPNRYSVNICC .. PAQLKSYKP 
EBV .. ... . . ...••......••. . .... . ... .. ... . ...... . ..... EDKGPINHPQYPGDVGLDVSLPKDLALfPHQTVSVTLTVP ... PPSIPHHRP 
EHV-1 ........................ . ........ VTSIGSTRDGRTSEANLFYD'lFAPKRVE YDI SAPEDATIDPDESHFVDLPIVf .. ANSNPAVTP 
EHV-4 .......... . .................... . . VTNINLTENGRSPRVNIFYDYfAPKROE YDISAQTNATIEPDESYFVELPIVf .. SSSNPAVTP 
BHV-1 .. .. .. . . . . ..................... LIAVDDDANAGTEAGVEVPfFATFAPKRDEDAGYDIAMPYTAVLAPGENLHVRLPVAY .. AADAHAAAP 
HSV-1 GAGlREDPWLEGALGAPSVTTALPARRRGRSLVYAGELTPVQTEHGDGVREAIAFLPKREEDAG FDIVVRRPVTVPANGTTVVQPSLRML . HADAGPAAC 
HSV-2 LAGLREDPWLDGALATAGGAVALPARRRGGSLVYAGELTQVTTEHGDCVHEAPAfLPKREEDAG FDILIHRAVTVPANGATVIQPSLRVL.RAADGPEAC 
PRV ........... . .....•.. ... ......... .. ......... . .... VPFfEVfAPKRDE GYDI PCPRELVLPPGGAETVTLPV . .. . HRTDGRHWA 
VZV rKSIQVQPLSNSPSNYEKPVIPEFADISTVOOGQPLHRDSAEYHIDVPLTYKHIINPKRQEDAGYDICVPYNLYLKRNEfIKIVLPIIRDWDLQHPSlNA 
VAR 3 continued Motif 1 
301 400 
EHV-2 VVFGRSGLATRGVVVDVVKWTHS . PLTLKIYNFTDNTLRYSAGTRICQVVfVHRRHFPSKLKH . FFTYINLNSKTSFYWANVSFV .. DCQNDAYRSLVTL 
HVS VLFGRSGLAAKGLTIKVSRWQN . . QLQIIFYNYTKSQIT'lTARTRIAQVVFMHKKHLPTTLTR.LKPTMHLSENIKYSWARVSFQDIKTFPVQDEKL'lSS 
EBV TI FGRSGLAMQGILVKPCRWRRG.GVDVSLTNFSDQTVFLNKYRRFCQLVYLHKHHLTSFYSP.HSDAGVLGPRSLFRWA ....... SCTFEEVPSLAMG 
EHV-1 CI FGRSSMNRRGLIVLPTRWVAGRTCCFFILNVNKYPVSITKGORVAQLLLTEDIDDALIPPT.VNYDNPFPTYSPSEST . .. .. .. KAPQSPVLWKFTT 
EHV-4 CI FGRSSMNRRGLIVLPTRWVTGRTCCFFILNINKYPVYITKGQRVAQLVLTEDIDEALIPTN.VNYNTPfPTYSPTGAV . . .... . KHNPTPILWKFTE 
BHV-1 YVFGRSSCNLRGLIVLPTAWPPGEPCRFVLRNVTQEPLVAAAGQRVAQLLLL.ARRLEWLPSG.LNDREPFPTSPRAAPP . ..... . APGAPRLRWRRVA 
HSV-1 YVLGRSSLNARGLLVVPTRWLPGHVCAFVVYNLTGVPVTLEAGAKVAQLLVAGADALPWIPPDNfHGTKALRNYPRGVPDST .... . AEPRNPPLLVFTN 
HSV-2 YVLGRSSLNARGLLVMPTRWPSGHACArvvCNLTGVPVTLQAGSKVAQLLVAGTHALPWIPPDNIHEDGAFRAYPRGVPDAT . .... ATPRDPPILVFTN 
PRV YVFGRSSLNLRGIVV,' PTPWESG. PCRFRIQNRGAHPVTLESGORVl'.QLVLT. REPLGWITGR ..... SPFPATPR . . ......... APMQHRPAWLfAR 
VZV YI FGRSSKSRSGIIVCPTAWPAGEHCKFYVYNLTGDDIRI KTGDRLAQVLLIDHNTQIHLKHN.VLSNIAFP'lAIRG .... .. .. . . KCGIPGVQW'lFTK 
MOTIF 2 MOTIF 4 VAR 4 
401 432 
EHV-2 PCOEDTDRG GDSGFGSSGMR .... .. ... . 
HVS SKDTSDSQH5RGDAGLGSSGLM ......... . 
EBV DSGLSEALEGRQGRGFGSSGQ . .... . .. . . . 
EHV-1 DFDREAPSSLRADGGFG GL ... . ...... . 
EHV-4 AFDHDAPSSARSEGGFGSTGL .. . ....... . 
BHV-1 DLAAAVPPSARGPRGFGSTGL . ......... . 
HSV-1 EFDAEAPPSERGTGGFGSTGI. ......... . 
HSV-2 EFDADAPPSKRGAGGFGSTGI. . ...... . . . 
PRV Of .. VAPSSARGARGFGSTGL . ... . . . . . . . 
vzv TLDLIATPSERGTRGFGSTDKETNDVDfLLKH 
MOTIF 5 
Figure 4.9 Class II sequence alignment using SAGA 
This alignment was generated by the program SAGA with the standard set of 10 class IT sequences. 
Motif regions are highlighted in yellow and variable regions in blue text. Note that the order of 
sequences is different than in Figure 4.8. 
96 
Variable region 2 is almost identical in both alignments. Alignment in this 
region is constrained by insertions in the EHV -1 and EHV -4 sequences. Region 3 is 
the main area of variability between class II species and of significant importance to the 
class II model. Both alignments show very similar resolutions, notably constrained by 
insertions in the HSV-l and HSV-2 sequences and to a lesser degree the VZV 
sequence. Between the two alignments the position of the gap regions varies by only a 
few residues in all the sequences. It is the position and length of this gap that is of 
importance and both alignments are in general consensus by these criteria. This region 
of class II variability is considered in depth in the following sections. 
Variable region 4 is found between motifs 4 and 5. In comparison to the FD 
result, the SAGA method favours the condensation of single gaps into one region. 
These gaps are fairly small compared with the other variable regions but will be taken 
into account in the model. Finally it is of consequence to note that there is variability in 
terms of sequence length at the N-terminus while at the C-terminus, only VZV has 
additional residues. 
4.3.3 Proposed relationship between class I and class II dUTPases 
The intragenic duplication model proposed by D.l. McGeoch (1990b) accounts 
for the genetic rearrangement of the five motifs in class II dUTPases compared to the 
class I group. The genetic evidence for this rearrangement in addition to the structural 
data from the class I enzymes supports the following hypotheses: 
- the five motifs which make up the active site in the class I dUTPases constitute a 
highly homologous active site in the class II dUTPases 
- the active site which is assembled from motifs donated by three subunits in the class I 
trimer can be successfully duplicated in the class II monomer by a single protein chain 
To further these hypotheses in a structural context it was necessary to provide a 
model to link the class I and class II dUTPases. It has been shown that the class I genes 
encode a subunit structure which subsequently assembles into a trimeric arrangement. 
Since the class II genes are approximately double the length of the class I genes and 
encode a monomer, a more defmed hypothesis was proposed: 
- duplication of the ancestral class I gene led to a duplication of the trimer subunit 
structure to create a double length class II monomer 
This hypothesis has implications for the class II model. In terms of overall 
structural arrangements, the class II dUTPase is proposed to be constructed by two 
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trimer subunits joined as a single protein chain. For this new structure to be viable it 
would have to be able to condense all five of its single copy motifs into one functional 
active site. 
To test this model it was necessary to provide sequence lineups between the 
class I and class II dUTPases. Since it was proposed that the class II arrangement 
originated by a duplication of the class I gene, the two classes were compared directly. 
This was achieved by duplicating the E.coli primary sequence to create a single chain 
doublet. This double length E. coli sequence was then used to align with the class II 
sequences. A representation of this alignment is shown in Figure 4.10. 
E.coli subunit sequence E. coli subunit sequence 
2 3 4 5 Ic + NI 2 3 4 5 Ic 
E. coli doublet sequence 
N'----I -2 - 3--4 - 5---'1::::::: ::=1 :==2===3 ==4==1 ::::::0 C 
3 2 x 4 5 IC 
HSV-l Class II sequence 
Figure 4.10 Comparison of class I and class II sequences utilising an E.coli doublet 
Figure shows a representation of the E.coli class I and the HSV-l class II sequences indicating the 
position of the motif regions. The class I sequence is effectively duplicated and joined to create a double 
length chain. To permit correct alignment of the motif regions, gaps must be inserted for the extended 
joining region and the extension between motifs 4 and 5 in the HSV -1 sequence. This allows direct 
sequence comparison between the two classes. The motif region labelled 'X' is discussed in Section 4.7. 
In this diagram the single copy of the five class II motifs is aligned with the 
respective E.coli motifs. What cannot be seen is how closely related these motifs are 
between the two classes. In fact when they are compared directly it can be seen that all 
of the key residues identified in the class I structures are present in the class II motifs. 
E.coli 
HSV-l 
1 2 3 
AGLDL PRSGL GLIDSDYQG 
AGFDI GRSSL GLIDSGYRG 
4 
GERIAQMI 
GAKVAQLL 
Figure 4.11 Direct comparison of E.coli and HSV-l motifs 
5 
RGEGGFG 
RGTGGFG 
E.coli motifs are shown on top with the equivalent HSV-I motifs below. The residues which interact 
directly with dUDP in the E.coli co-crystal are shown in yellow. Note that these residues are almost 
totally conserved throughout the class II group as well as the class I group. 
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4.3.4 Discussion 
The class II dUTPases have been shown to be more heterogeneous between 
species than their class I counterparts. The use of alignment programs has allowed 
them to be compared at the primary sequence level. By using different methods to 
analyse the same data set it was possible to identify distinct areas of homology and 
variability within the class II group with a degree of confidence. The use of the 
program SAGA for this purpose proved to be very useful. This type of alignment 
program has only become possible with the advances in computing power and even 
with a powerful VMS system, processor time for a single alignment was in the region 
of 10 hours. 
Finally a method has been developed to allow direct comparison of the two 
dUTPase classes at the primary sequence level. Although this method is based on the 
specific hypotheses in Section 4.3.3, an element of caution must be used. It should be 
noted that the intragenic duplication is likely to have occurred from a common ancestor 
of the class I and class II dUTPases. It is therefore probable that the class I enzymes 
have diverged to some degree since that time. This should be taken in the context of 
the available infonnation, and given that the structural conservation between diverse 
class I species is high, it is likely that significant changes are few. In tenns of this 
study, the doublet molecule generated from the E.coli gene must be considered to be at 
least partially divergent from the original ancestral doublet. This is considered more 
thoroughly in Section 4.6 but at this stage only major structural elements which are 
more likely to have been conserved through time will be examined. The extended 
regions present in the HSV-l sequence compared to the E.coli doublet are discussed in 
the next section. 
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4.4 Secondary structure prediction 
4.4.1 Introduction 
As will be shown, the class I subunit structures all possess a signature secondary 
structure arrangement. If the hypothesis in the previous section holds true then it is 
likely that each half of the class II enzyme will contain some of these secondary 
structural elements. This was tested by using computer analysis to predict secondary 
structure from primary sequence lineups of the class II dUTPases. The predicted class 
II ~-sheet arrangement was then compared with the class I doublet of known structure. 
4.4.2 Class I ~-sheet structure 
E.coli dUTPase was the fIrst class I structure to be solved by crystallography 
and the secondary structure is depicted in the introduction Figure 1.11. Given the low 
inter-motif sequence homology between the class I enzymes it was of interest to 
compare these structural elements with the other subsequently solved structures. It was 
immediately obvious, as in the comparison of quaternary structures in Section 4.2.3, 
that the class I group share highly homologous secondary structure arrangements. This 
section details these conserved secondary structural elements in order to obtain a 
consensus to probe the class II enzymes. 
It was fIrst noted in the E.coli structure that the arrangement of ~-strands 
conforms approximately to a 'jelly roll' fold (Cedergren-Zeppezauer et al., 1992) which 
is depicted in Figure 4.12. Each subunit possesses 1 0 ~-strands and a short a-helix. 
Eight ~-strands form two ~-sheets and create an overall ~-barrel arrangement. The two 
remaining short anti-parallel ~-strands are not part of the ~-barrel. The eighth ~-strand 
in the 'jelly roll' fold confIguration is donated by an adjacent subunit (more clearly 
visualised in the introduction Figure 1.11). 
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(a) Idealised jelly roll fold 
C N 
8 1 2 7 4 5 6 3 
C' 
(b) E.coli secondary structure 
-------1----- - - --2-- ---9--- ------3------- ---4--- HELIX 
EIAV MLAYQGT QIKEK RDEDAGFDLCVPYD IMIPVS DTKIIPTDVKIQVP 
FlV MIIEGD GILDK RSEDAGYDLLAAKE IHLLPGEVKVIPTGVKLMLP V r..V'Wr..l· . T 
Human MQLRFARL SEHATAPTRGSARAAGYDLYSAYD YTIPPMEKAVVKTDIQIALP 
E. col i MMKKI DVKI KEFPLPTYATSGSAGLDLRACLNDAVELAPGDTTLVPTGLAln .Lr\Ur~""""""l"l.U'''' 
Motif 1 Motif 2 
-a---S--b-- ---6- - ---- -10- - - - --7 - --- - - - -8----
ElAV LLlN GGll DEGYTGE IQVlCTNI GKSNI KL IEGQKFAQLIILQHHSNSRQPWDENKISQRGDKGFGSTGVF 
FlV LDVL GGVI DEGYRGEIGVIMINVSRKS ITLMERQKIAQLIILPCKHEVLEQGKVVMDSERGDNGYGSTGVF 
Human IDVG AGVIDEDYRGNVGVVLFNFGKEKFEVKKGDRIAQLICERIFYPEIEEAQALDDTERGSGGFGSTGKN 
E . coli I VLGNLVGLI DSDYQGQLMISVWNRGQDSFT IQPGERIAQMIFVPVVQAEFNLVEDFDATDRGEGGFGHSGRQ 
Motif 3 Motif 4 Motif 5 
(c) Comparison of four class I secondary structures relative to primary sequence 
Figure 4.11 Comparison of the class I secondary structure to a "jelly roll" fold 
Two topological diagrams are shown: (a) an idealised 'jelly roll ' fold and (b) the structure of E.coli 
dUTPase. p-strands are depicted as arrows representing their direction and the a-helix as a cylinder. A 
direct comparison of p-strand positions in relation to primary sequence is given in (c). The eight p-
strands composing the jelly roll fold are highlighted in yellow with the additional strands in grey. a-
helices are highlighted in red. A four residue insertion in the E.coli sequence is highlighted in cyan (see 
text below for details). p-strands are numbered 1-10 for comparison. 
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All four class I enzymes follow a homologous ~-sheet profile as depicted in 
Figure 4.12 (b) with the following exceptions. In E.coli, FIV and human dUTPases, the 
C-terminal region provides the eighth ~-strand in the 'jelly roll' fold. This means that 
each globular domain contains polypeptide chains from two different subunits which 
are tightly interlocked. In EIA V dUTPase the C-terminal strand donated by the 
neighbouring subunit does not take part in the ~-sheet structure but still makes intimate 
contact with the adjacent subunit. The only other deviations from the pattern are a 
result of splitting long ~-strands into two smaller strands. This is apparent in Figure 
4.12(c) where strand 1 and 3 are split in the retroviruses, EIAV and FIV and strand 5 is 
split in all but the E.coli dUTPase. 
Although there are subtle differences between each species the general pattern 
of ~-strands is highly conserved. This can be seen in the comparison of the 3D 
structures in Figure 4.13. The four available class I subunit structures closely resemble 
one another demonstrating that the splitting of ~-strands has little structural 
consequence. This can been seen visually in the figure by comparing the bottom right 
area (N-terminus) of each structure. Each subunit has been positioned relative to the 
orientation of the extended C-terminal tail for comparison. From this view it can be 
seen that the overall ~-sheet arrangement in each species is highly conserved relative to 
this position. The small a-helix is also in an almost identical position in each species. 
The E.coli dUTPase possesses a small additional bulge which corresponds to the 
insertion of four residues at positions 11 to 14 (Figure 4.I2c in blue). This chain 
extension (visible in Figure 4. 13 (a) and (e)) loops back towards the main body and does 
not affect the ~-sheet pattern. 
Figure 4.13(e) shows all four class I structures superimposed without any 
structural modifications. Apart from the small extended loop visible in the E.coli 
dUTPase and to a lesser degree in the human dUTPase the structural backbones match 
almost exactly. This is a fascinating observation given the diversity of these four 
speCIes. It highlights the relative unimportance of inter-motif primary sequence 
conservation in comparison to conservation of polypeptide chain length to the 
maintenance of the subunit structure. 
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(a) E.coli (b) FIV 
(c) Human (d) EIAV 
(e) Superimposed ribbon traces 
Figure 4.13 ~-sheet homology between class J dUTPases 
Comparison of secondary structure of the class I dUTPases. Each subunit is depicted as an a-carbon 
ribbon. p-strands are shown as yellow arrows depicting their direction while a -helical regions are in red. 
In part (e) all four species are superimposed in the following colours: E.coli-yellow, FIV-green, human-
red, EIA V -cyan. The Swiss-PDB Viewer was used to generate these ribbons and to superimpose the four 
class I species by aligning a-carbon backbones. 
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Given the strong conservation of these secondary structural elements in the class 
I dUTPases it was of interest to compare this pattern to the class II enzymes. Since 
there was no structural data available for any member of the class II group it was 
necessary to employ secondary structure prediction programs. The results of this 
analysis are given in the following sections. 
4.4.3 Secondary prediction of class II dUTPases 
The program used for secondary structure prediction of the class II group was 
PredictProtein at the automated server at EMBL, Heidelberg. This program is stated to 
give expected 3 state accuracies (helix, strand, other) of over 72% depending on the 
input data (Rost and Sander, 1993 and 1994). This program is based on a system of 
trained neural networks which allows greater reliability than single sequence or 
statistical alignment inputs. 
The basis behind the prediction method is the utilisation of multiple sequence 
alignments. This program was therefore appropriate for comparing the class I and II 
dUTPase using the previously refmed alignments. The program can use a single query 
sequence or a multiple alignment can be supplied. For single sequence input the 
program scans the Swiss-Prot database for homologues and generates an alignment 
using the MaxHolm method (Sander and Schneider, 1991). 
The main objective of this work was the secondary structure prediction of HS V -
1 dUTPase. Initial experiments were therefore carried out using whole or part of the 
HSV -I primary sequence as single input data. This allowed the PredictProtein program 
to calculate its own alignments with the MaxHolm program. Given the potential for 
alignment problems using single sequence input this strategy was improved. 
Experiments using the HSV -I sequence as single input data were unreliable. 
This was due to the lack of conserved sequences detected and aligned with the HSV-l 
sequence by the automated MaxHolm program. Improved alignments could be 
generated by splitting the HSV-l sequence into smaller fragments. This allowed the 
MaxHolm program to align the C-terminal half of the HSV-l protein to class I species 
due to the local similarities in motifs 1,2,4 and 5. However, the N-terminal half could 
not be satisfactorily aligned by the MaxHolm program. The lack of conserved 
sequences found in this area was below the criteria recommended for secondary 
structure prediction. This is not surprising given that there is no sequence homology 
with the class I structures outside motif 3 in this half of the HSV-I sequence. 
The PredictProtein program has the ability to utilise ready made alignments for 
its prediction. Although it was specifically the HSV-I sequence which was of interest, 
a better prediction would be realised with refined class II lineups. Given the primary 
sequence differences between the class II dUTPases it was decided to use a bank. of 
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alignments including all the available class II sequences and subsets based on 
phylogenetic relationships. This was deemed appropriate since the Feng and Doolittle 
alignment program had successfully partitioned each of the class II dUTPase into the a 
and y subfamilies directly from dUTPase primary sequences. 
An example prediction using pre-aligned sequences as input data is given in 
Figure 4.14. The most obvious observation from the ProteinPredict output data is the 
abundance of predicted ~-strands throughout the lineup. It is important to note that this 
is not a prediction of the EHV -1 sequence alone and this sequence is given only as an 
alignment marker. The prediction is in fact from an alignment of 8 class II sequences. 
An overall reliability index is shown (Rei sec) and is relatively high in areas of 
predicted ~-strands ('E'). This reliability index is broken down into helix, strand and 
loop and again the majority of ~-strand are predicted with a high probability. Further 
confidence is given by the fmal line of output data which indicate areas where the 
prediction is likely to be over 82% accurate. Predicted ~-strands have been highlighted 
in yellow for clarity. 
It must be noted that the reliability index is based on an efficient alignment with 
sequence conservation varying from 80% identity down to 20% and any deviation from 
these criteria will result in a lower reliability. Since the sequences used here do not 
align with great efficiency it is likely that the secondary structure predictions will be 
several percentage points lower than the 72-82% accuracy range. Even so, although the 
alignment is constructed from the class II group exclusively, species are included from 
the two different subfamilies a and y. Members from these groups differ substantially 
at the primary sequence level which is actually advantageous to the prediction program 
as it more closely satisfies the ProteinPredict variability criteria. Additionally greater 
weight can be inferred from the predictions by using several independent alignments. 
In addition to the ~-strand prediction shown, there are several predicted 
extended loop regions. Interestingly these areas correspond approximately to variable 
regions 2 and 3 (see previous section) which are highlighted in blue. This observation 
supports the theory that variation in sequence length between the class II species is 
caused by the insertion of additional loop regions and not by a change in the overall ~­
sheet arrangement. 
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PHD sec 
Re1 sec 
prH sec 
prE sec 
prL sec 
SUB sec 
AA 
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Rel sec 
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Figure 4.14 Typical output from ProteinPredict program 
The 8 sequence alignment generated by SAGA in Figure 4.8 was used as input data to the ProteinPredict 
program. This bypassed the MaxHolm alignment method which is the program default. The output data 
are arranged with respect to the EHV -2 sequence, corresponding to the first entry in the SAGA 
alignment. ~-strands over 3 residues in length are highlighted in yellow and variable regions 2 and 3 are 
highlighted in blue. Further annotations from the ProteinPredict program are as follows: 
AA - amino acid sequence of first entry in lineup (in this case EHV-2) 
PHD sec - Profile network prediction Heidelberg: H=helix, E=extended (sheet), blank=other (loop) 
ReI sec - Reliability index of prediction (0-9) 
prH - 'probability' for assigning helix 
prE - 'probability' for assigning strand 
prL - 'probability' for assigning loop 
SUB sec - a subset of the prediction, for ail residues with an expected average accuracy > 82% 
For the latter subset the following symbols are used: L is loop and 1t . 1t means that no prediction is made 
for this residue, as the reliability is less than 5. 
4.4.4 Comparison of class I structure to class II predictions 
Each data set obtained from the ProteinPredict program contained large amounts 
of data similar to that in Figure 4.14. All of these predictions were compared directly to 
the E.coli doublet sequence using a new alignment. This was achieved by aligning the 
class II sequences to the E.coli doublet by the standard Feng and Doolittle method. The 
position of the predicted strands was noted and transposed onto this new lineup for 
comparison. An example of such a comparison is shown in Figure 4.15. 
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Figure 4.15 Comparison of class II predicted secondary structure to the E.coli doublet 
The class II sequences shown were aligned with the E.co/i doublet sequence using the GCG Pileup 
program. Three lines of secondary structure information are sandwiched between the class II group and 
the E.coli doublet. Secondary structures are indicated as an 'E' for extended ~-strand and 'H' for helix, 
'PHSV-I ' indicated the secondary structure prediction using the HSV-l sequence as single input data. 
'Ptotal ' indicates a prediction using a lineup of all available class II sequences as input data. ' Cryst' 
indicates the solved secondary structure in the E.coli crystal structure. Homologous ~-strands are 
highlighted in yellow and numbered. The joining region and extension region (between motifs 4 and 5) 
are highlighted in blue. 
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Given the complexity of the data set generated by the ProteinPredict program it 
is useful to look at an overall summary. Each known ~-strand in the E.coli structure 
was analysed for the presence of a homologous class II ~-strand in various predictions. 
Table 4.1 shows prediction summaries for HSV-l and EHV-l single input sequences, 
the a subfamily and the total class II group (see legend for details). 
Section Strand HSV-1 EHV-1 Alpha Total 
1 • • 
2 • • • • 9 • • 3 • • • • N-terminal 4 • • • • 
5 • • • • 
Half 6 • • • • 10 • • 
7 • • • • 8 
1 
2 ? ? ? ? 
9 ? • • 
3 • • • • 
C-terminal 4 • • • ? 5 • • • • 
Half 6 • • • • 
10 • • • • 
7 H H H • 
8 ? ? 
Table 4.1 Summary of Protein Predict data 
The results of four predictions, 2 single sequences and 2 alignments, were compared to the E.coU doublet 
sequence. ~-strands are numbered according to how they appear in the primary sequence (same as Figure 
4.13). Detection of a ~-strand homologue is shown by a circle '.'. Those homologues which have less 
than 50% of the E. coli doublet strand length are marked as '?'. Prediction of a helix in place of an E. coli 
doublet ~-strand is indicated by an 'H'. Class II species included in the two alignments are as follows: 
Alpha: HSV-1, HSV-2, EHV-l, BHY-I, PRY and VZV 
Total: Alpha plus HYS (y) and EBV (y) 
From these data it can be seen that the ~-sheet arrangement in the E. coli 
dUTPase is predicted to be approximately duplicated in the class II dUTPases. This 
should be taken in the context of the alignment between the two classes represented in 
the previous section (Figure 4.10). There are two obvious gapped regions which are 
indicated on this figure and can also been seen highlighted in blue in the sequence 
comparison Figure 4.15. The latter of these gapped regions lies between motifs 4 and 5 
corresponding to the region between ~-strands 7 and 8. This extension is present in all 
the class II species analysed. It is clear that there is some divergence between the 
classes in this area and this is reflected in the low ~-strand homologue predictions for 
strands 7 and 8. This is a key feature of the class II model discussed below. 
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Similarly, the region representing the join between the two class I subunits to 
fonn the monomeric class II molecule is extended with respect to the E.coli doublet. 
This region spans j3-strands 8 from the N-tenninal half to strand 2 from the C-tenninal 
half. Comparison of class II sequences alone has demonstrated that this region is highly 
variable between species (Section 4.3). Again this is reflected in the absence of 13-
strand homologues predicted for this region. This is discussed with reference to the 
model below. 
4.4.5 Proposed class II dUTPase structural arrangement 
Several key observations were assembled to construct the class II structural model: 
the class I group are trimers while the class II group are monomers of 
approximately double the protein chain length 
each half of the class II molecule has a congruent j3-strand arrangement to the 
class I subunit (by secondary structure prediction) 
a variable extended joining region exists between the two halves of the class II 
monomer 
a relatively conserved additional chain length exists between motifs 4 and 5 in 
the class II molecule 
each of the three class I active site regions is fonned by motifs donated by all 
three subunits of the trimer 
the class II monomer has only one copy of each motifwith which to fonn an 
active site. 
In order to model the class II structure all of the above points must be accommodated in 
order to arrive at a structure which has the potential to be active, monomeric and have 
evolved through intragenic duplication. It is proposed that the class II active site will 
be constructed by the condensation of the five motif regions and as such will mirror the 
class I active site in tenns of arrangement and enzymatic mechanism. Figure 4.16 
shows a diagrammatic representation of the class II model. 
This model was constructed using the Glaxo Wellcome Swiss-PDB Viewer. 
The starting point in the modelling process was the E. coli dUTPase structure 
complexed with dUDP (a). The trimer is shown with the 3 subunits coloured blue, 
green and yellow and rendered as ribbons. The dUDP molecules are coloured red and 
for clarity rendered as Van der Waals surfaces. Three dUDP molecules occupy the 
three active sites situated at the subunit interfaces. The visible motif regions 1-4 are 
highlighted in pink for the top-right active site. The motif 3 loop is clearly visible and 
is donated by the blue subunit. Motifs 1, 2 and 4, donated by the green subunit, are just 
visible behind the dUDP molecule. The C-tenninal 16 residues containing motif 5 are 
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not visible in the E.coU crystal structure but extend from the yellow subunit tail. This 
tail can be seen pointing in the direction of the active site and is proposed to fold akin to 
the human dUTPase structure where motif 5 interacts with the substrate molecule and 
caps the active site. The model is progressed in four stages. 
Diagram (b) shows the E.coU structure with the yellow subunit removed. This 
dimeric structure represents the approximate chain length equivalent of the class II 
dUTPases. The blue subunit represents the N-terminal half of the class II molecule 
while the green subunit represents the C-terminal half. The four motifs which 
constitute the active site in diagram (a) are conserved in structure (b) shown here 
interacting with a single dUDP molecule. 
In the class I enzymes the active site is composed of motifs donated by all three 
subunits. A model is proposed to generate a homologous active site using only the two 
subunits available in structure (b). Motifs 1, 2 and 4 from the green subunit plus motif 
3 from the blue subunit are forming an active site pocket mirroring the trimeric 
ancestor. In order to complete the active site, motif 5 is proposed to be donated from 
the extended arm of the green subunit. Structure (c) shows how this can be easily 
accomplished. To position motif 5 the extended arm is allowed to rotate by 
approximately 90° in the plane of the paper. The green subunit arm now occupies a 
homologous position to the yellow subunit arm in the original trimer. 
This rearrangement is accomplished with minimal disruption to the overall 
structure and generates the possibility to condense all 5 motifs in a monomeric 
molecule. All that is required is an extension of this C-terminal arm to position motif 5 
over the active site. As seen in the primary sequence studies, all class II dUTPases 
possess an extra chain length between motif 4 and 5 as compared to the class I group. 
This additional chain, of approximately 30-35 residues, is conserved exclusively within 
the class II group and is now proposed to allow correct positioning of motif 5. This 
extra chain is demonstrated in structure (d) where motif 5 is depicted in pink at the end 
of the C-terminal arm. 
The only remaining rearrangement necessary is the connection of the two 
subunits to form a single chain. The last visible C-terminal residue of the blue subunit 
and the N-terminus of the green subunit are highlighted in yellow. Structure (e) shows 
the joining of these ends to complete the transformation in a monomer. A small loop is 
shown for this joining region but there is a large chain length variability between the 
class II species. This structure is therefore more representative of the shorter species 
such as EBV, EHV-2 and PRY. To arrive at a model more closely representing the 
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(a) (b) 
(c) (d) 
(e) 
Figure 4.16 Modelling of the class II dUTPase structure from a class I template 
The figures are hybrid models based on the original E.coli dUTPase 3D coordinates (a and b) plus 
regions of diagrammatic predictions (c-e). See main text for details. 
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longer species like HSV -1 and VZV this loop would have to be extended. Given the 
location of the joining region on the opposite side from the active site, an extended loop 
could be efficiently accommodated without disrupting the active site or interfering with 
the conserved j3-sheet arrangement. 
This model satisfies the criteria given at the beginning of this section and gives 
a graphical interpretation of the structural consequences of an intragenic duplication of 
the class I dUTPase. The fmal model shown in (e) represents a monomer formed 
directly by the joining of two trimer subunits. It therefore possess a copy of the subunit 
structure in each half of the molecule and in this context can be seen as a visualisation 
of the secondary structure predictions in the previous section. For clarity this model 
does not highlight the extended sequence found between motifs 4 and 5 in the class II 
dUTPases. This is discussed in detail in Section 4.5. 
4.4.6 Discussion 
DNA and protein sequence data have the ability to highlight relationships 
between distantly related molecules. In the case of dUTPases these data has been 
utilised to propose the intragenic duplication which links the two distinct classes. The 
absence of any crystallographic data for the class II dUTPases prevented further 
investigation at the structural level. Utilising sequence analysis with computer 
prediction methods it was possible to continue the investigation into interclass 
relationships. Results from secondary structure prediction work allowed the generation 
of class II model which provides insight into the structural evolution of these 
molecules. 
Secondary structure prediction was carried out using the ProteinPredict 
program. This allowed multiple sequence alignments to be used to predict an overall 
class II secondary structure. Various alignments were used to decrease any biasing 
effects. The first observation was the large quantity of predicted j3-strands in the class 
II group. Alignment of these predictions with the E.coli doublet sequence demonstrated 
a high degree of congruency. It appears that each half of the class II molecule is a 
structural relative of the class I subunit structure. 
A model was constructed accommodating all previous data plus the secondary 
structure predictions and demonstrates how the class I trimer could evolve into the class 
II monomer. The variable length joining region between the two halves of the class II 
molecule plus the extended region found between motifs 4 and 5 are explained 
structurally. The model satisfies all the criteria necessary for an intragenic duplication 
creating an active monomeric dUTPase from an ancestral trimer. 
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4.5 Hydrophobic modelling of HSV -1 dUTPase 
4.5.1 Introduction 
To test the class II model further an investigation into molecular surfaces was 
carried out. It was proposed that if the class II dUTPases assembled as predicted from 
the model then specific hydrophobic regions would be conserved between the two 
groups. Experiments were carried out to test this conservation firstly on the internal 
hydrophobic regions and secondly on the subunit interacting regions. The methodology 
was to identify conserved regions of hydrophobicity within the class I group, generate a 
data set of conserved residues and use this to probe the class II molecules. 
4.5.2 Identification of class I hydrophobic regions 
Several hydrophobic regions are proposed to be conserved throughout the class 
I dUTPases. This assumption is based on the extremely conserved class I subunit and 
trimer structures identified in previous sections. Two regions of potential hydrophobic 
interaction were investigated: the subunit core and the trimer core. 
The subunit secondary structure is made up mainly of /3-strands (Figure 4.13) 
and it is clear that these structural elements contribute to the folding of a stable tertiary 
structure. It is proposed that in addition to this mechanism there is a hydrophobic bias 
in the subunit core generating energetically favourable conditions for folding. It is also 
proposed that a similar hydrophobic bias exists in the trimer core and increases the 
efficiency of subunit assembly. This was examined using the E.coli crystal structure to 
identify hydrophobic residues within the subunit and trimer cores. 
There are various defmitions for measuring hydrophobicity based either on 
amino acid positions in known 3D structures (Janin, 1979; Rose et aI., 1985) or the 
specific physicochemical properties of their side chains (Wolfenden et at., 1981; Kyte 
& Doolittle, 1982). The residues chosen here represent a compromise between these 
different scales. Four scales were used (two from each measurement method) and 
residues were chosen that were found to be the most hydrophobic in all four. The 
hydrophobic subset used for this investigation was therefore Ala, Cys, Leu, G ly, lie, 
Met, Phe and Val. 
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(a) (b) 
(c) (d) 
Figure 4.17 Distribution of hydrophobic residues in the E.coli trimer and subunit 
Residues based on the defined hydrophobic subset are coloured in red. All other residues are coloured 
blue. (a) and (b) show the E.coli trimer as a surface view and a 50% slice through the middle 
respectively. (c) and (d) show the subunit as a surface view and a 50% slice through the middle 
respectively. The subunit is orientated with the C-terminal tail pointing away from the viewer. The 
angle of this view relative to the trimer is shown by an arrow in (a). 
Molecular viewing programs permit efficient identification of internal 
hydrophobic residues. Each residue was coloured based on the above hydrophobic 
subset and slices were taken through the structure. Figure 4.17 gives a general 
indication of the distribution of hydrophobic residues in the E.coli trimer and subunit 
structures. The trimer is made up of a mixed outer surface with a strongly hydrophobic 
core (red). The subunit structure shows a similar pattern again with a mixed outer 
surface and a hydrophobic core. The subunit however has two regions of surface 
hydrophobicity which lie at the subunit-subunit interfaces and are shown in Figure 4.20. 
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4.5.3 Generation of the class I internal hydrophobic data set 
To allow direct comparison between the two dUTPase classes, the hydrophobic 
regions identified had to be expressed in terms of primary sequence data. This was 
achieved with the surface accessibility program Sleuth (Dudek & Ponder, 1995). All 
water molecules were removed from the E.coli subunit coordinates and the program 
was used to calculate the surface accessibility of each atom in the structure. This was 
averaged over the atoms of each amino acid in order to categorise those residues which 
were on the surface and those which were buried. The set of buried residues was then 
refmed to hydrophobic buried residues. Finally these residues were compared in a class 
I alignment to identify buried hydrophobic residues which were highly conserved 
within the group. Figure 4.18 shows such an alignment where the E.coli internal 
hydrophobic residues are shown in red and conserved inter-species hydrophobic loci are 
shown in yellow. Note that data are missing from the C-terminal portion due to the lack 
of structural data available from the crystal structure in this area. 
Hpmv ... . .. . .... . .. SLWGSQ ... . ....... LCSSQQKQPI SKLTRATPGSAGLDL .. CSTSHTVLTPEMGPQALSTGIYGPLPPNT FG . LILGRSS I .T 
Srvl .. .. ...... . ... SLWGGQ . .. ... . .... LCSSQQKQPI SKLTRATPGSAGLDL .. SSTSHTVLTPEMGPQALSTGIYGPLPPNT FG . LILGRSSI. T 
Jsrv .. .. ......... . MLWG ..... .. .•.. . . . NTAGSKRTIADLCRATRGSAGLDL .. CATSYTVLTPEMGVQTLATGVFGPLPPGTVG. LLLGRSSA.S 
Mmt v ... . .....•. . .. GVKGSG . .... . ... . . LNPEAPffPI HDLPRGTPGSAGLDL . . SSQKDLl LSLEDGVSLVPTLVKGTLPEGTTG. LIIGRSS .. N 
f1 v ...... . . .. ..... ... . .. ...... . . . ...... HII EGDGILDKRSEDAG YDL .. LAAKEI HLL. PGEVKVI PTGVKLML PKGYWG. LIIGKSSI. G 
Omvs ............. . . .. ....... . ...... . SElfLAREGSGILPKRAEDAG YDL .. lCPQEVCI P. AGQVRKI PlNLRINLKEDQWA. MVGTKSS F.A 
Visn ............ . .. . ............... . SElFLAKEGRGlLQKRAEDAGYDL .. lCPQEI SI P.AGQVKRIAlDLKINLKKDQWA.HIGTKSS F .. 
Caev .... . .. .. ..... . .... . ...... . ... .. SEl FLAKEGEGILPKREEDAG YDL . . ICPEEVTI E. PGQVKCI PI ELRLNLKKSQWA. HIATKSSH .... 
E1av .. . •...•.... . . . ........... . .. . ... .. HLAYQGTQlKEKRDEDAG E'DL .. CVPYDl MI P. VSDTKIIPTDVKI QVPPNSFG . WVTGKSSH .. 
Coxb . . .. .. .. . ... . HTHSVQLK ..... . . . . . ILDKRLGSEFPLPAYATTGSAGLDLRACLDEPLKI E.PDETCLI STGLAIYLGHS NV ...... TILPRSGL.G 
Eeol ............ HMK40VK .. ......... ILDPRf:;KElPLPTYATSGSAit CWD . PGDTT P PRS .• 
Vaeee ............ HfNMNINSP .......... VRfVKETNRAKSPTRQSPGAAGYDL .. YSAYDYTl P.PGERQLI KTDISHSHPKICYG.RIAPRSGL.S 
VarY ........ . .. . HfNMNINSP . ...... . .. VRfVKETNRAKSPTRQSPYAAGYDL . . YSAYDYTI P. PGERQLI KTDI SHSMPKFCYG. RIAPRSGL. S 
Human ........... . ... HQ . . .. . ... . ..... LRFARLSEHATAPTRGSARAAGYDL . . YSAYDYTI P. PMEKAVVKTDIQIALPSGCYG. RVAPRSGL.A 
Orfv ............ . MEFCHTET . ...... . .. LQVVRLSQNATIPARGSPGAAGLDL .. CSAYDCVI P. SHCSRVVFTDLLI KPPSGCYG. RlAPRSG .. A 
Fadv . . ........ MDPFGSSSVPPCSTSDLPEPKLYfVRLSPHAVPPVRATHGAAGYDL .. FSAYDIKVP.ARGRALVPTDLVFQFPPGCYG.RIAPRSGL.A 
Calb ........ . .... HTSEDQSLKKQKLESTQSLKVYLRSPKGKVPTKGSALAAGYDL .. YSAEAATI P . AHGQGLVSTDISIIVPIGTYG. RVAPRSGL. A 
Seer .... .. ....... HTATSDKV ....... . .. LNlQLRSASATVPTKGSATAAGYDI . . YASQDI TI P.AMGQGMVSTDI SFTVPVGTYG.RIAPRSGL.A 
Lyee. MAENQINSPEITEPSPKVQKLDHPENGNVPFFRVKKLSENAVLPSRASSLAAGYDL .. SSAAET KV P.ARGKALVPTDLSIAVPQGTY ... . RIAPRSGL.A 
Cev MDFNTDRGSAIPTGDDRGYQCGVIGDSVRFSVFTGYDAADVSIPKlSSPGSAGfDL . . SVLEDREFl.RGCHYRL PT IAVPRGYVG . lITPRSS .. Q 
Motif 1 Motif 2 
Hpmv HK. GLQVYP .. GVIDNDYTGEI KIMA . KAVNNlVTVSQGNRIAQLlLLPLlETDNKV . . ..... QQPYRGQGSFGSSDI. .... . .. .. . . .. . ... . 
Srvl IK. GLQVYP . . GVIDNDYTGEI KlMA . KAVNNIVTVPQGNRIAQLILLPLIETDNKV .... . .. QQPYRGQGSFGSSDIYW .. . .........•.... 
Jsrv LK. GlLIHP .. GVIDSDYTGEIKILA . SAPNKIIVl NAGQRIAQLLLVPLVIQGKTI . ....... NRDRQDKGFGSSDAYW .... . . . . . ... . ... . 
Hmtv YKKGLEVLP . . GVIDSDFQGEIKVMV . KAAKNAVI I HKGERIAQLLLLPYLKLPNPVI ...... . KEERGSEGFGSPSHVHW .. .. .. . .... . ... . 
Fiv SK. GLDVLG .. GVIDEGYRGEIGVIHINVSRKS I TLMERQKIAQLIILPCKH. EVLEQG .. KVVMDSERGDNGYGSTGVFSSW . ............. . 
Omvs SK. GVfVQG .. GI I DSGYQGI IQVVVYNSNDKEVI IPQGRKFAQLILHPLIH.EDLEAW .. GETRRTERGNQGFGSTGAY . .............. . . . 
Visn ANKGVfVQG . . GI I DSGYQGT IQVVIYNSNNKEVVIPQGRKFAQLILHPLIH.EELEPW .. GETRKTERGEQGFGSTGHYW .. . . . ........... . 
Caev AK. GVFTQG .. GII DSGYQGQIQVIHYNSNKIAVVIPQGRKFAQLILHDKKH. GKLEPW .. GESRKTERGEKGFGSTGHY . ........... . •... . 
Eiav AKQGLLING .. GII DEGYTGEIQVI CTNIGKSNIKLI EGQKFAQLIILQHHS. NSRQPW .. DENKISQRGDKGFGSTGVFW .... . .......•.... 
Coxb HKHGIVLGNLVGLI DSDYQGPLHVSCWNRGKEPYTI NPGDRIAQLVVLPI LK. AQFAVV .. EEFELTERGAGGFGSSGQN .............•.... 
Eeol H L~SDY D~PlE PlVa .AEfNLV .. £DFDATDRGEGGFGHSGRQ .............•.... 
Vaeee LK. GIDIGG .. GVI DEDYRGNIGVILINNGKCT FNVNTGDRIAQLIYQRI YY . PELEEV .. QSLDSTNRGDQGFGSTGLR . . ... . .......•.... 
VarY LK. GI DI .. GVI DEDYRGNIGVILINNGKYTFNVNTGDRIAQLIYQRI YY.PELKEV . . QSLDSTDRGDQGFGSTGLR ................. . 
Human AKH FIDVGA .. GVI DEDYRGNVGVVL FNFGKEKFEVKKG DRIAQLICERI FY.PEIEEA .. QALDDTERGSGGFGSTGKN . ............ . ... . 
Orfv VKH FIDVGA . . GVIDEDYRGNVGVVL FN FGNSDFEVKKGDRIAQLICERI SC.PAVQEV .. NCLDNTDRGDSGFGSTGSGACGGRDTAWYIS ..... . 
fadv AKFFIDVGA . . GVIDPDYRGNVSVVLFNFSESSFNIRRGDRVAQLILERIMV.PELSEL .. TQLGETDRGASGFGFTGHGAVDRNQRSVLEWLTPGSR 
Calb VKHGISTGA .. GVI DADYRGEVKVVLFNHSEKDFEl KEGDRIAQLVLEQI VN . ADIKEISLEELDNTERGEGGFGSTGKN . . . . . .. .... .. .... . 
Seer VKNGIQTGA .. GVVDRDYTGEVKVVLfNHSQRDFAIKKGDRVAQLILEKIVDDAQIVVV . . DSLEESARGAGGFGSTGN . . . ... . ........... . 
Lyees WKYS I DVGA • . GVI DADYRGPVGVVLFNHSEVDFEVKVGDRIAQLIVQKIVT.PEVEQV .. DDLDSTVRGSGGFGSTGV .................. . 
Cev AKNFVST .... GI I DSDFRGH I HIMV .. SAIADFSVKKNQRIAQLVVT PCLTQSEVVPY .. ETLERTRRGTGGFGSSGQ .................. . 
Hotif 3 Motif 4 HotH 5 
Figure 4.18 Conservation of internal hydrophobic loci within the class I group 
Internal hydrophobic residues in the E.coli structure are highlighted in red. Conserved hydrophobic 
residues in the other class I species are highlighted in yellow. Strongly conserved hydrophobic loci are 
marked with an asterisk (*). 
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It can be seen that internal hydrophobic loci are highly conserved within the 
class I sequences. This is especially interesting since many of these loci lie outside the 
conserved motif regions. Motifs 1 and 4 however contain a large percentage of internal 
hydrophobic residues. This is consistent with motif 4 having only one residue in direct 
contact with dUDP in the co-crystal (Q1l9) and motif 1 having no direct substrate 
interactions. I propose that these internal residues are conserved for a structural role 
rather than substrate binding or catalysis. Given their relative position it is likely that 
these motif residues stabilise the condensation of motifs from different subunits. Since 
the class I dUTPases are the only trimeric enzymes known to date in which the active 
site is made up from 3 different subunits it is not surprising that internal residues are 
conserved to maintain this unusual coordination. 
Despite the variation in inter-motif primary sequences there is a high degree of 
hydrophobic conservation. This is consistent with the homologous nature of the class I 
structures. The most highly conserved loci are highlighted on the alignment with an 
asterisk (Figure 4.18) and it is these positions that were used to probe the class II 
molecules. 
4.5.4 Comparison of class I and II subunit bydropbobic cores 
The internal hydrophobic loci identified in the class I group were compared 
directly to the class II group with the standard E.coli doublet alignment used for 
secondary structure comparisons. A diagrammatic representation of this alignment is 
shown in Figure 4.19. The positions of the hydrophobic residues was obtained by 
superimposing the data form Figure 4.18 onto the alignment shown in Figure 4.15. 
E. coli doublet sequence 
N 1rrr-nlll l.....-rrIIl~--".--yIII...........,.11 ~ I....-r.-II F~ IIIII,..---,-5 I :::::::::: rrTf""""11 111 1 1........-n111l~211 ~1131 rr-rn-IIII~-,y--"Ti I ::::: ::[IE] c 
1 1 
N I I 111111311111 1181111 5 1111112111 131 1181 115 I C 
Alignment of 10 class II sequences 
Figure 4.19 Comparison of the class I hydrophobic loci to the class II sequences 
A diagrammatic representation of the hydrophobic sequence alignment is shown (not to exact scale). The 
E.coli doublet sequence is represented as a box with the position of each motif shown. The 31 class I 
conserved hydrophobic loci (identified with an asterisk in Figure 4.18) are represented by red bars. 
These were aligned with 10 class II sequences and the position of congruent hydrophobic loci is shown in 
the bottom diagram (22/31 in the N-terminal half and 20/31 in the C-terminal half). 
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A positive hit was defmed as an E. coli locus which had 5 or more conserved 
hydrophobic loci out of the ten species in the class II lineup. There was 31 E. coli loci 
aligned with each half of the class II lineup. In the C-tenninal half there was 20 
positive hits (64%) while in the N-tenninal half there was 22 positive hits (71%). This 
yields an average of over 67% positive hits over the entire class II lineup. 
This gives an indication that internal hydrophobic loci are well conserved 
between class I and II dUTPases. More significantly it demonstrates that each half of 
the class II structure has a similar hydrophobic distribution to the class I subunit 
structure. It follows that each half of the class II molecule has an internal hydrophobic 
core corresponding to the class I subunits core. This supports the class II model 
supplying further evidence that the class II monomer approximates a condensation of 
two class I subunit structures. 
4.5.5 Identification of the class I interface hydrophobic data set 
It is not only the subunit core which has an internal bias for hydrophobic 
residues but also the trimer itself (Figure 4.17b). The internal core of the trimer is 
partly composed of hydrophobic subunit surfaces. These surfaces can be readily 
identified mathematically by defming their accessibility in two coordinate data sets. 
First the surface is calculated for a single subunit. The surface is then calculated from 
the entire trimer. Subtraction of the subunit surfaces from the trimer surface yields the 
internal subunit interfaces. It is these surfaces which allow subunit-subunit interaction 
in the fonnation of the trimer. 
To allow graphical interpretation of these interfaces it was useful to transpose 
the mathematical data onto a spacefilling model of the E.coli dUTPase. Figure 4.20 (a) 
shows a single subunit with the C-tenninal tail pointing directly towards the viewer at 
the bottom of the diagram. The residues identified from the mathematical calculations 
are highlighted in red and green. These two colours represent the two subunit surfaces 
which interact to fonn the trimer. The same residues are highlighted in all three 
subunits of the trimer in (b). To improve the visualisation of how the subunit surfaces 
interact with one another (c) shows the same trimer sliced in half. White lines indicate 
the approximate boundaries of each subunit. 
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(a) (b) 
(c) (d) 
Figure 4.20 Identification of E.coli subunit interfaces 
Spacefilling diagrams are shown for the E. coli subunit (a), trimer (b) and trimer 50% slice (c). The class 
II model is shown in (d). Interacting surfaces are shown in red and green. Diagrams were created with 
RasMol. See text for details. 
It can be seen that each subunit possesses two major interacting surfaces 
coloured red and green. What is interesting is the fate of these surfaces in the class II 
molecule. Referring back to the model in Figure 4.16, the class II molecule is 
composed of two class I subunits joined in one chain. This model is represented as a 
space filling diagram in Figure 4.20 (d). One of the three trimer subunits has been 
removed to represent the class I monomer. Subunit 'A' represents the N-terminal half 
of the protein while subunit 'B' represents the C-terminal half. 
What becomes apparent is that while three subunit interfaces are required to 
generate the trimer, only one subunit interface is required to generate the monomer. 
The N-terrninal half requires only the red surface (2) while the C-terminal half requires 
only the green surface (3). The remaining two surfaces (1 and 4) are now in solvent 
contact. It is proposed that hydrophobic residues in the interacting region (2 and 3) will 
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be conserved while hydrophobic residues in the solvent accessible regions (1 and 4) 
will be substituted by energetically more favourable hydrophilic residues. This was 
tested at the primary sequence level. 
4.5.6 Comparison of class I and II hydrophobic subunit interfaces 
An identical approach to the previous section was used. From the E.eoli subunit 
interface regions, 10 residues were classed as hydrophobic using the previously defmed 
subset. These residues were lined up in the class I alignment as before in Figure 4.18 
and 8 residues were found to be highly conserved throughout the group. This is shown 
diagrammatically in Figure 4.21 where the position of the residues was obtained by 
superimposing the 8 residue positions onto each half of the alignment in Figure 4.15. 
E. coli doublet sequence 
NIIII 11 12 13 31 I 
_ ... _- .. --
1111 11 12 13 311 ~:~:~~~QJ e 5 
------ -- --
1 1 
NI 1 II 2 13 41 5 ~Il 12 3 41 5 
Alignment of 10 class II sequences 
Figure 4.21 Comparison of hydrophobic interfaces at the primary sequence level 
Alignment of the class I sequences identified eight highly conserved hydrophobic loci at the subunit 
interfaces. Four loci were found for each subunit surface and are coloured either red or green for 
comparison to Figure 4.20. The diagrammatic alignment shows that only loci from the red surface are 
conserved in the N-tenninal half of the class II sequences while only loci from the green surface are 
conserved in the C-terminal half. This is proposed to indicate the conservation of hydrophobic surfaces 2 
and 3 in Figure 4.20(d) and the loss of hydrophobic surfaces 1 and 4. 
Four residues were identified on the red surface and four on the green surface. 
These residues were highlighted in the E.eoli doublet sequence and aligned with the 
class II dUTPase sequences as before. A positive hit was defmed as an E. coli 
hydrophobic locus which had 6 or more homologous loci out of the ten species in the 
class II lineup. The following results refer to Figures 4.20( d) and 4.2 1. 
Surface Colour in figure Donor subunit Class II region Conservation 
1 Green A N-terrninal half 0/4 = 0% 
2 Red A N-terrninal half 4/4 = 100% 
3 Green B C-terrninal half 4/4 = 100% 
4 Red B C-terrninal half 0/4 = 0% 
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The data shown above support the theory that only those hydrophobic loci 
which are situated on the class II subunit interface (2 and 3) are conserved between the 
classes. The remaining surfaces (1 and 4) are solvent exposed in the class II model and 
are not necessary for structural interactions. Caution must be used with this 
interpretation of the results given the small data set available: only 8 hydrophobic loci 
are highly conserved throughout the class I group. In order to put these data in 
perspective the probability of an E. coli probe locus matching a random hydrophobic 
locus in the class II alignment was calculated. From 388 loci in the alignment 85 were 
classed as hydrophobic (conserved between at least 6 species). The chance of matching 
a hydrophobic locus by chance is just below 22%. This was deemed a reasonable 
background error. 
4.5.7 Discussion 
Hydrophobic modelling was found to be a useful tool for analysing the class II 
model. Sequence alignments in combination with structural data identified highly 
conserved hydrophobic loci within the class I group. This follows on from the 
structural analysis in previous sections and demonstrates the close relationship between 
primary sequence and tertiary structure. It was of particular interest that regions of 
internal hydrophobicity were found within the motif regions. Previous studies have 
concentrated on the binding or catalytic role of the residues contained within the five 
motif regions. These studies support an additional structural role for the motifs in the 
consolidation of three subunit surfaces to form each active site. 
It is clear that there are interacting surfaces between the main body of the trimer 
and the extended tail regions. Small alterations in the position of the tail would 
rearrange hydrophobic loci in the primary sequence to a high degree and this was 
judged to be incompatible with the methods used. Only the globular regions of the 
subunits were therefore analysed. Comparison of the internal hydrophobic residues 
between the classes demonstrated a high degree of congruency. This supports the view 
that the class II molecules approximates two class I subunits joined in a single chain. It 
appears that the hydrophobic core supporting each subunit in the trimer has been 
conserved in duplicate in the class II enzymes. 
Analysis of subunits within the trimer identified two surfaces containing 
conserved hydrophobic residues. Using these loci to probe the class II molecules a 
distribution pattern was revealed which again supports the class II model. These 
studies have the same fundamental constraints as the secondary structure predictions, 
namely the accuracy of inter-class primary sequence alignments. Although this analysis 
uses the same underlying comparisons as the secondary structure predictions the 
methods used are sufficiently divergent to strengthen support for the class II model. 
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4.6 Structural evolution of the class II dUTPases 
4.6.1 Introduction 
Previous sections have addressed the relationships between the class I and II 
dUTPases both at the primary sequence level and at the structural level. Although 
secondary structure prediction and hydrophobic modelling support the class II model it 
is also necessary to assess evolutionary relationships. The class II model is based on 
the intragenic duplication model proposed by DJ. McGeoch (1990b) plus the structural 
modelling data presented here. It is clear from the model that not only must the class I 
subunit gene be duplicated but also there must be a structural rearrangement to produce 
an active enzyme. It is therefore possible that a functional evolutionary intermediate 
existed between the class II monomer and the class I trimeric ancestor. 
The class II model shown in Figure 4.16 demonstrates that a single active site 
cavity can be formed from the joining of two subunit structures. This cavity produced 
from motif 3 in the N-terminus and motifs 1, 2, and 4 in the C-terminus constitutes the 
majority of a functional active site. Now that structural data has become available for 
the human dUTPase C-terminal region it seems likely that motif 5 is necessary for 
catalytic function in the class I enzymes. A homologous situation for the class II 
enzymes is supported by HSV-l mutagenesis data in the following chapter. Based on 
this fmding an intragenic duplication cannot, by itself, create an active class II 
monomer. As can be seen in the class II model (Figure 4.16) an extension chain is 
necessary between motifs 4 and 5 to allow the correct positioning of motif 5 over the 
active site. The result of this structural constraint on the evolution of the class II 
dUTPases was investigated. 
4.6.2 Maintenance of enzyme function during class II evolution 
Chapter 1 introduced the role of the dUTPase enzyme demonstrating its 
importance in a variety of biological life cycles (Section 1.4.4). Clearly an intermediate 
between the class I and class II structures which lacks function could compromise an 
organism that is required to generate dUTPase activity. In short, the evolution of the 
class II dUTPase must be realised without the loss of dUTPase function at any stage. A 
model was generated which successfully meets this criterion. 
Figure 4.22 demonstrates the genetic rearrangements necessary to generate a 
class II dUTPase. Each stage is set out with a genetic arrangement and a corresponding 
structure in order that all intermediates may be easily visualised. The evolutionary 
ancestor of the class II molecule is proposed to be structurally homologous to the 
present class I dUTPases. 
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(a) NI 1 2 3 4 S Ie X3 
(b) NI 1 2 3 4 5 Ie X2 
(c) NI 1 2 3 4 Isle X 2 
(d) 
N I 1 2 3 4 I Isle X 2 
(e) 
NI 1 2 3 4 [1 sl 1 2 3 4 [] sic 
Figure 4.22 Structural and genetic evolution of the class II dUTPase 
The left hand diagrams represent the structural consequences of the corresponding genetic 
rearrangements depicted on the right. The quantity of each protein chain required to construct the 
structure is indicated to the right of diagrams (a-d). The final diagram (e) represents the class II 
monomer as a single chain structure. Details are given in text. 
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The most complete class I structure available is the human dUTPase which was 
therefore used as the starting point in this model. Part (a) shows the human trimer with 
each subunit highlighted in a different colour. The position of the active site is 
represented by spacefilling molecules of dUDP. The C-terminal arms from each 
subunit can be seen to extend over the active site areas. This allows efficient 
positioning of motif 5, at the end of these arms, to interact with the substrate. The class 
I genetic arrangement is depicted as three identical subunit chains, each with a full 
complement of all five motifs. As seen previously each active site is made up from 
motif 3 from the first subunit, motifs 1, 2 and 4 from the second subunit and motif 5 
from the third subunit. 
Part (b) represents the quandary with the standard intragenic duplication theory. 
The potential interaction of two standard subunits is shown demonstrating the 
possibility to form the majority of the active site region. In this case motif 3 from the 
blue subunit and motifs 1, 2 and 4 from the green subunit form the basic active site 
cavity. Unfortunately motif 5 at the end of the green subunit arm cannot substitute 
motif 5 from the missing subunit due to a shortage in protein chain length. These two 
subunits cannot be easily rearranged to accommodate positioning of motif 5 without 
significant disruption to the overall structure and consequently the active site cavity. It 
is therefore likely that the joining of two subunits, as in the intragenic duplication 
model, cannot efficiently generate a functional active site by itself. There is however an 
additional chain length insertion between motifs 4 and 5 in the class II molecules. 
Since it is unlikely that an intragenic duplication created a non-functional enzyme 
which required a subsequent insertion to restore activity, the following theory is 
proposed. 
Parts (c) and (d) demonstrate that insertion of an extra chain length between 
motifs 4 and 5 before the intragenic duplication allows maintenance of functionality. It 
is clear that this insertion would destroy the activity of the trimer due to the incorrect 
positioning of motif 5. However, it is possible that an insertion between motifs 4 and 5 
(show in red) allowed the instant formation of a functional dimer. This dimer would be 
made from two identical subunits produced from the single length gene containing an 
insertion. The insertion would allow the green subunit to supply motif 5 in the correct 
position due to the extension of the C-terminal arm. The corresponding extension in 
the blue subunit would not have significant effect since it points away from the active 
site region. This dimer containing a single functional active site is proposed to be the 
intermediate molecule between that class I and class II families. 
An intragenic duplication at this stage effectively converts the functional dimer 
into a functional double length monomer. This is shown in part ( e) where the joining 
region has been teased out for clarity. Minimal structural rearrangement is necessary to 
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link the two subunits since additional chain length has already been supplied by the 
duplication of the insertion region. Conservation pressure is no longer maintained for 
the additional copies of the motifs which do not form part of an active site. In terms of 
primary sequence analysis these extra motifs are seen to be lost although a class II 
specific motifhas replaced the C-terminal copy of motif 3. 
4.6.3 Discussion 
It order for the class II model to be viable, a mechanism had to be demonstrated 
showing the genetic and structural evolution from the class I ancestor. This model was 
constrained by the fact that any structural rearrangement from intragenic duplication 
must result in a functional dUTPase. In the proposed model an insertion between 
motifs 4 and 5 destroys trimer activity but allows the assembly of a functional dimer. 
This dimer structure is proposed to be the functional intermediate between the class I 
and class II families. 
The reason why a dimeric dUTPase has not been discovered may be due to the 
efficiency of subunit assembly. As shown from the evolutionary model, the genetic 
rearrangement necessary to generate a double length monomer from the dimer 
intermediate is a simple intragenic duplication. This allows a single gene to produce a 
single protein chain without the need for subsequent subunit assembly. It may be that 
this method of enzyme construction is energetically more favourable since the 
production of single subunits does not guarantee functionality. The question may then 
be asked: why is the trimeric version seen so widely in nature? Subunit assembly in the 
trimer generates three functional active sites whereas dimer assembly only generates a 
single active site. Clearly a trimeric dUTPase has a lower energetic cost to the 
organism per active site. 
The fmal question is the most difficult to answer: why does the herpesvirus 
family utilise a double length monomer and not the class I trimer? From an energetic 
standpoint it appears that the trimer is more efficient. The trimer produces 3 active sites 
per three subunits compared to the monomers equivalent of one active site per two 
subunits. It may be that subunit assembly is so inefficient in the herpesvirus host 
environment that production of a single folding protein allows large scale enzyme 
production in a shorter time period. It may be that given the complex nature of the 
trimer organisation with all three subunits contributing to each active site that even a 
slight error in one of the subunits folding renders the entire trimer useless. There may 
be another reason however. The next section investigates the possibility that the class II 
monomer produces a secondary element which may endow a secondary accessory 
function. 
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4.7 Investigation of a class n specific motif 
4.7.1 Introduction 
Sequence analysis of the class II dUTPases revealed a C-tenninal conserved 
region occupying the corresponding position of the class I motif 3. This conserved 
region was named motif X and represents the only major region of primary sequence 
conservation specific to the class II dUTPases. Although no function has been assigned 
to motif X as yet, its potential significance is discussed below. 
4.7.2 Sequence analysis ofthe class II motif X 
The motif X region of the class II dUTPases occupIes the corresponding 
position of motif 3 in the class I group. In the intragenic duplication model the original 
copy of motif 3 is lost as it no longer constitutes part of the class II active site. This is 
best visualised in Figure 4.10 (Section 4.3.3). One of the intriguing properties of motif 
X is that it is found not only in the a- and y-herpesvirus dUTPases but also in the p-
herpesvirus dUTPase homologues. These homologues share little sequence 
conservation with the class II dUTPases and possess no convincing copies of motifs 1-
5. Although there are small areas of local conservation (typically no more than two 
consecutive residues) these homologues are not thought to be functional dUTPases. 
Their classification in the Swiss-Prot database as putative dUTPases is based on the 
congruent position of their ORF in the p-herpesvirus genome compared to a- and y-
herpesvirus. Figure 4.23 shows the motif X region in both a- and y-herpesvirus aligned 
with four J3-herpesvirus species. 
SS Predict E 
(y) EBV 
(y) EHV- 2 
(y) HVS 
(a ) HSV- l 
(a ) HSV- 2 
(a ) EHV- l 
(a ) EHV- 4 
(a ) BHV-l 
( a ) PRY 
( a ) VZV 
EEEEE 
Motif 2 Motif X Motif 4 
( ~ ) HCMV GVRQFSQS DLIIRPTI PGTAAGVTi SHTTVCISPHTTVAKAV 
( ~ ) MCMV PCRHLATKRVLLDPT RPNSLAVLRV SDEHVDLEAGMAMAKII 
(P ) HHV- 6 PSKEIAK LIETYI KDTIPSIKI STRKTIYIPTGICIARII 
(P ) HHV-7 ANKEILCH VVETNI KNTTPSVKI PTSQRIFVQAGICIATII 
Figure 4.23 Class II alignment showing relative position of motif X 
Ten class II dUTPases from the 0.- and y-herpesvirus are aligned on the top of the diagram with four p-
herpesvirus dUTPase homologues on the bottom. The position of motif X (yellow) is shown relative to 
motifs 2 and 4 (cyan). Residues completely conserved in the 0.- and y- herpesviruses are indicated in 
green. Note that the p-herpesvirus species do not possess full copies of the flanking motifs 2 and 4 
although there are small regions of sequence conservation. Secondary structure predictions from the 
ProteinPredict program are shown at the top of the alignment ('E' represents a predicted p-strand). 
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The motif X region contains several highly conserved residues (highlighted in 
green) which are also reasonably well conserved in the j3-herpesvirus homologues. The 
majority of the other non-conserved loci in each motif X have largely similar residue 
substitutions. This is true of both the (l- and y-herpesvirus dUTPases and also the j3-
herpesvirus dUTPase homologues. 
4.7.3 Secondary structure prediction of the class II motif X 
The fact that the class I dUTPases do not possess a motif X is intriguing. It 
opens up the possibility that the class II dUTPases share a new structure which may 
endow them with a novel secondary function. This theory is compounded by the 
fmding that a group of j3-herpesvirus proteins share only this motif X region and not the 
other 5 motifs which constitute the dUTPase active site. It is conceivable that these j3-
herpesvirus proteins share only a function supported by motif X. 
Experimental work is required to test the function of the j3-herpesvirus proteins 
and any potential role of the conserved motif X region. In the class II dUTPases, motif 
X can be mapped on various models to yield structural predictions. Although these 
predictions cannot identify functional significance they do reveal some interesting 
points. Several prediction methods were employed including ProteinPredict, Threader 
and Swiss-Modeller. 
The class II motif X region was initially analysed with the ProteinPredict 
program during the study of the class II j3-strand predictions (Sections 4.4.3 & 4.4.4). 
The secondary structure predictions for this region are shown in Figure 4.23 at the top 
of the class II alignment. Motif X is predicted to contain two j3-strands with the 
conserved Trp residues close to the middle of the joining sequence. This is interesting 
because it resembles the class I motif 3 structure which is composed similarly of two 13-
strands with a highly conserved Tyr in the middle of the joining sequence. It may not 
be surprising that motif X is similar to motif 3 in overall structure given that motif 3 
originally occupied this position after the initial intragenic duplication. To further test 
this theory, more detailed modelling approaches were used. 
4.7.4 Structural fold recognition by protein sequence threading 
The program Threader (Jones et al., 1992) was used to predict the local 
structure of the class II motif X region. Protein threading employs a different 
methodology than the previously used ProteinPredict program. Basically a library of 
unique protein folds is obtained from the database of known protein structures. 266 
folds were present in the library used for these predictions. These folds are defined as 
3D chains and the original primary sequences are ignored. The test sequence, in this 
case motif X, is then optimally fitted or 'threaded' onto each 3D fold in the library. The 
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energy of each possible fit is then calculated by the addition of each pairwise interaction 
between the test sequence and each known fold. These energy or 'threading' values are 
then ranked in order. The library fold with the lowest energy (easiest fit) is predicted to 
be the closest match to the test sequence. Threader gives each fold a pairwise energy 
score (Z) which is based on the following scale: 
Z - Score Explanation 
Z < -3.5 Very significant - probably a correct prediction 
Z < -3.0 Significant - good chance of being correct 
-2.7 < Z < -3.0 Borderline - possibly_ correct 
-2.0 < Z < -2.7 Poor - needs other confirmation 
Z > -2.0 Very poor - probably no suitable folds in the library 
Table 4.2 Interpretation of Threader Z-scores 
Each structure which is threaded against the test structure is given a Z-score which relates to the 
significance of the match. Taken from the Threader user notes (D.T. Jones, 1994). 
At the time of using Threader there were no dUTPase structures present in the 
fold library. Both the E.coli and HSV-l motif 3 regions were both analysed by 
Threader in order to determine how closely they matched the known E.coli structure. 
Threader predicted a loop structure for motif 3 with two flanking S-strands which is 
essentially the correct structure for the class I motif 3 region. The closest match was a 
S-loop-S region of a fatty acid binding protein (lMDC) of the Tobacco Homworm 
(Manduca sexta). The Z-score for the IMDC loop as a structural homologue motif 3 
was -3.69. This score is extremely low and represents a highly significant Threader 
prediction. This was encouraging since the program did not have a dUTPase motif 3 
loop in its fold library. 
(a) (b) 
Figure 4.24 Comparison of E.coli motif 3 structure to Threader prediction 
The structure of the E.coli motif 3 structure is shown in (a). Figure (b) shows the Threader predicted 
structural homologue, a ~-loop-~ structure in the fatty acid binding protein IMDC. ~-strands are shown 
as yellow arrows. The red region in the IMDC structure indicates where Threader predicts an insertion 
of two residues. This insertion would increase the similarity between (a) and (b). 
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Note that the IMDC structural homologue is predicted to have a two residue 
insertion in the loop region (shown in red in Figure 4.24). This insertion would 
essentially lever the two ~-strands apart and generate a much more homologous 
structure to motif 3 than that shown in the figure. Although there is no functional 
relationship between motif 3 and the predicted homologue, the structural relationship is 
clear. 
Since reasonable data were obtained from the motif 3 predictions, Threader was 
subsequently used to predict the structure of the motif X region of HSV -1. The closest 
related fold to the motif X test sequence was again IMDC. The Z-score for this 
structural homologue was -2.84. This score is inferior to the prediction for the motif 3 
loop and represents only borderline significance. However, when alignments are made 
of the top ten Z-scores for both HSV -1 motif 3 and motif X, the consensus predictions 
are highly similar. This is seen in Figure 4.25 where the best threaded homologues are 
given in descending order from top to bottom. 
consensus 
1MDC 
1SHAA 
2CTVA 
2MNR 
2CBA 
135L 
2BBKH 
1STP 
1S1M 
1RA1B 
10 20 
HHV1LGL1DSGYRGTVMAVVVA 
__ ..... ~ _ • consensus 
• 
• 
(a) Motif 3 
1MDC 
1TTAA 
3BLM 
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2DNJA 
1ATR 
1PKP 
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1HSBA 
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10 20 
ARGLLVVPTRWLPGHVCAFVVYNL 
- . -
• • 
• • 
• • 
• • 
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(b) Motif X 
Figure 4.25 Comparison of Threader predictions for HSV-l motif3 and motif X 
The ten best Threader predictions are shown for HSV-l motif 3 (a) and motif X (b). The structural 
homologues (PDB codes at right) are ranked in order with the best (lowest) Z-score at the top. p-strands 
are shown as blue arrows, helices as red and white spirals and loops as solid black lines. Note that 
predicted insertions in the structural homologues are shown as gaps. The consensus sequence is an 
unweighted compilation of the top ten homologous folds. 
Although the best Threader prediction for HSV -1 motif X is not as good as 
motif 3, the comparison of the consensus results plus the previously determined 
ProteinPredict results suggests that the two structures may be related. In order to 
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generate a 3D structure based on the primary sequence (as opposed to a structural 
homologue) a new modelling approach was used. 
4.7.5 Three dimensional modelling of HSV-l motif X 
The previous data demonstrate the possibility that the class II motif X may have 
evolved from the ancestral motif 3 and has retained a similar basic structure. In order to 
achieve a more direct relationship between the HSV-1 primary sequence and the 
predicted structure a local model was created for motif X. This work was done in 
collaboration with N. Arbuckle in the MRC Virology Unit. The HSV -1 motif X 
sequence was used to probe the PDB database for primary sequence homologues using 
the TBLASTX program (Altschul et aI., 1990). The top five structures corresponding 
to the primary sequence matches were used as input to the modelling program, ProMod 
(Peitsch, 1995; Peitsch, 1996). This program basically creates an average structure 
based on the structures with the best primary sequence similarity and produces a 3D 
model. The predicted structure of motif X utilising the actual HSV-1 amino acid 
sequence is shown in Figure 4.26(a). 
(a) (b) 
Figure 4.26 Modelling ofHSV-l motif X using the Swiss-Model Pro Mod program 
Figure (a) shows the predicted structure of the HSV -J motif X based on known structures with primary 
sequence similarity. Figure (b) shows the structure of the E.coli morin loop for comparison. 
Comparison of the predicted structure of the HSV -1 motif X to the structure of 
E.coli motif 3 reveals several similarities. The overall fold is generally homologous 
although the arms of the motif X loop (which fonn two anti-parallel ~-strands in motif 
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3) are spread further apart. Notably there is a Trp at the base of motif X occupying a 
similar position to the highly conserved Tyr in motif 3. 
The limitations of this type of modelling are clear. The prediction relies on the 
PDB database containing structures with primary sequence which closely match the test 
sequence. This modelling approach also assumes that similar primary sequences have 
similar folds which is not always the case. Surrounding protein interactions can 
influence local folding and cannot be predicted from this type of program. Despite 
these reservations it is encouraging to see that three different methods, ProteinPredict, 
Threader and Swiss-Modeller, are all in general agreement on the overall structure of 
the motif X region. 
4.7.6 Discussion 
Interest in the motif X region of the class II dUTPases was generated when 
primary sequence analysis by 0.1. McGeoch at the MRC Virology Unit revealed 
sequence conservation outwith the known dUTPases. Several ~-herpesvirus ORFs 
which occupy congruent genome positions to the a- and "(-herpesvirus dUTPases were 
shown to possess a copy of the class II motif X. These ~-herpesvirus ORFs are 
unlikely to encode functional dUTPase given that they do not possess any of the five 
motifs which constitute the standard dUTPase active site. The fact that the only 
conserved region in the ~-herpesvirus ORFs is motif X, lays open the possibility that 
this motif encodes a specific function. In terms of the class II dUTPases this function 
would be additional to dUTPase activity while in the ~-herpesvirus homologues it could 
potentially constitute the sole function. 
Three different approaches were used to predict the structure of the class II 
motif X region. Looking at the overall consensus between the ProteinPredict, Threader 
and Swiss-Modeller data there is evidence to support an anti-parallel ~-strand loop 
structure with similarity to the motif 3 structure. This does not give a direct indication 
of potential function but it does support the theory that motif X structure originated 
from the motif 3 ancestor and retains some of these characteristics. In the class II 
model, the position of motif X relative to the rest of the protein is on the opposite side 
to the dUTPase active site. This is shown in the later Figure 5.17(a) which highlights 
motif X in the class II model. If this prediction is correct then it would be possible for 
motif X to possess a binding or catalytic function for example, without disrupting 
dUTPase activity. 
The significance of an additional structure similar to motif 3 in the class II 
dUTPases is not clear. What is apparent is that the motif 3 ~-hairpin structure is the 
basis for nucleotide recognition in the dUTPase active site allowing discrimination 
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between sugar and base. It is even possible that motif X retains this discriminatory 
function and is itself involved in nucleotide binding although this remains to be tested. 
A secondary function supplied by motif X would be consistent with the class II 
evolutionary model proposed in the previous section (4.6). From an energetic 
perspective the class I dUTPases contain three active sites from three subunit chains. 
The class II dUTPase have only one active site for the equivalent of two subunit chains. 
This apparent inefficiency in the amount of protein synthesis required per active site 
would be redressed if the class II enzyme had an additional function besides dUTPase 
activity. These theories require to be tested experimentally and it is probable that not 
only the class II dUTPases need to be investigated but also the ~-herpesvirus dUTPase 
homologues. Given that this motif X is specific to herpesviruses and therefore 
represents a potential drug target, the grounds for expanding research in this area are 
clear. 
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Chapter 5 - RESULTS OF EXPERIMENTAL WORK 
5.1 Recombinant expression of HSV-1 dUTPase 
5.1.1 Introduction 
In order to perfonn detailed analysis of the HS V -1 dUTPase it was necessary to 
devise a system capable of generating a reliable supply of active enzyme. The major 
considerations were the ease of manipulation of the ORF, the quality and quantity of 
over-expressed enzyme and the potential for rapid purification. Several bacterial 
expression systems were investigated for their ability to meet these criteria. 
5.1.2 The Kodak FLAG Biosystem 
5.1.2.1 Overall Strategy 
The Kodak: FLAG system was employed to provide high expression levels 
combined with efficient detection and purification of the recombinant dUTPase. This 
system offered two main advantages compared to standard bacterial expression 
systems. The ORF could be cloned into the pFLAG vector resulting in a fusion protein 
with the OmpA signal peptide for secretion to the periplasmic space and the FLAG 
marker peptide for detection and purification. Generation of pure native enzyme could 
then be achieved with affmity purification using murine anti-FLAG IgG monoclonal 
antibodies followed by enterokinase digestion. 
Signal peptide 
pennits secretion 
-
i 
FLAG peptide pennits 
affinity column purification 
Figure 5.1 The illI FLAG™ system components 
HSV - 1 dUTPase 
FLAG peptide is cleaved to 
generate intact native dUTPase 
The OmpA signal peptide - a 21 amino acid fusion peptide to allow secretion to the periplasmic space 
and resultant cleavage as it crosses the inner cytoplasmic membrane. Benefits included i olation of the 
recombinant protein from the cytoplasmic proteases and an efficient extraction protocol (Movra el al., 
1980). 
The FLAG marker - a hydrophilic, 8 amino acid fusion peptide (DYKDDDDK) with a high surface 
probability representing good accessibility on the protein surface. The FLAG marker would allow 
column affinity purification using the anti-FLAG monoclonal antibody covalently linked to an agarose 
support. 
The tac promoter and lacI repressor - the tac promoter is a combination of the trp promoter and the lac 
operator to allow strong controllable expression under the lacI repressor (Amann et al. , 1983). 
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The strategy was to insert the HSV-l UL50 ORF into the MCS of the 
pFLAG.ATS vector to express a fusion protein with an N-tenninal OmpA signal 
sequence and the FLAG octapeptide tag for binding anti-FLAG antibodies. 
5.1.2.2 Results using the Kodak IBI System 
The UL50 ORF was successfully amplified from purified HSV-l (strain 17+) 
DNA by PCR using primers (FIIF2) designed to generate a 5' HindIII site and a 3' 
EcoRI site with 8bp overhangs. 
Fl. 5' GTG TGT GTA AGC TTA GTC AGT GGG GAT CCG GGG CGA TC 3' 
HindII! 
F2. 5' GTG TGT GTG AAT TCT CTA AAT ACC GGT AGA ACC AAA ACC 3' 
EcoRI 
Figure 5.2 Oligonucleotides synthesised for IBI FLAG system 
Oligonucleotides Fl and F2 were designed to amplify HSV-l UL50 by peR generating a 5' HindIII site 
and a 3' EcoRl site. Note that each primer is flanked by a (GTh tail to allow efficient restriction 
digestion of the fragment. 
The PCR reaction was optimised until a sufficient quantity of product could be 
obtained at 25 cycles without contaminating products. Titration of MgCb was found to 
have a large effect with a 2rnM concentration providing at least 2X the product quantity 
than the standard 5rnM concentration. The PCR product was gel purified and digested 
separately with HindIII and EcoRI. The pFLAG.ATS vector was successfully digested 
with HindIII in buffer B and EcoRI in buffer H as detennined by agarose gel 
electrophoresis. 
The HindIIllEcoRI digested PCR product and pFLAG.A TS vector were ligated 
and transfonned into E.coli DH5a. Prospective clones were analysed by restriction 
digestion, PCR and fmally sequencing. Clones were isolated with the HSV-l UL50 
ORF in the correct reading frame (pFLAG.ATSIUL50). 
Expression of recombinant HSV -1 dUTPase fusion protein was perfonned 
according to Section 3.2.1. Plasmid pFLAG.ATSIUL50 was transfonned into E.coli 
strain DH5a and cultures were grown up. Bacteria transfonned with the host plasmid, 
pFLAG .ATS, were used as a control. Protein expression was induced by the addition 
of IPTG and extraction was perfonned according to Section 3.2.2. 
Expression of the dUTPase-FLAG fusion protein was monitored by SDS-PAGE 
analysis of the bacterial protein extracts. A fusion protein of the predicted size was 
observed amongst the background of bacterial proteins (Figure 5.3 A). Further analysis 
of the bacterial extracts con finned that this fusion protein was found exclusively in the 
insoluble fraction (Figure 5.3 B). Various changes in the expression conditions were 
133 
tested, aimed at increasing the solubility of the recombinant protein. The bacterial 
culture temperature was lowered down as far as 15°C in an attempt to moderate protein 
expression but there was no increase in the solubility of the recombinant dUTPase. 
Various experiments were performed changing conditions such as temperature (3 7Co, 
30°C, 26°C or 15°C), induction time (I-20hr), IPTG concentration (O.S-O.OSmM), 
bacterial media (L-broth or 2YT-broth) and bacterial host strain (DHSa or BW313) but 
the recombinant dUTPase protein remained insoluble. 
Markers 
Gel A kDa GelB 
3 4 5 
200 
97.4 
69 
46 
30 
21.5 
Lane Sample Lane Sample 
1 High MW Markers 1 High MW Markers 
2 Crude extract Clone l~e-induction 2 Insoluble periplasmic fraction 
3 Crude Extract Clone 1 post induction 3 Soluble periplasmic fraction 
4 Crude extract Clone 2 ~e-induction 4 Insoluble whole cell extract 
5 Crude Extract Clone 2 !>Ost induction 5 Soluble whole cell extract 
6 Control vector only post induction 
Figure 5.3 Expression and solubility of FLAG-tagged recombinant HSV-l dUTPase 
Gel A shows the expression of 2 pET3a!UL50 positive clones tagged with the OmpA signal sequence 
and the FLAG tag as is Figure 5.1. Comparison of pre- and post-IPTG induced expression (Lanes 2-5) 
demonstrates the appearance of a novel band of 40kDa corresponding to the tagged HSV -1 dUTPase 
(black arrows). Lane 6 shows the IPTG induced host plasmid control, pET3a, inclicating the novel band 
is produced by the inserted UL50 gene. 
Gel B shows the fractionation of a crude extract of Clone 1 as prepared according to Section 3.2.2. 
Comparison of the periplasmic fractions (Lanes 2 and 3) inclicates that the tagged HSV -1 dUTPase is 
transported to the peri plasmic space but remains insoluble. Comparison of the whole cell fractions 
(Lanes 4 and 5) confirms that the recombinant dUTPase is insoluble. 
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5.1.3 The pET T7 expression system 
5.1.3.1 Overall Strategy 
The plasmid pET-3a/UL50 was obtained as a kind gift from Dr. O. Bjomberg, 
Lund University, Sweden. This construct contained the UL50 ORF in the pET-3a 
vector to allow expression under the control of the T7 promoter. This system was 
shown to allow efficient expression of active soluble HSV-l dUTPase by Bjomberg et 
al. (1993). 
The UL50 gene was sub cloned from pET-3a/UL50 into the more recently 
developed pET-23a vector (Novagen, Inc.). The strategy was to maintain the successful 
expression obtained in the pET -3 a/UL5 0 and in addition supply an fl origin to facilitate 
mutagenesis and sequencing in the same plasmid. 
5.1.3.2 Subcloning of UL50 
The pET-3a/UL50 construct was transformed into Ecoli DH5a. for the 
propagation of plasmid DNA. The plasmid was harvested using the Promega Wizard 
system (Section 3.1.11) to obtain a large quantity of purified pET-3a/UL50 DNA. The 
fragment containing the UL50 gene was excised by double restriction digests using 
HindIII and Xbal and gel purified (Sections 3.1.4 and 3.15). The pET23a plasmid was 
harvested from transformed Ecoli DH5a. and digested with HindIli and Xbal as before. 
The DNA fragment containing the UL50 gene was ligated into the pET-23a vector and 
transformed into E coli DH5a.. Potential clones were screened by restriction analysis 
and agarose gel electrophoresis. 
Xbal Xbal 
T1 prom()~ter~t=aI ........... 
pET-3a/ULSO pET -23a1ULSO 
Figure 5.4 Plasmid map ofpET-3a/UL50 and pET-23a/UL50 
The pET-3a1UL50 vector contains the T7 promoter and a ribosome binding site (rbs). Plasmid election 
in bacteria is achieved with the bla gene expressing ampicillin. The ULSO ORF was transferred to the 
newer plasmid pET-23a using the Xba I and Hind ill restriction sites. 
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5.1.3.3 Expression and extraction of HSV-l dUTPase 
The method for expression of the pET23a1UL50 construct and extraction of 
HSV-l dUTPase was performed essentially according to O. Bjomberg et al. (1993) (see 
Sections 3.2.1 and 3.2.2). There were two main differences from the methods used in 
the Kodak IBI system. Lysis of the induced bacteria was performed by freeze/thawing 
in the presence of detergent as opposed to the addition of lysozyme. Detergent (Triton 
X-I00 or polyoxyethyiene-IO-tridecyl ether) was used at a concentration of 0.1 % in the 
extraction buffer and at 0.01% in all subsequent purification and storage buffers. 
Experiments had previously shown that although the addition of detergent did not 
increase the release of protein from the bacteria, it did result in an increased recovery of 
recombinant dUTPase activity (Bjomberg et aI., 1993). 
Extracts were analysed for the expression of HSV-l dUTPase from the 
pET23a1UL50 construct by SDS-PAGE (Section 3.2.3). Soluble HSV-l dUTPase was 
detected and shown to possess activity although there was still a significant amount of 
insoluble enzyme. This was in agreement with previous experiments with the donor 
construct, pET3a1UL50, which still allowed successful purification (Bjomberg et al., 
1993). With a source of active recombinant dUTPase in the vector of choice it was 
decided to continue to the purification stage. 
5.1.4 Discussion 
The original Kodak IBI bacterial expression system was chosen before 
experiments by O. Bjomberg et al. (1993) had shown that bacterially expressed HSV-l 
dUTPase was extremely insoluble. It is possible that the fusion of the OmpA signal 
peptide and the FLAG marker peptide decreased the solubility of the expressed protein 
even further. However, the potential benefits of the FLAG marker in the detection and 
purification of the HSV -1 dUTPase merited further experiments to try to resolve the 
insolubility problem. 
Expression of eukaryotic proteins in bacterial systems often leads to problems 
with solubility. In some cases this property can be used to advantage and the 
aggregated recombinant protein can be purified in inclusion bodies and subsequently 
refolded. Given the nature of this project, where a reliable and consistent source of the 
HSV-l dUTPase was required, this option was considered to be unsatisfactory. It was 
reasoned that there was potential for site directed mutations to alter the efficiency of the 
protein refolding. In such a case, it would be extremely difficult to determine whether a 
mutation was modifying enzyme activity by interfering with active site interactions or 
as a consequence of altered refolding. 
It is known that a reduction in the bacterial culture temperature during 
expression of recombinant proteins increases solubility in some cases. It is presumed 
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that by slowing the metabolism of the bacterial cell, and consequently the expression of 
the recombinant protein, correct folding is more likely to be achieved. This is 
exemplified in the bacterial expression of vaccinia virus ribonucleotide reductase (RR) 
(Slabaugh et ai., 1993). At 37°C bacterial expression of vaccinia virus RR large 
subunit yielded a completely insoluble product. Reduction of temperature to 15°C and 
IPTG concentration down from O.4mM to 0.05mM produced up to 70% of the 
recombinant RR subunit in a soluble form. Attempts at reducing the expression of 
HSV -I dUTPase by lowering temperature, reducing IPTG concentration and using less 
rich media (L-broth instead of2YT-broth) did not increase the solubility of the enzyme. 
It was known at this point that HSV-l dUTPase had been successfully 
expressed in the pET system as an untagged protein (Bj<>rnberg et ai., 1993). In this 
study it was discovered that the method of extraction was crucial to the recovery of 
active enzyme. For example Veda pressing, which was successfully used to extract 
overproduced E.coli dUTPase (Hoffman et at., 1987), was found to be unsatisfactory at 
extracting HSV -I dUTPase. A considerable quantity of protein was obtained by this 
method but the activity was very low. This problem was partially overcome by adding 
detergent to the extraction buffer. Following this example, detergent was used when 
lysing bacteria expressing the HSV-I dUTPase FLAG fusion protein, but again, there 
was no increase in solubility. 
It was decided in the light of the solubility problem that a new expression 
system should be tried. Various systems were considered but it seemed reasonable to 
choose the pET system which had been shown to produce partially soluble, untagged, 
HSV-I dUTPase. The expressing construct, pET3a1UL50, was kindly donated by Dr 
O. Bj<>rnberg, Lund University, Sweden. This construct was transformed into E.coli 
strain BL21 and found to produce active dUTPase. Unfortunately this construct did not 
contain an fl origin of replication and therefore the ORF would have to be shuttled 
between two vectors, one for mutagenesis and one for expression. To circumvent this 
problem, the UL50 ORF was successfully subcloned into the newer vector, pET23a, 
which contained an fl origin of replication. 
The reason why HSV -I dUTPase is more soluble in the pET system is probably 
twofold. Firstly, the enzyme is expressed in its native form with no additional amino 
acid residues. Secondly, from previous studies on the extraction of HS V -I dUTPase, it 
is likely that the method of extraction plays a large role in the recovery of soluble 
enzyme. In the pET system, freeze/thawing of the bacterial cells disrupts the cell 
membrane thus releasing the indigenous lysozyme present in the E. coli strain 
BL21 (DE3)pLysS. This technique may be instrumental in the release of a higher 
proportion of soluble enzyme. 
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The use of the pET system allowed the production of active, soluble HSV-l 
dUTPase. However, the production of untagged enzyme, one of the functions of the 
system which is necessary for its effectiveness, created a more complex problem for 
purification. The original plan for purification, based on affinity for a fusion tag, could 
not be applied therefore the native enzyme had to be purified on the basis of its specific 
biochemical characteristics. Although this was a major disadvantage when purifying a 
large number of enzyme constructs it allowed greater inference into the effect of site-
directed mutations in the context of the native enzyme. In short, there is a trade-off 
between preserving the protein close to the natural condition and devising a system 
whereby the recombinant protein can be easily manipulated and examined. 
The transfer of the HSV-I ORF into the pET23a vector combines the benefits of 
a soluble expression system with the potential for generating mutations in the same 
construct without subcloning. 
5.2 Purification of HSV -1 dUTPase 
5.2.1 Introduction 
The aim of this stage of work was to develop a reliable and consistent method 
applicable for the production of wild type and mutant HSV -I dUTPase in a pure state. 
Initially purification of the HSV -1 dUTPase was based on a two stage system 
employing phosphocellulose and Mono S cation exchange columns. This protocol was 
later rermed to allow a one step Mono S purification utilising the selective solubility of 
the HSV -I dUTPase in the presence of chelators. 
5.2.2 FPLC purification by cation exchange 
Phosphocellulose followed by Mono S cation exchange column chromatography 
had been previously shown to allow successful purification of HSV-l dUTPase 
expressed from the pET3a1UL50 construct dUTPase (Bjomberg et at., 1993). Initial 
experiments demonstrated that this protocol was also efficacious at purification from 
my own construct, pET23a/UL50 (Section 3.2.4). However, consistent with the 
Swedish study, the end product of this purification was not homogeneous and was 
degraded over time even in the presence of protease inhibitors. 
5.2.3 Selective buffer extraction 
A new purification protocol was investigated based on the selective solubility of 
HSV -I dUTPase in various buffers (A.-C. Bergman, personal communication). It was 
found that a high degree of purification could be achieved by altering the initial 
extraction buffers used immediately after recombinant expression. Following bacterial 
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lysis, cells were spun as normal and then resuspended in modified extraction buffer. 
This buffer differed from the standard pET extraction buffer (Section 2.2.4) by the 
exclusion of the chelators EDTA and EGTA normally present each at ImM. This had 
the effect of partitioning up to 90% of the HSV -1 dUTPase to the pellet. Re-extraction 
of this pellet was then performed with the standard pET extraction buffer containing 
ImM EDTA and ImM EGTA. The sample was allowed to re-extract overnight at 4°C 
followed by centrifugation. The supernatant contained about 40% of the HSV-l 
dUTPase from the pellet in an active and almost homogeneous state. 
This method was employed in preference to the original extraction method. 
Further purification was deemed necessary and column chromatography was used a 
final step. Several extracts were tested using various column and buffer combinations. 
Mono S chromatography was found to be the most reliable and consistent method using 
standard buffers containing 0.01% detergent and ImM EDTA and EGTA. Many of the 
mutant enzymes were repurified using this superior method. 
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Figure 5.5 FPLC and SDS-PAGE of recombinant HSV-l dUTPase 
The graph above is the gradient section of an FPLC trace taken directly from the Unicorn operating 
system of the Pharmacia FPLC machine. It shows an example of the fmal Mono S chromatography 
purification stage. The starting material is semi-purified HSV-l dUTPase from the modified buffer 
extraction method detailed above. Cleared supernatant was injected into a prewashed Mono S HR 5/5 
column and washed at a flow rate of Imllmin. A NaCI gradient from O.lM to 1M was applied to the 
column at the same flow rate. Fractions were collected and analysed by SDS-PAGE and dUTPase assays. 
The SDS-PAGE gel (M=MW markers, PF=peak fraction) shows the peak fraction (black arrow 
on trace) as a single band which corresponded to the peak dUTPase activity. The gel shows the ab ence 
of the low MW impurities found in the previous phosphocelluloseIMono S purification sy tern. 
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5.2.4 Discussion 
Initial purification based directly on the method of O. Bjornberg et al. (1993) 
proved to be problematic at producing homogeneous HSV -1 dUTPase from the pET 
bacterial expression system. Low molecular weight bands could be visualised by SDS-
PAGE and, as reported in the Swedish study, degradation products could also be seen 
over time. A further problem was the variability of the phosphocellulose columns. 
These were made up freshly in the lab and although every effort was taken to ensure 
consistent handling it was likely that inconsistencies in the packing of the 
phosphocellulose matrix caused overall variability. In practical terms this meant that 
these runs could not be automated and that there was a large variability in enzyme 
recovery and purity. For consistent purification in order to allow direct comparison of 
different mutant enzyme preparations this system was deemed unacceptable. To get 
round this problem a one stage Mono S purification was attempted. It was hoped that 
the pre-packed Mono S columns would allow more consistent purification. This was 
unsuccessful due to the low percentage of recombinant dUTPase compared to E coli 
proteins in the bacterial extract. 
The modified extraction method was a major advance in purification. The 
majority of Ecoli proteins were removed in the supernatant after the first spin with the 
HSV -1 dUTPase being forced to fractionate to the pellet. Recovery by resolubilising 
this pellet in the presence of chelators was almost entirely specific for HSV -1 dUTPase. 
This material proved to be ideal for FPLC chromatography. It was decided in the light 
of previous experiments to use Mono S in preference to phosphocellulose columns. 
Due to the relative purity of the starting material, the Mono S chromatography 
performed very well. Although it is likely that the bacterial dUTPase was removed in 
the soluble fraction of the buffer extraction, this further purification step gave added 
confidence that dUTPase activity was entirely due to recombinant HSV-I dUTPase. 
Cation exchange chromatography was ideal for this purpose since the Ecoli dUTPase is 
an acidic protein and would not be retarded on the column. 
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5.3 Site-directed mutagenesis of HSV-l dUTPase 
5.3.1 Introduction 
The method of Kunkel et al. (1987) was chosen to perform site-directed 
mutagenesis. This method was considered practical to allow a large number of mutants 
to be generated from a single batch of HSV-l UL50 ssDNA template. Each specific 
mutation required a single oligonucleotide to be synthesised thus providing an efficient, 
low cost system. A substantial amount of time was dedicated to optimising the 
mutagenesis system so that any future mutations could be made quickly. 
5.3.2 Mutagenesis rationale 
Initially the tyrosine at position 100 in the motif 3 region of the HS V-I 
dUTPase was chosen to mutate to an alanine (3YlOOA). This was an ideal first target 
because this residue appears to be of major importance in the E.coli enzyme (Vertessy 
et al., 1995) and is highly conserved in both class I and class II dUTPases (Sections 4.2 
& 4.3). The DNA sequence change required to make this mutant involved the loss of a 
unique KpnI restriction site which allowed fast screening of potential mutated plasm ids 
by restriction analysis. 
Wild type UL50 
3Y100A mutant 
5' ..... TCG GGG TAC CGC GGA ..... 3' 
,J.. 
5' ..... TCG GGG GCT CGC GGA ..... 3' 
Figure 5.6 Position of3Y100A mutation in relation to wt KpnI restriction site 
The changed nucleotides are underlined and the Kpnl restriction site is coloured yellow (recognition site 
GGTAC·C where the star indicates the cutting position). Mutation of the wt UL50 coding sequence 
from T AC (tyrosine) to GeT (alanine) disrupted the Kpnl site allowing for fast mutation screening. First 
nucleotide shown is 292 bases from the 5' end ofUL50. 
5.3.3 Mutagenesis results for 3YIOOA 
Kunkel mutagenesis was performed according to Section 3.1.14. It was found 
that the preparation of high purity uracil enriched ssDNA template was a key factor for 
efficient mutagenesis. The mutagenesis reactions were eventually refmed to yield over 
10% positive mutant colonies from those picked and analysed. This was an acceptable 
level to allow generation of approximately 20 mutant constructs. Figure 5.7 shows 
restriction digest analysis of ten plasmids generated by the mini-prep method. digested 
with KpnI and visualised by gel electrophoresis (Sections 3.1.10 & 3.1.3). Note that 
the wt plasmid, pET23a1UL50, contains only one KpnI site which lies in the motif 3 
region of the UL50 gene. Efficient restriction with this enzyme therefore produces 
linear DNA from the circular plasmid which can be visualised as a single band. 
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Plasmids which have lost the KpnJ site remain intact and are visualised as multiple 
bands corresponding to the various forms of plasmid DNA. 
Figure 5.7 Scanning for 3YIOOA mutation by restriction digestion 
10 potential colonies from the Kunkel method were grown up and mini-prepped ( ection 3.1.1 0). 
Standard restriction digests were performed with KpnI restriction enzyme (Section 3.1.5) and products 
visualised by agarose gel electrophoresis. Lanes 5 and 7 show undigested plasmid as a result of site-
directed mutagenesis within the KpnI site. All other lanes represent wt plasmids linearised by digestion 
with KpnI. 
To confIrm that this was indeed the correct mutation the area in the region of the KpnI 
site was sequenced. Figure 5.8 shows the nucleotide sequence of the wild type HSV-1 
UL50 gene with the corresponding nucleotide changes in the 3YIOOA mutant. 
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Figure 5.8 Sequencing of the wt HSV-l UL50 and corresponding mutant 3YIOOA 
Figure shows the result of sequencing the complementary DNA strand. Note the base change from GT A 
(reverse complement TAC) coding for tyrosine to AGe (reverse complement G T) coding for aJanine 
(highlighted in yellow). 
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5.3.4 Large scale mutagenesis of HSV-I UL50 
The targets for mutagenesis were based primarily on two criteria: those residues 
which were highly conserved between class I and class II dUTPases (Section 4.3) and 
specific areas of interest within the HSV-l dUTPase tertiary model (Section 4.4.S). 
All the oligonucleotides were designed to yield a single amino acid change in 
the HSV-I dUTPase protein. Each one was designed to give a specific codon change 
with the exception of primer IS which was synthesised to give a mixed population. 
This primer was included to test the efficiency of generating multiple mutants at a 
specific locus with a single mixed primer synthesis. Table S.I shows the mutant 
oligonucleotides which were synthesised for the specific mutagenesis of the HSV-I 
ULSO ORF. 
No Mutant Nucleotide Oligonucleotide Sequence 
Change 
1 3YI00A TAC-+GCT 5' CAT AAC GGT TCC GCG AGe CCC CGA GTC GAT AAG 
2 3YI00S TAC-+AGT 5' CAT AAC GGT TCC GCG ACT CCC CGA GTC GAT AAG 
3 3YI00F TAC-+TIT 5' CAT AAC CGT TCC GCG AAA CCC CGA GTC GAT AAG 
4 3D97A GAC-+GCC 5' TCC GCG GTA CCC CGA GGC GAT AAG ACC CAG TAT 
5 3D97E GAC-+GAA 5' TCC GCG GTA CCC CGA TTC GAT AAG ACC CAG TAT 
6 XW275A TGG-+GCG 5' TAC GTG CCC GGG GAG CGC GCG CGT AGG AAC GAC 
7 XW275F TGG-+TIT 5' TAC GTG CCC GGG GAG AAA GCG CGT AGG AAC GAC 
8 XT273S ACG-+TCC 5' CCC GGG GAG CCA GCG GGA AGG AAC GAC CAG GAG 
9 XT273A ACG-+GCG 5' CCC GGG GAG CCA GCG CGC AGG AAC GAC CAG GAG 
10 4Q303N CAG-+AAC 5' CCC CGC AAC CAG GAG GTT GGC GAC CTT GGC GCC 
11 4Q303D CAG-+GAC 5' CCC CGC AAC CAG GAG GTC GGC GAC CTT GGC GCC 
12 4Q303E CAG-+GAG 5' CCC CGC AAC CAG GAG CTC GGC GAC CTT GGC GCC 
13 4Q303T CAG-+ACG 5' CCC CGC AAC CAG GAG CGT GGC GAC CTT GGC GCC 
14 NC76A TGC-+GCC 5 ' GGC GTG AAT AAT CGC GGC AAA GTC AGC CGG CAT 
15 4Q303L CAG-+TTG 5' CCC CGC AAC CAG GAG SNN GGC GAC CTT GGC GCC 
16 5F366Y TIT-+TAT 5' AAT ACC GGT AGA ACC ATA ACC CCC GGT CCC GCG 
17 5F366A TIT-+GCT 5' AAT ACC CGT AGA ACC AGe ACC CCC GGT CCC GCG 
18 4K300A AAG-+GCG 5' CAG GAG CTG GGC GAC CGC GGC GCC GGC CTC GAG 
19 2R260A CGG-+GCA 5' GGC GTT GAG CGA CGA TGC CCC CAA CAC ATA GCA 
20 ID222A GAC-+GCC 5' GCG ACG GAC GAC AAT GGC GAA ACC GGC ATC CTC 
Table 5.1 Oligonucleotides synthesised for site-directed mutagenesis ofHSV-1 ULSO 
Mutagenic primers are the reverse complement of the 5'-+3' UL50 nucleotide sequence due to the 
direction of the Fl origin in pET23a. Primer 15 was synthesised to produce a mixed population of the 
following bases: S=G/C, N=T/A/G/C. The first mutant sequenced from this primer was 4Q303L 
(CAG~TTG). 
Due to the nature of the Kunkel mutagenesis system it was decided to fully 
sequence all of the ULSO mutant constructs. It was essential to have confidence that 
there was no secondary mutations anywhere in the HSV -1 dUTPase coding region. A 
primer set was generated to cover the entire ULSO gene allowing good overlap between 
each successive sequence reading. These oligonucleotides are shown in Table S.2. 
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Code Distance from UL50 Direction Oligonucleotide sequence 
Number A TG start codon (bps) 
P1 98 R 5 ' GCC CCC GCG AGT AGC GAG GG 3 ' 
P2 31 F 5 ' TCC AGC CGG ACA GCT TGG GT 3 ' 
P3 131 F 5 ' CGC GGT GGC TTT TAT GCC GA 3 ' 
P4 221 F 5 ' CTT TTG CGC GAT TAT TCA CG 3 ' 
P5 331 F 5 ' CTA AAA GGA CGC GGG AAT TT 3 ' 
P6 421 F 5 ' CGA TTT CCC TGC GGC AGT TC 3 ' 
P7 518 F 5 ' AAG CGT GAC TAC GGC CCT AC 3 ' 
P8 630 F 5 ' TTC CTT CCA AAA CGC GAG GA 3 ' 
P9 721 F 5 ' CAT CCC TCC GCA TGC TCC AC 3 ' 
P10 846 F 5 ' TTT GTT GTT TAC AAC CTT AC 3 ' 
Pll 966 F 5 ' ACC AAA GCG CTT CGA AAC TA 3 ' 
P12 1038 F 5 ' GTG TTT ACG AAC GAG TTT GA 3 ' 
P13 424 R 5' ATC GGC TCG GTG AGG GCC GG 3 ' 
P14 1030 R 5 ' GGC GGG TTC CTG GGT TCG GC 3 ' 
P15 810 R 5' CGA CCA GGA GGC CGC GGG CG 3 ' 
Table 5.2 Oligonucleotides synthesised for sequencing HSV-I UL50 
Oligonucleotides denoted with an 'F' were designed to sequence in the forward direction (5'~3') and 
'R ' in the reverse direction (3'~5'). Distances are calculated from the first nucleotide in the ATG start 
codon to the 5' terminal nucleotide of the primer. All primers are 20 nucleotides in length 
This primer set was used extensively since the majority of subsequent mutations 
did not change the restriction profile of the UL50 gene and therefore had to be screened 
by sequencing. This led to the development of small volume single track sequencing. 
This method differed from the standard sequencing method (Section 3.1.13) in that 
reactions were performed in microwell plates using only l/Sth of the standard reaction 
volumes. The same single dideoxynucleotide was chosen to terminate each reaction 
based on one base change expected from the mutagenic oligonucleotide. 
Figure 5.9 Mutation screening by single track sequencing 
Prospective mutant plasmids were analysed by single track sequencing. This gel hows a typical 
screening for mutant ID222A. The expected nucleotide changes in this mutant were GA ~G 
Plasmids were sequenced in single reactions using ddA TP as a chain tenninator. Lane 5 represents a 
mutant with the expected substitution of an adenine nucleotide. 
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This allowed the rapid screening of potential mutant plasmids by sequencing 
while being very economical with reagents and Sequenase enzyme. It proved to be very 
useful since mutations could initially be picked out clearly by eye without the need to 
produce large numbers of linear nucleotide sequences. Figure 5.9 shows a typical 
example of this method. 
Using this method it was possible to isolated plasmids positive for all of the 20 
targets shown in Table 5.1. Each of these constructs was then fully sequenced using the 
primer set in Table 5.2. 
5.3.5 Results of sequencing mutant constructs 
Due to the large number of sequence reactions required to fully sequence all the 
mutant UL50 genes a similar method to the mutation screening was employed. For each 
primer, modified 1/8th volume reactions were set up for all 19 mutants plus the wt 
control. Narrow wells were used to allow 80 reactions to be run on each gel. The 
samples were loaded in groups of 20 with the same tennination dideoxynucleotide 
(Figure 5.10). This allowed secondary mutations to be identified easily. 
Figure 5.10 Screening for secondary mutations by multiple track sequencing 
Section of autoradiograph shows 80 sequencing reactions split into 4 groups of 20. ach group 
represents 19 mutant plasmids and one wt sequenced with a single dideoxynuc\eotide. Mutations can be 
see as the absence and presence of single bases (arrows). 
It was found at this stage that some constructs possessed additional mutations. 
These were generally single base mutations at sites distal from the annealing area of the 
mutagenic oligonucleotide. Six out of the nineteen starting mutants were found to 
contain additional mutations. It was decided to carry on to the analysis stage with the 
thirteen remaining constructs. 
5.3.6 Discussion 
The Kunkel method of site-directed mutagenesis proved to be useful at 
producing UL50 mutant constructs but did have some unexpected problems. It was 
hoped that this method would have the advantages of reproducibility and accuracy 
compared to other methods. Site-directed mutagenesis by peR had also been 
investigated but was ruled out at an early stage due the possibility of polymerase errors 
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causing secondary mutations. In the light of the Kunkel mutagenesis results, with 6 out 
of 19 mutants synthesised with additional mutations, this rationale was unjustified. It 
was hoped that because each mutation was produced from the same batch of uracil 
emiched ssDNA, with the mutagenic oligonucleotide the only variable, that secondary 
mutations would be uncommon. It was expected that any additional mutations which 
did occur would be in the annealing region of the mutagenic primer caused by poor 
synthesis of the oligonucleotide. It was therefore surprising to find that all of the 
secondary mutations occurred at sites distal from the mutagenic oligonucleotide. 
These mutations were either a single base change, single base insertion or single 
base deletion. The most likely explanation for such random mutations was T7-DNA 
polymerase errors during the in vitro second strand synthesis. It is unlikely that the 
uracil emiched ssDNA template was at fault since no two mutations occurred at the 
same site. The reason for the T7 DNA polymerase errors is unknown. What remains 
clear is that for any mutagenesis reaction using similar methods it is essential to 
perform complete sequencing of the gene of interest for every construct synthesised. 
5.4 Crude extract analysis of HSV -1 dUTPase mutant enzymes 
5.4.1 Introduction 
Experiments were conducted to test the feasibility of analysing the dUTPase 
mutant enzymes in crude extracts. It was recognised that the bacterial host dUTPase 
would exhibit background activity in this type of analysis but at this stage it was 
reasonable to suggest that this could be measured effectively in control experiments. 
5.4.2 Expression 
The 16 sequenced UL50 mutant constructs were transformed into the E.coli 
BL21 (DE3)pLysS strain allowing expression under the T7 promoter (see Section 
5.1.4.4). 100ml cultures were grown up from glycerol stocks of transformed bacteria. 
These were induced and expressed according to Section 3.2.1(b). Lysis was performed 
by freeze thawing and extracts were assayed for dUTPase activity by the TLC method 
(Section 3.2.6). 
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5.4.3 Crude extract results 
Initial expression experiments produced a range of dUTPase activity in the 
various mutants. It was shown that the specific activity calculated for individual mutant 
constructs was variable between assays and within a narrow range compared to the 
controls. 
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Figure 5.11 Comparison of dUTPase activity in crude extracts 
Activity measurements are given for 6 mutant constructs plus a positive (pET23a1UL50) and negative 
(pET23a) control. Three readings are given for each sample representing three separate expression 
experiments. dUTPase activity is calculated as the amount of dUTP converted to dUMP in one minute 
per mg of total protein. 
Attempts were made to produce consistent activity values for the mutants by 
regulating expression. Culture growth was followed closely and IPTG induction was 
performed only when exact OD600 readings were reached. Although some progress was 
made, it became clear that crude extract analysis was not an acceptable method to 
measure small differences between mutant dUTPase constructs. 
Figure 5.11 shows data for three such expression experiments. The background 
activity from the negative plasmid only control was relatively consistent, however, 
cultures expressing recombinant HSV -1 dUTPase varied considerably between 
different expression experiments. The wt positive control could not be standardi ed by 
this method with activities ranging from 10 Onrn 01 mg-Imin°l (Assay 1) down to 
44nmol mg"lmin-1 (Assay 2). There is a reasonable level of consistency in many of the 
mutants assayed such as 3YIOOA and 3YlOOS. Unfortunately these data are not 
sufficient to analyse the mutant enzymes with any degree of precision due to the small 
range between the negative and positive controls. 
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In every assay a control was set up containing all the reaction components 
except enzyme. This was used to calculate any background degradation of the dUTP 
substrate and was subtracted from the results shown. In this respect, the activity 
measured for the negative control is due entirely to the E.coli host dUTPase. This 
background is high compared to the positive control representing approximately 30% of 
the wt value on average. This results in a relatively small measurement window for the 
mutant enzymes. Although sampling errors would be reduced by multiple assays the 
apparent lack of range is not applicable to the measurement of mutants, especially those 
expected to generate only modest activity changes. This is compounded by instability 
in the top range of the measurement window as seen in mutant XT273S and the wt 
control. 
From the results shown it is apparent that the mutant XT273S consistently 
exhibits activity greater than the wt HSV-l dUTPase. However, it was later determined 
that this result was a product of the sampling method and not a mutation which was 
more efficient than the wt. Purification studies show this mutant actually exhibits 85% 
ofwt activity (Section 5.5.4). Similarly mutant XW275A consistently exhibited activity 
close to background whereas detailed purification and quantification of this mutant 
demonstrated that it possesses 29% ofwt activity (Section 5.5.4). 
The most significant difference between the crude assay data presented here and 
the detailed analysis presented later in Section 5.5 was the method by which specific 
activity is calculated. In crude extract analysis, enzyme activity is measured in terms of 
total bacterial protein. In order to compare extracts in this way it must be presumed that 
the fraction of total protein which is HS V-I dUTPase remains constant between 
expression experiments. Subsequent comparison of activities calculated from crude 
extracts compared to purified enzyme demonstrated that this was not the case. 
5.4.4 Discussion 
The literature contains many examples of experiments where the activity of 
mutant enzyme constructs expressed in E. coli are measured directly in crude extracts. 
The initial line of investigation in this study was to employ a similar methodology for 
the HSV-I dUTPase mutants allowing a fast resolution of results. Although efforts 
were made to overcome the problems, clearly crude extract analysis is not compatible 
with this expression system. 
It was noted that E.coli transformed with only the control plasmid, pET23a, 
grew faster than cultures expressing recombinant HSV -I dUTPase from plasmid 
pET231UL50. This gave a direct indication that recombinant expression was mildly 
toxic to the host bacteria. This could potentially create positive selection pressure for 
any bacteria harbouring plasmids which are deficient at expressing the recombinant 
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protein. It is likely in large bacterial cultures grown over long periods that these non- or 
low-expressing bacteria would outgrow the high expressing bacteria to some degree. 
This effect would be amplified by the use of starter cultures. 
This problem arose due to the fact that even in the absence of IPTG, there was 
still a low level of recombinant expression. This leaky expression was caused in this 
system by low level expression of T7 RNA polymerase from the lacUV5 promoter in 
the pLysS lysogen and subsequent transcription of the UL50 gene. This may explain 
why several rounds of selective single colony isolation, fresh transformation plus the 
discontinued use of overnight starter cultures improved culture growth consistency. 
Cultures grown to saturation, such as overnight cultures, contain large amounts 
of ~-lactamase from the bla gene in the pET plasmid (Studier et aI., 1990). If such a 
culture is then used to inoculate a larger flask, much of the ampicillin in the media can 
be destroyed. Since there is selection for bacteria carrying the pET plasmid only when 
there is a source of ampicillin there may be a resultant outgrowth of bacteria deficient in 
the pET plasmid completely. 
It is likely that these effects contributed significantly to the variability seen in 
the crude extract analysis. Aside from expression itself, further effects would be 
incorporated due to the variation in soluble enzyme recovery. It is probable that this 
property resulted in the misleading mutant data shown in Figure 5.11. Mutant XT273S 
showed consistently higher activity than the wt enzyme. Subsequent purification and 
quantification of this mutant revealed that there was up to a 3 times greater recovery of 
soluble enzyme compared to the wt HSV-I dUTPase. This suggests that the mutant 
dUTPase from this construct may be either expressed to a higher percentage of total 
bacterial protein or is more soluble than the wt enzyme. The activity result is therefore 
explained since crude extract comparison calculates activity in terms of total soluble 
protein. Likewise mutant XW275A appears to have a lower recovery than the wt 
enzyme and may be expressed to a lower degree or is more insoluble than the wt. 
Crude extract analysis is therefore measuring three distinct variables: enzyme activity, 
enzyme expression and enzyme solubility. To separate these three factors it was 
necessary to perform activity analysis on purified quantifiable enzyme. 
Since purification of the wt HSV-I dUTPase had been reasonably well 
optimised (Section 5.2) it was decided to employ the same methodology with a 
selection of mutant enzymes. 
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5.5 Detailed analysis of HSV -1 dUTPase mutant constructs 
5.5.1 Introduction 
In order to perform activity analysis in a more controlled environment, attempts 
were made to purify and quantify the recombinant HSV-I dUTPase enzymes. 
Purification of the mutant enzymes was based on the methodology used for the wt 
enzyme (Section 5.2). These enzymes were then quantified by SDS-PAGE allowing 
accurate comparison between each mutant. 
5.5.2 Purification of HSV -1 dUTPase mutants 
To produce sufficient quantities of the mutant HSV-I dUTPase constructs for 
purification, multiple 300ml cultures were grown up in 21 flasks. It was noticed that 
bacterial growth varied considerably for different mutant cultures inoculated at the 
same time and in the same incubator. After consultation with A.-C. Bergman on this 
matter it was discovered that three rounds of single colony selection of E.coli 
BL21(DE3)pLysS followed by fresh transformation with the appropriate mutant 
plasmid improved growth consistency. This method, although time consuming, was 
effective and therefore used for all subsequent expression experiments. 
Initially extraction and purification was performed according to the method of 
O. Bjomberg et al. (1993). The low purity of the recombinant enzymes purified in this 
way presented a major problem. SDS-PAGE revealed multiple bands and evidence of 
protease activity. The majority of mutants purified by this method were deemed 
unacceptable for activity analysis. As attempts were being made to improve the 
existing method, details of the new method became available. Five mutant enzymes 
plus a wt control were extracted and purified according to the modified method as 
detailed in Section 5.2.2. The combination of the highly selective chelator extraction 
plus Mono S chromatography allowed these samples to be purified to a high degree. 
5.5.3 Quantification of HSV -1 dUTPase mutants 
Correct measurement of specific enzyme activity was shown to be highly 
significant in this analysis. There were many variables which had to be considered. 
Firstly expression levels varied between mutants therefore total protein calculation 
could not be used. Standard Bradford assays of the purified sample could not be used 
due to the variability of the extraction, solubility and overall purification of the mutant 
extracts. In order to achieve direct comparison between purified mutant extracts it was 
decided to use SDS-PAGE visualisation. Purified samples were mixed with a standard 
quantity of BSA. Doubling dilutions of these solutions were loaded and run on SDS-
PAGE gels. The proteins were visualised by staining the gels with Coomassie brilliant 
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blue R250 solution (Section 3.2.3). Purified enzyme was then directly compared to the 
BSA standards by eye and quantified on this basis (Figure 5.12). 
Gel A GelB 
2 3 4 5 6 7 2 3 4 5 6 
Figure 5.12 Quantification ofHSV-1 dUTPase by SDS-PAGE 
Gel A shows SDS-PAGE of HSV-l dUTPase mutant 5F366Y compared to BSA standards. Lanes 2-7 
show doubling dilutions of BSA standards (black arrow) compared to purified dUTPase (red arrow). Gel 
B shows quantification of mutant XT273S by the same method. The green arrow highlights additional 
bands in this extract indicating a reduction in purity compared to Gel A. This method allows the 
quantification of both the pure sample, Gel A, and the impure sample, Gel B, by allowing a direct vi ual 
comparison of the recombinant dUTPase against the BSA standards. 
The SDS-PAGE method allowed direct quantification of soluble HSV-1 
dUTPase. The two samples shown in Figure 5.12 have a large variation in overall 
purity. Determination of total protein content in these two extracts would not give a 
true indication of the amount of recombinant dUTPase present. This visual method 
allowed direct quantification and therefore correct calculation of specific activity even 
when samples had contaminating protein. 
5.5.4 Specific activity of HSV-l dUTPase mutants 
The method described above for quantifying recombinant enzyme requires the 
production of a good quantity of pure samples. Unfortunately with many of the enzyme 
extracts this was difficult to achieve. The majority of mutants purified by the original 
two-stage column method could not be quantified by the SDS-PAGE method. 
Although enzyme activity was measurable and could be calculated in terms of activity 
per mg of protein, these values were regarded as unreliable. As mentioned previously, 
the relative amount of recombinant HSV-1 dUTPase compared to total protein was 
variable between extracts. The new method for purification based on selective buffer 
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solubility and Mono S chromatography provided enzyme quality much more applicable 
to this quantification method. 
Six HSV-I dUTPase samples were in a state pure enough to allow 
quantification by the SDS-PAGE method. These enzymes expressed well and could be 
easily visualised by SDS-PAGE after purification. Their activity was measured and 
expressed as units per mg of soluble enzyme. Direct comparison between these 
enzymes is given as a percentage ofwt activity (Table 5.3). 
HSV-ldUTPase Code Specific activity • %wt 
construct J.UIlol mg·1 min' I 
WT 18-56 18.7 100 
NC76A 36-11 16.3 87 
XT273S 27-5 15.9 85 
5F366Y 28-5 5.8 31 
XW275A 33-5 5.4 29 
5F366A 34-6 0.17 0.9 
Table 5.3 Activity of purified HSV -1 dUTPase mutants compared to wt 
Activities were calculated by measuring the conversion of [ 3H]dUTP to [ 3H]dUMP (Section 3.2.6) and 
quantification of soluble enzyme was performed as in Figure 5.12. In the nomenclature of NC76A, "N" 
refers to Non-motif since this mutation lies out with any of the conserved motif regions. 
• Note specific activity is measured as the amount of dUMP formed per mg of recombinant HSV-l 
dUTPase per minute. 
The activities of these mutants occupies a wide range from close to wt levels 
down to less than 1 % of wt. Mutant NC76A lies out with the expected active site 
region and was used as a control while the remaining four mutants were designed to 
affect what were thought to be key residues in the HSV-I dUTPase enzyme. These 
mutations are described graphically in the following Section 5.8. 
5.5.5 Discussion 
Efficient separation of the mutant dUTPase enzymes from the bacterial host 
enzyme was achieved by the purification method. E.coli dUTPase is highly soluble in 
the extraction buffers used and would be separated by the chelator fractionation. 
Further confidence is gained from the Mono S purification stage where the E. coli 
dUTPase would not be retarded on the column. Activities calculated can therefore be 
attributed directly to the recombinant enzymes. 
As proposed with the crude extract results, expression levels between individual 
mutants varied considerably. In order to study these enzyme preparations on 
comparable level it was necessary to devise a method of quantification. SDS-PAGE 
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visualisation allowed not only a direct comparison of the enzymes as a single band, it 
also provided an indication of purity directly before activity was measured. This later 
point was of obvious importance since purified enzyme could fall out of solution on 
storage. 
5.6 Truncation of the HSV -1 dUTPase C-terminal region 
5.6.1 Introduction 
Truncation of the HSV -I C-terminal region was used as a quick method to test 
the potential function of the conserved motif 5 region. Data from these experiments 
preceded the site directed mutagenesis studies and gave the first indication of the 
importance of the C-terminal tail in the class II dUTPases. A summary of the methods 
and results is given. 
5.6.2 Truncation of HSV -1 UL50 by peR 
Truncation of the C-terminal portion of HSV-l dUTPase and subsequent 
deletion of the motif 5 region was accomplished by PCR mutagenesis. Four 
oligonucleotide primers were designed to amplify two truncated forms of the UL50 
ORF (-16 and -32 uu) and one full length control. 
~----------------------------------~ I HSV-l UL50 
Tl. 5' (GT)3 CAT ATG AGT CAG TGG GGA TCC GGG GCG 3' 
NdeI 
T2. 5' (GT)3 AAG CTT eTA AAT ACC GGT AGA ACC AAA ACC 3' 
HindIII 
T3. 5' (GT)3 AAG CTT eTA CTC CGC GTC AAA CTC GTT CGT AAA 3' 
HindIII 
T4. 5' (GT)3 AAG CTT eTA TTC GGC GGT TGA GTC CGG AAC ACC 3' 
HindIII 
Figure 5.13 Oligonucleotide design for HSV-I UL50 truncations 
Four oligonucleotides were designed with (GT)3 tails for efficient restriction digestion. Tl corresponds 
to the 5' end ofUL50 and incorporates an NdeI site (underlined) at the start ATG codon. T2 corresponds 
to the 3' end of UL50 with the natural stop codon (bold) followed by a HindIII site. T3 and T4 
correspond to the deletion of 16 and 32 C-tenninal residues respectively by the insertion of an engineered 
TAG stop codon into the ORF (reverse complement CTA shown in bold). These oligonucleotides were 
also flanked by a HindIll restriction site. 
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PCR products were successfully obtained for the primer pairs TIff2 full length 
UL50 (Trunc-O), TIff3 deletion of 16 residues (Trunc-16) and Tlff4 deletion of 32 
residues (Trunc-32). These were digested with NdeI and HindlII, ligated into the 
vector pET23a and transformed into E.coli DHa. Prospective colonies were grown up 
and plasmids harvested. Restriction digest analysis confirmed that the UL50 fragments 
had been inserted correctly. 
Trunc-16 
Trunc-32 
. .... APPSERGTGGFGSTGI (C-term) 
..... PRNPPLL VFTNEFDAEAPPSERGTGGFGSTGI (C-term) 
Figure 5.14 Regions deleted by PCR truncations 
Figure shows the residues deleted from the HSV -1 dUTPase by the insertion of an engineered stop codon 
into the UL50 ORF. The position of motif 5 is shown in yellow. 
5.6.3 Expression and analysis of truncated constructs 
The truncated constructs plus the wt PCR control were transformed into 
BL21(DE3)pLysS bacteria and expressed according to Section 3.2.l(b). To determine 
the initial activity of these mutants, dUTPase assays were performed on crude extracts 
of the two truncated enzymes plus the wt PCR control. No measurable activity was 
found in either of the truncated proteins Trunc-16 or Trunc-32. The wt HSV-l 
dUTPase generated by this PCR method, Trunc-O, exhibited activity corresponding to 
the original pET23a. 
Extracts of Trunc-O and Trunc-16 were semi-purified using the selective buffer 
method (Section 5.2.3) and visualised by SDS-PAGE. Bands were identified 
corresponding to the full length HSV -1 dUTPase for Trunc-O plus a smaller band 
corresponding to the Trunc-16 construct. 
The position of truncation, Trunc-16, can be visualised in the human dUTPase 
structure in Section 5.8 (Figure 5.16a). The 11 terminal residues are shown as a 
wireframe representation and constitute the homologous area that is deleted in the 
shorter of the two truncations (5 C-terminal residues not visible in human structure). 
Using this structure as a model for the HSV-l dUTPase, removal of this portion of the 
enzyme can be seen to expose the substrate to the solvent. It is likely that a catalytic 
environment cannot be achieved without motif 5 and therefore accounts for the 
complete activity loss seen in both truncated HSV -1 dUTPases. 
5.6.4 Discussion 
Truncation of the C-terminal region was performed before data were available 
for the motif 5 mutants. Analysis of one such mutant, 5F366A, in Section 5.5.4 
demonstrated that it possessed less than 1 % of wt activity. Given that this effect was 
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realised by the substitution of a single amino acid in motif 5, it is not surprising that 
deletion of the entire motif 5 region resulted in the expression of truncated proteins with 
no detectable activity. 
Although these truncations proved to be crude in the light of the single residue 
mutations, they were advantageous in highlighting the importance of motif 5 at an early 
stage. The PCR method employed to generate these truncations by deletion of coding 
nucleotides at the terminal end of UL50 proved to be very efficient. Using the same 
strategy it would be of interest to generate more subtle deletions of the C-terminal 
region ranging from 1 to 15 C-terminal residues. This would be a quick way to 
investigate how much of the C-terminal region was required for efficient binding and 
hydrolysis of dUTP. It is likely that a specific truncation would give partial activity. 
This would be a very interesting mutation to obtain kinetic data by stopped-flow 
analysis in order to determine the role of this region in binding and/or catalysis. Further 
experiments were explored with the truncated proteins generated in this study and are 
detailed in the following Section 5.7. 
5.7 Analysis of the C-terminal region with oligopeptides 
5.7.1 Introduction 
A facility in the MRC Virology Unit existed for the synthesis and purification of 
oligopeptides. It was decided to utilise this technology to generate peptides for the 
analysis of the C-terminal region of HSV -1 dUTPase. Previous studies by SDM and 
PCR truncation had demonstrated that this region was important by modifying the 
activity of the enzyme (Sections 5.5 & 5.6). 
The rationale behind the use of peptides was based on the model created for the 
HSV-l dUTPase detailed in Chapter 4. It was envisaged that the C-terminal region acts 
as a flexible clamp, only adopting defmed tertiary structure when the substrate is 
situated in the binding site. If this was indeed the case it is possible that short peptides 
corresponding to the C-terminal tail could disrupt this clamping action by competing for 
the site normally occupied by the tail. It was envisaged that soluble peptides might 
interact at the active site region containing bound dUTP thus preventing the C-terminal 
arm adopting the tertiary structure necessary to complete hydrolysis of the dUTP. 
5.7.2 Design and synthesis ole-terminal peptides 
Five peptides were synthesised corresponding to the C-terminal region of 
HSV-l dUTPase. Each peptide was 16 residues in length and overlapped the adjacent 
peptide by 8 residues (Figure 5.15). The peptides were analysed by HPLC to determine 
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their purity. Peptides 1,2 and 4 had initial purities of 92%, 95% and 96% respectively. 
Peptide 3 (60%) and 5 (69%) were re-purified to over 90% by HPLC. Peptide 3 was 
found to be insoluble in water and although it could be successfully solubilised in 
ammonia it was not used in this study. Lysophilised stocks of the other 4 peptides were 
frozen and reconstituted in water at a concentration of Imglml before use. 
--------.,------------------------------, 
C-terrninal region of HSV -1 dUTPase 
------- -'---------------------,-----------1 
APPS ERGTGGFGSTGI 
Peptide 1 
Figure 5.15 Oligopeptide design for HSV-l UL50 C-terminal region 
Five oligopeptides were synthesised corresponding to the primary sequence of the HSV -1 dUTPase C-
terminal region. Peptides were 16 residues in length and overlapped the adjacent peptide by 8 amino 
acids. The motif 5 region is highlighted in yellow showing that the entire motif is present in Peptide 5. 
5.7.3 Analysis of peptides with HSV -1 dUTPase 
Purified wt HSV-l dUTPase was used to determine the effect of the generated 
peptides. Several approaches were used in an attempt to modify enzyme activity by the 
addition of the peptides in solution. Initially wt enzyme was assayed by standard 
methods (Section 3.2.6) to give a stable activity of 50% conversion of dUTP to dUMP 
in 10min at 37°C. The assay was then performed with single peptides added to a fmal 
concentration between 0.5-50 ~glml. No effect was found in these experiments. 
Experiments were then performed at much increased peptide concentrations. 
Purified wt enzyme was diluted to give dUTP conversion values in the region of 10-
15%. Single peptides were then added at a concentration of 800~glml. Control 
experiments were carried out without peptide and also with the substitution of peptide 
with BSA at 800~glml. Again no effect was detected with the peptides at this higher 
concentration. 
5.7.4 Analysis of pep tides with HSV-1 dUTPase C-terminal truncations 
An experiment was designed to test the effect of peptides in truncated versions 
of the HSV -1 wt. The rationale behind this was based on supplying the truncated 
enzyme with peptides in solution corresponding to the deleted sections. It was 
envisaged that if the peptides could mimic the C-terminal section of the HSV-l 
dUTPase in solution then they might restore a low level of enzyme activity. Various 
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concentrations of the mutant Trunc-16 and the peptides were tested but there was no 
detectable restoration of enzyme activity. 
Peptide 5, containing the motif 5 region, was tested in similar experiments 
combined in solution with mutant 5F366A. This mutant had been purified to such a 
degree that although it only exhibited 1 % of wt activity this could be easily measured in 
standard reactions. It was thought that the addition of a correct version of motif 5 in the 
form of a peptide in solution might increase the activity of the mutant. Again no 
activation was seen at peptide concentrations up to 500Jlg/ml. 
5.7.5 Discussion 
Peptide inhibition studies have generally been targeted at the disruption of 
interactions between distinct protein subunits. In this type of study there is usually a 
clear and identifiable region of protein-protein interaction for which peptides can be 
generated to interact. In the case of HSV-l dUTPase it is not clear if there is a real 
protein-protein or protein-substrate interaction between the C-terminal region and the 
active site area. However the crystal structure of the human dUTPase showing the C-
terminal arm clamping down on the substrate in the active site merited these peptide 
experiments. Given the high homology of motif 5 between the human and HSV-I 
dUTPases, and indeed all the other class I and II dUTPases, it is not unreasonable to 
predict a similar mechanism. 
The peptides used in these experiments were all 16 amino acids in length. It 
was hoped that this would allow high quality synthesis yet still provide an adequate 
length for the formation of a tertiary conformation. From the E.coli crystal structure 
data it is presumed that the C-terminal 16 residues are disordered and only form a 
dermed structure when dUTP is bound in the active site. Since the reaction products of 
the hydrolysis of dUTP could not leave the active site until this arm becomes disordered 
again, it is likely that the formation of a tertiary clamping structure is an extremely 
fleeting event. Ifa similar case exists in the HSV-I dUTPase then the probability ofa 
peptide ordering itself over the newly bound substrate before the C-terminal arm has a 
chance to clamp may be extremely small. This would essentially mean that any 
modification of enzyme activity would be undetectable by standard methods. 
It is unfortunate that these peptide studies did not produce any insight into the 
mechanism of the HS V -I C-terminal region especially since previous experiments 
demonstrated the importance of this region in catalysis. It may prove worthwhile to test 
these peptides using the more rigorous methods of stopped-flow analysis. 
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5.8 Interpretation of HSV -1 dUTPase mutant data 
5.8.1 Introduction 
The results from Chapter 4 on the modelling of the class II dUTPases allow the 
interpretation of the mutagenesis data in a structural context. The HSV -I mutant 
dUTPase data given in the previous sections stem from two distinct target regions: the 
C-terminal tail containing motif S and the class II specific motif X. The specific 
activity data allow a basic indication of the importance of the mutated residues relative 
to the reduction in activity compared to the wild type enzyme. It does not however 
offer any insight into the mechanism of this effect. To address this, the class II 
modelling data were amalgamated with the experimental mutagenesis data. This 
section is divided between the motif 5 mutants and the motif X mutants. 
5.8.2 Interpretation of the motif 5 mutagenesis data 
Chapter 4 demonstrated the likelihood of the class II active site closely 
mirroring the class I active site. Based on this assumption the class I structural data 
were used as a basic model for the class II active site. Previous to the publication of the 
human dUTPase structure there was no data available for the C-terminal region 
encompassing motif S. Its role in the function of dUTPase was not clear and the HS V-I 
mutagenesis target Phe366 was chosen based on its high sequence conservation 
between the two classes. In the class I dUTPases the motif S Phe is conserved almost 
completely throughout the group (see class I alignment Figure 4.1). The only notable 
exception to this is the FIV dUTPase where the motif 5 Phe has been substituted for a 
Tyr. The motif S Phe is also highly conserved in the class II dUTPases. This is seen in 
the class II alignment shown in Figure 4.7. From the ten species shown only HVS does 
not carry a Phe in motif S where it is substituted by a Leu. 
Based on the primary sequence data two mutations were selected at the HS V -I 
Phe366 locus. A conservative mutation to Tyr (SF366Y) was made on the basis that 
this substitution already exists in nature in the class I FIV dUTPase. In order to assess 
the possible role of a the Phe aromatic ring structure in the functioning of the active site 
it was decided to remove the entire side chain by substitution to Ala (5F366A). To gain 
a visual perspective of the likely function of this residue the human dUTPase structure 
was used to represent the HSV-I mutations. Figure 5.16 shows the position of the 
conserved Phe in relation dUDP bound in the active site. 
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(a) (b) 
(c) (d) 
Figure 5.16 The human dUTPase active site as a model for HSV-l mutagene i 
Four diagrams of the human dUTPase co-crystallised with dUDP. Figure (a) shows the position of the -
terminal tail in relation to the active dUDP. The 11 terminal residues are hown in wir frame 
representation. Figures (b, c and d) are all shown from the same perspective with the viewer looking out 
from the active site cavity towards the bound substrate. Figure (b) shows the wild type ituation where 
the C-terminal tail (yellow) reaches over to cap the active site. The side chain of the motif 5 re idu 
Phe135 (equivalent to HSV-l Phe366) can be seen stacking over the uracil ring of dUDP. Figure (c) 
shows the mutation of this Phe to a Tyr (equivalent to HSV-1 mutation 5F366Y) and (d) to an Ala 
(equivalent to HSV-l 5F366A). 
The human dUTPase structure is a useful model given the main section of the 
C-terminal tail, including motif 5, becomes ordered in the crystal structure with bound 
dUDP. The terminal 5 residues remain unordered but since the fmal residue, Gly136, 
constitutes the C-terrninal span of motif 5, the structure encompasses the mutation sites. 
Figure 5.16(a) shows the position of the C-terrninal tail relative to the substrate. Figure 
(b) shows the side chain ofPhe135 (top left in yellow) acting as a 'Phe-lid' by stacking 
on the uracil ring of dUDP. It was proposed by C. Mol et al. (1996) that this 
conformation may hold the uracil in the appropriate position for cataly is while 
excluding water from the active site. In support of the importance of this interaction the 
same group reported that mutation ofPhe135 to an Ala in the human dUTPase re ulted 
in greatly reduced activity. Based on the class II model in Chapter 4 it is pre urned that 
this conserved motif 5 Phe has a homologous function in the HS V-I active site. 
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Figure 5 .16( c) represents the mutagenic substitution of the HS V-I motif 5 Phe 
to a Tyr (5F366Y). The precise torsion angle of the Tyr side chain cannot be 
detennined in this model but it is proposed to stack on the uracil ring in a homologous 
position to the wt Phe. In physicochemical tenns the difference between the wt and 
mutant side chains is the addition of a hydroxyl group in Tyr compared to Phe. Since 
the aromatic ring is conserved, only minimal disruption to enzyme activity was 
predicted by this substitution. It was therefore surprising that the 5F366Y mutation 
resulted in an activity drop of almost 70% compared to wt. There are several possible 
mechanisms for this reduction. It is clear that Phe is an important residue for the 
correct functioning of the active site. It is possible that even a small torsion angle 
change as represented by the shifted aromatic ring in Figure 5.l6(c) is sufficient to 
incorrectly position the uracil ring of the substrate and therefore reduce catalytic 
efficiency. The additional hydroxyl group of Tyr may also create a steric clash with the 
surrounding cavity edge and disrupt ordering of the tail. Given that the hydroxyl group 
of Tyr is potentially reactive it is also possible that the hydroxyl may participate in 
hydrogen bonding and hinder the release of cleaved substrate. This latter point is of 
potential significance since the reaction product dUMP is a competitive inhibitor. 
Figure 5.16(d) represents the mutation 5F366A where the stacking aromatic ring 
structure is removed completely. The resultant activity drop to under 1% of wt was 
expected in the light of the substantial activity reduction in the more conservative Tyr 
substitution. Loss of the aromatic ring most likely results in positional instability of the 
substrate due to the absence of the uracil moiety clamping mechanism. Figure 5.16(a) 
shows the position of the conserved Phe in the human active site viewed from the 
solvent. From this angle it can be visualised that removal of the bulky Phe side chain 
may also increase the likelihood of solvent penetration into the active site. In fact what 
is most interesting about this mutation is that it results in an enzyme with any activity at 
all. This supports the role of the conserved Phe as a secondary effector and not as part 
of the cleavage mechanism. Overall these data highlight the role of motif 5 in capping 
the active site and creating an efficient catalytic environment. 
5.S.3 Interpretation of motif X mutagenesis data 
Mutagenesis of the motif X region was based on primary sequence conservation 
within the class II dUTPases. The motif X alignment in Figure 4.23 demonstrates that 
HSV-I residue Trp275 is totally conserved between the ten class II species shown. 
Since the functional significance of motif X is unknown it was decided to substitute 
Trp275, the largest conserved side chain in motif 5, to an Ala. The thinking behind this 
mutation was to disrupt any function of motif X while maintaining the correct 
confonnation of the dUTPase active site region. 
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The other target in the motif X region was Thr273 which is conserved among 
seven of the ten class II species in alignment Figure 4.23. This residue is substituted 
by Val, Cys and Ser in EHV-2, EBV and HVS respectively. The mutation XT273S was 
chosen in order to substitute the conserved Thr273 with the residue Ser already found in 
nature. This target was selected in order to make a more subtle change to motif X. 
There was a potential hazard with making a large substitution, as in Trp275 to Ala 
since the structural significance of the residue could not be determined. Motif X lies 
between motifs 4 and 5 and therefore any dramatic local structural change could 
potentially cause misfolding. Based on these assumptions it was decided to select one 
radical change (XW275A) and one conservative change (XT273S) for comparison. 
Motif X is specific to the class II dUTPases and therefore cannot be visualised 
using the class I structures. In order to get some representation of the function of motif 
X and its relation to the mutagenesis data it is necessary to utilise the class II model. 
Figure 5.17(a) shows the predicted position of motif X (coloured red) in the class II 
model. Secondary structure predictions using the Threader program demonstrated that 
this motif region is structurally related to motif 3 (Section 4.7.4) and is shown as such 
in the model. Figure 5.17(b) gives a more detailed representation of the Swiss-Model 
ProMod prediction of the motif X loop region (Section 4.7.5) and the position of the 
two mutation targets XT273S and XW275A. 
(a) (b) 
Figure 5.17 Graphical visualisation ofthe HSV-l motif X mutations 
Figure (a) shows the class II model with the position of motif X highlighted in red. Note that it i in th 
opposite side of the molecule from the active site region. Figure (b) shows the motif X region as 
predicted by the wiss-Model ProMod program. The backbone is highlighted in yellow with the ide 
chains of Thr273 and Trp275 highlighted in green. 
The data gained from the Threader and Swiss-Model programs in Section 4.7 
provide some e idence that the motif X region forms a loop structure. Using these 
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predictions directly the position of the mutations can be superimposed on a model loop. 
The Swiss-Model prediction for the motif X region is shown in Figure 5.17(b). In this 
model, residue Trp275 is situated at the bottom of the loop in the equivalent position to 
Tyr at the base of the motif 3 loop. The residue Thr273 would therefore occupy a 
position on one of the ~-strands close to the bottom of the loop. As mentioned in 
Section 4.7, the predicted motif X loop is quite similar to the class I motif 3 loop 
(Figure 4.4) with a bulky ring side chain pointing inwards at the base of the loop. 
The mutagenesis data demonstrate an activity reduction of 15% for XT273S and 
70% for XW275A compared to wt HSV-l dUTPase. This result is consistent with a 
dramatic residue substitution and a conservative substitution respectively. 
Interpretation of these results in the structural model is difficult. It is however 
interesting that the removal of the largest side chain in motif X results in an enzyme 
which still produces 30% ofwt activity. Comparing this to the motifS mutations above 
suggests that motif X does not play any role in the conversion of dUTP to dUMP. The 
reason for the activity reductions may be due to minor alterations in the folding of the 
protein although further investigation is necessary. 
5.8.4 Discussion 
The data gained from the mutational analysis of the HSV-l dUTPase were 
investigated in a structural context. This allowed a basic insight into the possible 
mechanisms for the reduced activity seen in these mutants. The class I human dUTPase 
structure was used to model the class II motif 5 mutations. This was based on the 
assumption that a homologous active site region is shared between the two classes. 
This is backed up by the mutational analysis of the highly conserved Phe residue in the 
motif S region. From the data it is likely that the HSV -1 C-terminal arm, encompassing 
motif 5, possesses a similar active site capping mechanism to the class I dUTPases. 
Further mutagenesis is required to test the functions of other highly conserved motif 5 
residues but it is likely that a full understanding of this region will only become 
possible with the addition of a class II crystal structure. 
This latter point is also true of the class II specific motif X. Although modelling 
can be used to enhance the mutagenic data, without a structure or defmed function the 
details of this area of the class II dUTPases remain unresolved. There is not yet a 
sufficient quantity of mutagenesis data to determine if the motif X region is a separate 
functional locus from the dUTP hydrolysis site. The data show however that 
substitution of the highly conserved Trp residue, constituting the removal of the largest 
side chain in this motif, results in an active enzyme possessing 30% ofwt activity. It is 
tempting to suggest therefore that the motif X region has a separate function, but again 
further investigation is required. 
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Chapter 6 - Final Discussion 
The dUTPase of HSV-I belongs to a distinct structural subset encoded 
specifically by the (l- and y-herpesviruses. Although four members from the class I 
dUTPase trimers have been crystallised there is no available structure for any member 
of the class II monomers. Attempts to crystallise the HSV-l dUTPase have been 
severely compromised by the poor solubility of the recombinant enzyme expressed in 
E.coli. Several groups are now involved in recombinant expression and crystallisation 
trails of VZV and EBV dUTPases. 
In order to investigate the HSV -I dUTPase it was decided that a structural 
model was necessary. Since no structural data was available for the class II dUTPases 
the model was based on the evolutionary relationships with the class I enzymes. The 
model therefore encompasses the class I structures of E.coli, FIV, EIAV and human to 
arrive at a general structural arrangement for the class II dUTPases. Analysis of the 
class I enzymes allowed not only the characterisation of elements which produced 
overall tertiary structure but also the functional roles of specific residues at the active 
site. The structural similarity within a group containing dUTPases from such diverse 
species was startling especially since no other enzyme has yet been described with an 
active site consisting of regions from all three subunits of a trimer. It can be concl uded 
that these enzymes have evolved to maximise structural integrity, catalytic efficiency 
and substrate specificity. The class I dUTPase therefore provides a strong basis for the 
modelling of the class II enzymes which are most likely variants which have diverged 
from an ancestor common to both classes. 
The class II dUTPases proved to be substantially heterogeneous compared to 
the class I enzymes and the model had to be flexible enough to accommodate these 
differences. Analysis at the primary sequence level provided a method for directly 
comparing the two classes. This was achieved by generating a class I doublet sequence 
and applying different alignment methods. Secondary structure predictions revealed 
that the overall structure of the class II monomer approximated two copies of the class 
I subunit structure joined as a single protein chain. This led to the hypothesis that the 
intragenic duplication had effectively duplicated the class I subunit structure to produce 
a functionally active monomer. This model was supported by hydrophobic modelling 
data. An evolutionary pathway was described whereby dUTPase functionality could be 
maintained utilising a dimer intermediate. Although this model satisfies the criteria for 
assembly of a functional active site it does not directly address the question as to why 
the herpesviruses have adopted a different structural arrangement compared to the 
diverse class I species. 
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Investigation into a conserved region between the class II dUTPases and the p-
herpesvirus homologues (motif X) provides a possible solution. From a general 
energetic point of view it appears that the provision of a trimer with three active sites is 
more favourable that a monomer representing the mass two subunits generating only 
one active site. Additionally it is noted that the p-herpesvirus do not encode their own 
dUTPase and are presumed to utilise the cellular class I enzyme. As previously 
discussed, the replicating environment is presumably critical in terms of the necessity 
for a virally encoded enzyme. What is interesting is that not only do the (l- and y-
herpesviruses not utilise the cellular class I dUTPase, or encode a class I enzyme like 
several other virus families, but they encode a substantially variant form. The 
properties of this enzyme that make it evolutionarily more advantageous remain 
unclear. What is apparent is that the class II variant takes up double the genome space 
and is predicted to be less energetically favourable that the class I version. 
It is possible that the class II dUTPases perform an unknown function 
specifically related to the replication of these herpesviruses. It is also possible that the 
motif X region in the p-herpesvirus dUTPase homologues represents a functional site 
in a protein without dUTPase activity. If this was indeed the case the class II molecule 
could potentially possess dual functionality, satisfying the conservation pressure 
inherent in the double length monomer. To investigate this theory further, this region 
was targeted for modelling and mutagenesis studies. 
The absence of any class II structural data make local prediction difficult. The 
three methods used (secondary structure prediction, protein fold threading and primary 
sequence homology modelling) arrived at a general consensus but this is not enough in 
itself to predict potential function. Motif X was predicted to be structurally related to 
the ancestral motif 3 despite the almost complete lack of primary sequence similarity. 
In the dUTPase active site, the motif 3 loop is the basis for nucleotide binding and 
specificity. If there was an additional function attributable to motif X, nucleotide 
binding would be a potential candidate. Mutagenesis of this region modulated 
dUTPase activity relative to the severity of the residue substitution and although a 
structural prediction exists, the effect of these mutations on general folding were not 
determined. Without further mutagenesis data, and ideally a class II crystal structure, 
the disassociation of the motif X region from dUTPase activity cannot be substantiated. 
Investigation of the replication machinery of HSV -1 has revealed many 
interactions between specific enzymes. An extension of this localisation is seen in 
bacteriophage T4 in which enzymes involved in nucleotide metabolism are linked in a 
dNTP synthesising complex which may in turn be linked directly to the enzymes 
localised at the DNA replication fork. The advantages of such co-localisation are clear, 
generating DNA building blocks for replicative enzymes in a confined physical space. 
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An evolutionary step forward could be envisaged as a single enzyme involved in 
nucleotide metabolism with dual functionality. Future work involving a more detailed 
analysis of the motif X region in the class II enzymes would prove interesting, 
especially if paralleled with investigation into the J3-herpesvirus homologues. Even if 
the class II dUTPases do not posses a secondary function it would be interesting to 
reveal the function of the J3-herpesvirus homologues. 
The mutagenesis studies in this course of study highlight several potential areas 
of homologous function between the class I and class II enzymes. The class II model 
predicts an overall structural consensus for the active site regions between the two 
classes. Truncation of the C-terminal arm containing motif 5 demonstrated that this 
region was necessary for the function of the HSV -I dUTPase. Site-directed 
mutagenesis allowed these data to be refined by identifying the importance of a key 
residue which is highly conserved between the class I and class II dUTPases. Phe 366, 
the HSV -I equivalent of Phe 135 in the human dUTPase, is predicted to provide a 
homologous function to the class I enzymes. Even conservative substitution of the 
residue produced a dramatic reduction in catalytic activity. The position of this 
mutation, only six residues from the C-terminus, gives some confidence that it is not 
disrupting the overall folding of the enzyme. It is likely that this residue is conserved 
for its capping function, interacting directly with the uracil moiety of the bound 
substrate. It would be interesting to apply the circular dichroism (CD) techniques used 
by Vertessy et af. (1998) to investigate the conformational shift in the C-terminal arm 
of the E. coli dUTPase during substrate binding. Utilising CD techniques, 
conformational change of the HSV-l C-terminal arm induced by substrate binding 
could be determined. Furthermore, using the HSV -1 mutants, it could be tested 
whether this mechanism was disrupted by mutation of a single motif 5 residue. 
The existence of a substrate capping mechanism homologous to that revealed in 
the class I dUTPases prompted the investigation into peptide inhibitors. The potential 
for conformational disruption of the C-terminal arm structure was investigated. Short 
peptides corresponding to the HSV-I C-terminal sequence were combined in solution 
with HSV -1 dUTPase under varying conditions. No inhibition was found, which may 
reflect the inability of the peptides to adopt a structural conformation capable of 
disrupting the capping mechanism. However, peptide inhibitors have traditionally been 
used to disrupt subunit interaction rather than conformational folding within a single 
protein species. There are energetic barriers which must be considered since the local 
protein chain is competing with a peptide in solution. In the absence of a class II 
structure it would be interesting to apply this experiment to the class I human dUTPase. 
The structural information available for the human dUTPase C-terminal arm would 
allow a more defined approach to the design of peptide inhibitors for this region. 
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The original experimental strategy combining site-directed mutagenesis with 
crude assay analysis proved to be inappropriate for the analysis of HSV-l dUTPase. 
This substantially reduced the number of recombinant enzymes which could be tested. 
The original strategy was compromised by the inherent insolubility of the recombinant 
enzyme expressed in bacterial systems. This unfortunate property of the HS V-I 
enzyme has now been well documented by a number of groups, not least those involved 
in crystallisation trials. It is possible that continued site-directed mutagenesis studies 
will eventually produce a recombinant mutant with a higher solubility although 
crystallisation of a native class II enzyme is more valued. It may be useful in parallel 
experiments to clone and express the HSV -2 dUTPase. Although this enzyme has high 
sequence conservation with the HSV-l dUTPase, this does not preclude the possibility 
that it may be more soluble in bacterial expression systems. The advantages of a highly 
soluble class II dUTPase for general experimental analysis are clear, allowing easier 
expression, extraction, purification and kinetic analysis. 
Overall, the analysis of the HSV -1 dUTPase proved to be a useful model for the 
class II enzymes. The modelling work has allowed a more in-depth evaluation of the 
evolutionary relationships between the two classes. Although the mutagenesis studies 
did not yield as much information as was initially anticipated, the common 
functionality predicted between the two dUTPase classes by structural modelling was 
supported. 
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